WO2007149555A2 - Adjustable tension incontinence sling assemblies - Google Patents
Adjustable tension incontinence sling assemblies Download PDFInfo
- Publication number
- WO2007149555A2 WO2007149555A2 PCT/US2007/014553 US2007014553W WO2007149555A2 WO 2007149555 A2 WO2007149555 A2 WO 2007149555A2 US 2007014553 W US2007014553 W US 2007014553W WO 2007149555 A2 WO2007149555 A2 WO 2007149555A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sling
- adjustment
- spacing
- chamber
- tension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
- A61F2/0045—Support slings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00805—Treatment of female stress urinary incontinence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0012—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting elasticity, flexibility, spring rate or mechanical tension
Definitions
- the present invention pertains to improved methods and apparatus providing support to a portion of the urethra or rectum or anus to alleviate urinary or fecal incontinence and particularly to elongated slings having mechanisms for selectively adjusting the tension applied through the sling to body tissue.
- Urinary incontinence is a condition characterized by involuntary loss of urine, beyond the individual's control, due to the loss or diminution of the ability to maintain the urethral sphincter closed as the bladder fills with urine.
- Male or female stress urinary incontinence (SUI) occurs when the patient is physically or emotionally stressed. Such patients may also experience urge incontinence.
- Fecal incontinence is a condition characterized by involuntary defecation or passage of feces through the anal canal due to injury to or weakness of one or more of the internal anal sphincter, the external anal sphincter, and the levator ani.
- Implantable urethral and anal prosthetic sphincter systems have been disclosed in the prior art to treat incontinence that comprise an inflatable balloon that is either pillow or cuff shaped, a balloon reservoir/pressure source filled with a fluid, a pump, and interconnecting tubing.
- the balloon is implantable beneath or surrounding the urethral tract (at or near the bladder neck in female patients) or around the anal sphincter and is coupled through tubing to the balloon reservoir/pressure source and pump that are implanted subcutaneously.
- the pump may be manually actuated to inflate the balloon compress the urethral tract to prevent incontinence and to deflate the balloon to allow voiding.
- Examples of such prosthetic sphincter systems are disclosed in U.S. Patent Nos. 4,222,377, 4,571 ,749, and 5,562,598, and one such system comprises the AMS-800 Urinary Control System available from American Medical Systems, Inc.
- Urethral tapes or slings have been developed that are implanted in a urethral sling procedure in which the urethral sling is inserted beneath the urethra and advanced in the retro pubic space, perforating the abdominal fascia.
- peripheral or end portions of the elongated urethral sling are affixed to bone or body tissue, and a central support portion of the elongated urethral sling extends under the urethral or bladder neck to provide a platform that compresses the urethral sphincter, limits urethral distention, and pelvic drop, and thereby improves coaptation.
- Elongated "self-fixating" slings have also been clinically introduced for implantation in the body that do not require that the end portions be physically attached to tissue or bone and that rely upon tissue ingrowth into sling pores to stabilize the sling as disclosed, for example, in commonly assigned U.S. Patent Nos. 6,382,214, 6,612,977, 6,641 ,524, 6,648,921 , 6,652,450, 6,702,827, 6,802,807, and 6,911 ,003 and publications and patents cited therein.
- the above-described slings comprise a central portion that is adapted to support the urethra, two end portions bracketing the support portion, a protective sheath or sheaths encasing at least the end portions, and connectors at the ends of the sling.
- Various ways of attaching a sleeve end and sling mesh end to a connector are detailed in the above-referenced * 450 patent, for example.
- Further ways of attaching sling ends to sling implantation tools are disclosed in U.S. Patent Application Publication Nos. 2004/0087970. 2005/0245787, and 2005/0250977.
- the sling implantation tools are employed to form tissue pathways extending from a vaginal incision to two abdominal skin incisions and to draw the sling end portions through the pathways to dispose the sling free ends out of the skin incisions and the central portion around the urethra.
- the connectors are detached from the sling ends, and the sheaths are drawn out of the skin incisions, allowing the incisions to be closed.
- Sling tension is typically adjusted at implantation sufficiently to take up any slack in the sling and impart at least a degree of increased tension to the urethra with the bladder empty.
- a surgical instrument may be placed between the sling central portion and the urethra, the sling ends drawn to tension and fully close the urethral tract, and the instrument withdrawn so that the uethra is relaxed sufficiently to function.
- Alternative tension adjustment mechanisms that may be employed during implantation are disclosed in the above- referenced commonly assigned " 827 and " 921 patents.
- such urethral tapes or slings are fabricated of a loose weave sling fabric or mesh that acutely engages tissue and encourages tissue ingrowth along the pathway through mesh pores to achieve chronic stabilization or "self-fixation. Tissue ingrowth takes about 2-3 weeks in the typical patient in the absence of any significant intentional or unintentional movement of the mesh. During this post-operative time, the patient monitors the degree of success achieved in ameliorating leakage and any discomfort that might occur if the applied tension is so high as to unduly slow voluntary urination.
- an elongated repositioning means e.g., an elongated inextensible tensioning member, is incorporated extending in or along the sling mesh from near the sling ends to or through the sling central portion. Tension applied to the repositioning means is transmitted along the length of the sling so the sling mesh does not substantially stretch during initial positioning and any repositioning during the acute healing phase.
- an expandable member or container is incorporated on or in the sling central support portion that can be inflated or deflated with bulking agent to apply more or less tension to the urethra.
- the container has a touchable internal valve element to permit the surgeon to palpate the area prior to injecting or removing the bulking agent.
- the bulking agent may be injected and removed via a two-way external port. When a bulking agent is injected into the container, the tissue between the mesh and urethra will expand. This results in two effects; a simple vertical lifting due to expansion and a vertical lifting due to stretching the outside of the mesh.
- a suitable bulking agent may be water or saline. A similar approach is disclosed in U.S. Patent Nos. 4,019,499 and 6,786,861.
- the mesh sling or tape is further modified to include a mechanical adjustment means to adjust the length of the tape in the end portions on either side of the central portion after the tape has been implanted in the tissue pathways.
- the mechanical adjustment means incorporate a tie-wrap mechanism or sutures and one-way suture retaining devices of the type disclosed in U.S. Patent No. 5,669,935 located along the tape on either side of the central portion. In each case, one suture end is affixed to the tape and extends along it and through a suture retaining device affixed to the tape closer to the central portion.
- the sutures or tie-wrap are not tensioned at implantation, and the tie-wrap or suture free ends extend through the vaginal incision. If the tension on the urethra is too light as determined during the acute healing phase, the surgeon may grasp and pull on the tie-wrap or suture free ends to shorten the lengths of the tape end portions and thereby increase sling tension. The exposed suture or tie- wrap ends may be severed during chronic implantation.
- tape or sling ends or the end of a tensioning cable coupled to a urethral support mechanism are coupled to an adjustment mechanism that is chronically implanted subcutaneously and can be accessed to adjust sling tension.
- an adjustment mechanism that is chronically implanted subcutaneously and can be accessed to adjust sling tension.
- Ratchet or gear adjustment mechanisms that are accessed using a driver inserted through the skin and thereby rotated to increase or decrease sling tension are disclosed in the ' 892 and 518 patents.
- the present invention involves improvements in an elongated incontinence sling, or simply sling, comprising a central support portion and end portions extending from the central portion to sling ends.
- sling or the expression "incontinence sling” without further qualification shall embrace urethral slings adapted to be placed through a tissue pathway disposing the central support portion between the urethra or bladder neck (hereafter collectively referred to as the urethra for convenience) and the vaginal wall to alleviate urethral incontinence and fecal slings adapted to be placed through a tissue pathway disposing the central support portion inferior to the anus, the anal sphincter or the lower rectum (hereafter collectively referred to as the anus for convenience) to alleviate fecal incontinence.
- Certain embodiments employ tensioning filaments or lines or sutures that are referred to as sutures for convenience.
- such slings are improved to enhance post-operative sling adjustment of the tension applied to the urethra or anus to enhance efficacy and patient comfort.
- Several categories of the invention are disclosed herein. The various embodiments disclosed herein are applicable to both males and females, to address issues of incontinence in both, to address issues of prolapse repair in female and perineal floor descent, as well as fecal incontinence in both.
- surgical techniques such as forming suprapubic, retropubic, transobturator, inside out, outside in tissue pathways between two skin incisions, or a tissue pathway formed from a single incision through the vagina or perineal floor (in male or female patients) are also contemplated for passage of a sling therethrough.
- sling tension adjustment mechanisms join separate sling pieces forming part of the sling mesh with the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing.
- Various adjustment actuators and techniques are employed to adjust the sling tension adjustment mechanisms to decrease or increase the adjustment spacing between the sling intermediate ends to thereby shorten or lengthen, respectively, the overall length of the sling end portions and to thereby increase or decrease, respectively, the tension applied by the central support portion to the urethra or anus.
- the sling tension adjustment mechanisms are disposed along the sling end portions so as to be disposed at tissue pathway locations that are proximate the patient's skin to enable application of the external adjustment actuator against the skin or through the skin and underlying tissues to operate the sling tension adjustment mechanisms.
- sutures are threaded back and forth through mesh pores adjacent the intermediate ends and across the respective adjustment spacings of each sling end portion.
- the suture ends are adapted to be extended through the skin incisions to function as adjustment actuators in the manner of draw strings for later adjustment of the adjustment spacings during the acute healing phase.
- the suture ends may be grasped and pulled to pull the sling intermediate ends closer together to decrease the adjustment spacing and thereby decrease the sling length and increase tension applied by the center support portion to the urethra or anus.
- the tensioning sutures are passed through suture or tissue anchors that engage subcutaneous muscle, the rectus fascia or the transobturator membrane and extend through the skin incisions employed to form the tissue pathway that the sling extends through.
- the tensioning sutures are passed through suture or tissue anchors that engage subcutaneous muscle, the rectus fascia or the transobturator membrane and extend through other skin incisions to be grasped and pulled on to adjust tension.
- tissue layers For convenience, such subcutaneous muscle, the rectus fascia or the transobturator membrane or other membranes and fascia are collectively referred to as tissue layers herein.
- the external adjustment actuator comprises a signal transmitter that is employed to generate a sling adjustment command that passes transcutaneously (through the intact skin), and the adjustment mechanism comprises a receiver for receiving the transmitted commands and increases or decreases the adjustment spacing.
- the external adjustment actuator is a magnetic field generator or permanent magnet that is employed to generate a magnetic field representing a sling adjustment command that passes transcutaneously through the skin, and the adjustment mechanism comprises a magnetic field responsive element that responds by increasing or decreasing the adjustment spacing.
- the sling tension adjustment mechanism comprises a temperature responsive element responsive to heat or cold applied transcutaneously by an external thermal heater or cooler to heat or cool the adjustment mechanism to thereby increase or decrease the adjustment spacing.
- the sling tension adjustment mechanism comprises light responsive elements responsive to certain wavelengths of light that can be generated by an external adjustment actuator and transmitted transcutaneous ⁇ to the sling tension adjustment mechanism to thereby increase or decrease the adjustment spacing.
- the external adjustment actuator is inserted percutaneously (penetrating the skin) to engage and operate the sling tension adjustment mechanism to increase or decrease the adjustment spacing.
- Various sling tension adjustment mechanisms are provided that can be rotated by the external adjustment actuator in one direction to draw the sling intermediate ends together to increase sling tension and that can be rotated in the other direction to allow the sling intermediate ends to separate apart to decrease sling tension.
- the external adjustment actuator is a syringe or the like that is inserted percutaneously to engage a port of a fluid retaining chamber of the sling tension adjustment mechanism, whereby the adjustment spacing is adjusted by injecting or withdrawing fluid from the fluid chamber to increase or decrease the adjustment spacing.
- the sling tension adjustment mechanism comprises a fluid reservoir to be implanted just below the skin, a fluid chamber disposed in the adjustment spacing and coupled to the intermediate ends, and a tube extending between the fluid reservoir and the fluid chamber in each sling end portion.
- the fluid reservoir has a fluid delivery/withdrawal port that may be percutaneously accessed to introduce fluid into the fluid reservoir or to withdraw fluid from the fluid reservoir following implantation of the sling to thereby adjust the amount of fluid in the fluid chamber and adjust the length of the adjustable spacing.
- the fluid chamber comprises a single action hydraulic cylinder disposed in the adjustment spacing coupled to one sling intermediate end, the cylinder containing a fluid operated piston within an elongated chamber, the cylinder coupled to a sling adjustment rod that is in turn coupled to the other sling intermediate end.
- the fluid volume introduced into the fluid chamber determines the piston location in the cylinder and the resulting length of the adjustment spacing.
- a dual action hydraulic cylinder having a pair of opposed pistons in the fluid chamber are each coupled to rods that are in turn coupled to sling intermediate ends governs the adjustment spacing.
- the fluid chambers are preferably empty of fluid when the sterile sling is supplied in the sterile package from the manufacturer. Implantation of the sling through body pathways may be simpler and easier with the fluid chambers empty.
- the fluid e.g., a sterile saline or other biocompatible hydraulic fluid, may be introduced through the fluid delivery port(s) while the port(s) are still accessible.
- the amount of fluid necessary to effect blockage of the urethral tract may be checked by draining and filling the patient's bladder through the urethral tract, determining efficacy, and adding or withdrawing fluid to adjust the applied urethral pressures in the pressurized and ambient pressure fluid distribution states. Similar procedures may be employed to effect constriction of the anal canal.
- the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin.
- the adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing ⁇
- sling end tissue anchors may be provided on sling ends to engage tissues, e.g., the rectus fascia or the obturator membrane to fix the sling ends and aid in tension adjustment of the sling end portions.
- a sling adjustment mechanism may be incorporated into the sling central support portion to enable the separate tensioning of the sling central support portion.
- FIG. 1 is a schematic view of an exemplary sling assembly enclosing a sling adapted to be modified in accordance with the invention to function as an adjustable tension urethral or fecal sling;
- FIG. 2 is a schematic illustration of the sling of FIG. 1 adapted to be modified in accordance with the invention to provide an adjustable tension function
- FIG. 3 is a schematic illustration of a urethral sling of FIG. 2 implanted in a female patient's body in relation to the urethra or bladder neck;
- FIG. 4 is a schematic illustration of a fecal sling of FIG. 2 implanted in a female patient's body in relation to the anus and rectum;
- FIG. 5 is a schematic illustration of the relation of the sling central support portion and sling end portions to the urethra or anus;
- FIG. 6 is a schematic illustration of a generic embodiment of an adjustable tension sling of the present invention having sling tension adjustment mechanisms formed in gaps or spaces in the sling mesh forming the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing;
- FIG. 7 is a schematic illustration of the generic embodiment of FIG. 6 having optional tissue anchors extending from the sling ends to aid in the operation of the sling tension adjustment mechanisms;
- FIGs. 8 and 9 are schematic illustrations of an embodiment of an adjustable tension sling, wherein sliding locks that engage intermediate ends or loops of the sling mesh are incorporated into the sling end portions to increase and/or decrease the sling tension;
- FIG. 10 is a schematic illustration of a further embodiment of an adjustable tension sling, wherein sling tension adjustment sutures bridge adjustment spacings in the sling end portions and extend through the skin to increase and/or decrease the sling tension;
- FIG. 11A is a schematic illustration of a variation of the adjustable tension sling of FIG. 10, wherein the sling tension adjustment sutures extend through or around tissue anchors and extend through the skin to be available to increase and/or decrease the sling tension;
- FIG. 11B is a schematic illustration of a further variation of the adjustable tension sling of FIG. 10, wherein the sling ends incorporate tissue anchors passed through and engaging tissue layers and the tension adjustment sutures extend through or around further tissue anchors and extend through the skin to be available to increase and/or decrease the sling tension;
- FIGs. 12 and 13 are schematic illustrations of further preferred embodiments of an adjustable tension sling having sling tension adjustment mechanisms bridging adjustment spacings in the sling end portions adapted to be adjusted by commands transcutaneously transmitted from an external adjustment actuator to increase and/or decrease the tension applied locally to the urethra;
- FIGs. 14 - 17 are schematic illustrations of further preferred embodiments of an adjustable tension sling having sling tension adjustment mechanisms bridging adjustment spacings in the sling end portions comprising serpentine roller adjustment mechanisms that adjusts the length of an adjustment spacing in response to an externally applied command;
- FIG. 18 is a schematic illustration of a further preferred embodiment of an adjustable tension sling, wherein the adjustment mechanism is adjusted by an external adjustment actuator comprising an external adjustment actuator having an engaging end at the end of a shaft adapted to be percutaneously advanced into engagement with the adjustment mechanism to adjust the length of an adjustment spacing between intermediate sling ends in the sling end portions;
- FIG. 19 is a schematic illustration of one embodiment of the sling tension adjustment mechanisms of FIG. 18 employing a rotatable bobbin, a fixed catch and detents around the bobbin circumference;
- FIGs. 20 - 22 are schematic illustrations of the adjustment mechanism of FIG. 19 that adjusts the length of an adjustment spacing in response to an externally applied external adjustment actuator;
- FIG. 23 is a schematic view in section of a variation on the embodiment of FIG. 19, wherein the adjustment mechanism housing supports a rotatable bobbin surrounded by a fixed detent ring providing an increased range of adjustments;
- FIGs. 24 - 26 are schematic plan illustrations of a further embodiment of the adjustment mechanism of FIG. 18, wherein a dual cam assembly having a first cam operates to decrease the adjustable spacings from the neutral length illustrated in FIG. 24 to the contracted length of FIGs. 25A - 25D and a second cam operates to increase the adjustable spacings to the extended length of FIGs. 26A - 26D;
- FIG. 27 is a schematic illustration of a further preferred embodiment of the adjustable tension sling, wherein the adjustment mechanism is adjusted by an external fluid delivery/withdrawal syringe adapted to be percutaneously advanced into engagement with a fluid port of the adjustment mechanism to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIGs. 28 - 31 are schematic plan side or top views illustrating one, single action, hydraulic cylinder, adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIGs. 32 - 36 are schematic perspective, side or top views in partial section illustrating a further single action, hydraulic cylinder, adjustment mechanism bf FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIGs. 37 - 40 are schematic perspective or top views illustrating a still further single action, hydraulic adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIG. 41 is a schematic illustration of a further preferred embodiment of the adjustable tension sling, wherein the adjustment mechanism is adjusted by an external fluid delivery/withdrawal syringe adapted to be percutaneously advanced into engagement with a fluid port of a subcutaneously implantable fluid reservoir coupled to the adjustment mechanism to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIGs. 42 - 44 are schematic perspective views in partial section illustrating a single action, hydraulic cylinder, adjustment mechanisms of FIG. 41 having fluid chambers adapted to be filled or be emptied of fluid using the syringe of FIG. 41 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIG. 45 is a perspective view in partial section of a further single action, hydraulic cylinder, adjustment mechanism adapted to be employed as depicted in FIG. 41 having fluid chamber portions adapted to be filled or be emptied of fluid using a syringe to add or withdraw fluid from subcutaneously implanted fluid reservoirs coupled to the fluid chamber portions to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIG. 46 is a perspective view in partial section of a dual action, hydraulic cylinder, adjustment mechanism adapted to be employed as depicted in FIG. 41 having fluid chamber portions adapted to be filled or be emptied of fluid using a syringe to add or withdraw fluid from subcutaneously implanted fluid reservoirs coupled to the fluid chamber portions to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
- FIGs. 47 and 48 are schematic plan views in partial section illustrating one form of locking mechanism incorporated into the single action hydraulic cylinder adjustment mechanism of FIGs. 28 - 31 ;
- FIGs. 49 and 50 are schematic plan views in partial section illustrating another form of locking mechanism incorporated into the single action hydraulic cylinder adjustment mechanism of FIGs. 28 - 31 ;
- FIG. 51 is a schematic Illustration of a miniaturized, single action, hydraulic cylinder, adjustment mechanism incorporating the locking mechanism illustrated in FIGs. 47 and 48;
- FIG. 52 is a side plan view of the miniaturized, single action, hydraulic cylinder, adjustment mechanism of FIG. 51 ;
- FIG. 53 is a top plan view in partial section of the miniaturized, single action, hydraulic cylinder, adjustment mechanism of FIG. 51 ;
- FIG. 54 is a schematic Illustration of a miniaturized, mechanical gear, adjustment mechanism that is adjusted by a gear drive extended temporarily through the patient's skin;
- FiG. 55 is a schematic expanded view in partial section illustrating the gear drive components within the adjustment mechanism of FIG. 54;
- FIG. 56 is a schematic Illustration of a further miniaturized, mechanical gear, adjustment mechanism that is adjusted by a gear drive external adjustment actuator extended percutaneously through the patient's skin to engage the gear drive and adjust sling tension;
- FIG. 57 is a schematic Illustration of a still further miniaturized, mechanical gear, adjustment mechanism that is adjusted by a rack and pinion gear drive extended temporarily through the patient's skin;
- FIGs. 58A - 58D are schematic views in partial section illustrating adjustment of sling tension through use of the rack and pinion gear drive extended temporarily through the patient's skin to adjust the miniaturized, mechanical gear, adjustment mechanism of FIG. 57.
- the various embodiments of the present invention are implemented in slings suitable for and methods of implanting such slings in the treatment of male and female urinary and fecal incontinence and to effect pelvic floor, perineal floor, and pelvic proplapse repairs employing a variety of surgical approaches.
- female pelvic floor repair slings may be implanted by techniques that involve transvaginal, transobturator, suprapubic, pre-pubic, or transperineal exposures or pathways
- male urinary incontinence slings may be implanted by techniques that involve transobturator, suprapubic, or transperineal pathways.
- any of the disclosed embodiments can be used as fecal incontinence slings which may be implanted by techniques that involve transvaginal, transobturator, suprapubic or via perineal floor pathways.
- the disclosed embodiments can be used to correct the anorectal angle in the rectum to re-establish continence in patients.
- the above methods can, but are not necessarily limited to, utilize helical needles of the type described in U.S. Patent No. 6,911 ,003 or C- shaped needles or elongate needles of the type used to perform suprapubic procedures.
- an exemplary embodiment of an elongated sling assembly 10 is depicted in which the embodiments of the present invention may be advantageously implemented.
- the elongated sling assembly 10 contains a sling 20 that may be implanted in any of the above-described manners and pathways pathways through which at least end portions of the elongated sling assembly 10 is drawn to dispose a central support portion 40 of sling 20 in operative relation to the urethral or bladder neck or around the anal sphincter or elsewhere in the pelvic region.
- the sling assembly 10 comprises the sling 20 coupled to sling end connectors 12 and 14 and encased in protective sheaths 22 and 24.
- the depicted exemplary sling assembly 10 thus extends between sling end connectors 12 and 14 that engage with the free ends of right hand and left hand sling implantation tools of the types described above, for example.
- the sling end connectors 12 and 14 are shaped to dilate the right and left passages or pathways through body tissue formed by the curved needles of the right and left hand implantation tools in the above-described trans-vaginal or transobturator procedures, for example.
- the sling 20 is enclosed within protective sheaths 22 and 24 extending from the sling end connectors, 12 and 14, respectively, to respective free and open sheath ends 26 and 28.
- the protective sheaths 22 and 24 are constructed of a flexible thin transparent plastic film that enables visual examination of the sling 20 and is sufficiently lubricious that it passes easily through the tissue pathways of the patient formed using the right hand and left hand sling implantation tools of the types described above or otherwise created.
- the sheaths 22 and 24 can include sheath indicia or tear scores, perforations or holes for assisting the surgeon in properly orienting sling 20 relative to the urethra. Embodiments of the present invention are contemplated that involve modifying the sheaths 22 and 24.
- the sling 20 that is left in place chronically comprises an elongated, rectangular (in this depicted embodiment) braided or preferably knitted, mesh strip or simply mesh 30 as shown in FIG. 2.
- the sling 20 and mesh 30 are subdivided into a central support portion 40 that is adapted to be placed through a pathway extending between the urethra or bladder neck and the vaginal wall.
- Proximal end portions 42 and 44 of sling 20 extend from the central support portion 40 to the mesh ends 32 and 34. In FIGs.
- the mesh 30 extends between mesh ends 32 and 34 and may be continuous throughout the length of the sling 20 between mesh ends 32 and 34.
- the central portion 40 of sling 20 may be formed of other materials such that the central portion 40 is physically attached to the end portions 42 and 44.
- the central portion 40 may be formed of any tissue-compatible synthetic material or any natural biocompatible material, including, but not limited to, treated autologous, allograft, or xenograft tissues, procine dermis, a tissue engineered matrix, or a combination thereof.
- the sling 20 of sling assembly 10 is therefore similar to those the disclosed in the above-referenced "450 and '003 patents but is modified herein to incorporate one or more of the aspects of the present invention.
- the mesh 30 may be dimensioned shaped in a variety of ways known in the art for implantation in the treatment of male and female urinary and fecal incontinence and to effect pelvic floor, perineal floor, and pelvic proplapse repairs employing a variety of surgical approaches.
- the sling 20 may comprise more than two end portions 42 and 44 coupled to connectors and extending at a variety of angles from a particularly shaped center portion 40.
- the sling connector ends 12 and 14 are fitted to the implantation tools and the proximal end portions 42 and 44 are drawn through the body passageway or pathway.
- the central support portion 40 is adapted to drawn against tissue to support the urethra or bladder neck or the anal sphincter or elsewhere in the pelvic region after the proximal end portions 42 and 44 are drawn through body pathways.
- the sling connector ends 12, and 14 are drawn out of the skin incision and detached from the implantation tool needle ends.
- the mesh 30 and sheaths 22 and 24 are severed just proximate to the connector ends 12 and 14, respectively.
- the tissue pathway was formed by passing needles through a vaginal skin incision 62 just adjacent to the vagina 60 through soft tissue between urethra 58 and vagina 60 and along each side of urethra 58 through layers of fat, muscle, and fascia and between pubic bone 54 and bladder 56 to first and second skin incisions through skin 52.
- Any of the known tissue pathways may be formed in this generally described manner.
- a sling is implanted via a single incision (vaginal incision 62) with the sling being pushed up into the transobturator or retro pubic space.
- FIG. 4 a schematic illustration of an incontinence sling implanted in a female (for example) patient's body for treating fecal incontinence is depicted.
- the sling central portion 40 extends underneath the anus or anal sphincter 67 or inferior portion of the rectum 65 (hereafter collectively referred to as the anus 67 for convenience) to correct the anorectal angle in the patient.
- Various surgical approaches can be used to implant sling 20 to correct fecal incontinence including suprapubic, transobturator, retropubic, prepubic, transperineal and transvaginal (including a single incision approach transvaginal ⁇ or transperineally).
- the tension T that sling 20 applies against the urethra 58 or anus 67 is adjusted as schematically illustrated in FIG. 5. Since the procedure may be performed using a local anesthesia, the patient 50 is able to provide feedback to the surgeon during adjustment of sling tension. In the procedure illustrated in FIG. 3, typically, the bladder 56 is filled with saline using a catheter, and the patient is requested to cough.
- the surgeon is able to determine whether leakage occurs and may adjust the tension on the sling 20 by pulling on the exposed sling ends 32 and 34 to increase tension of the center support portion 40 against the urethra 58 or by pulling on center support portion through the vaginal incision to decrease the tension of the center support portion 40 against the urethra 58.
- the exposed end sections of the end portions 42 and 44 are trimmed away, and the abdominal incisions and the vaginal incision (as well as the labia fold incisions for the transobturator approach) are closed.
- such slings as sling 20 are improved to enhance postoperative sling adjustment of the tension T applied to the urethra 58 or the anus 67 to enhance efficacy and patient comfort.
- a sling central portion adjustment mechanism may be provided to increase and/or decrease the tension applied locally to the urethra 58 or the anus 67.
- the sling central portion adjustment mechanism is associated directly or indirectly with the sling central support portion 40 and is distinct from the sling tension adjustment mechanisms incorporated in the sling end portion or portions.
- the sling central portion tension adjustment may simply comprise a suture 108 extending around the sling central portion and passing through the skin incision to provide post-operative tension adjustment of the sling central portion 40 by pulling on sling ends 106. Adjustments may be made until the suture is withdrawn through the skin 52 or is absorbed by the body.
- Longer-term post-operative adjustment of the sling central portion tension may be accomplished with sling central portion adjustment mechanisms that remain in place.
- the mechanism may be accessed for tension adjustment employing an external adjustment actuator that is percutaneously advanced through the skin 52 to engage the sling central portion adjustment mechanism.
- an external adjustment actuator that is percutaneously advanced through the skin 52 to engage the sling central portion adjustment mechanism.
- one such approach involves injecting or withdrawing fluid from a fluid chamber of a pillow of the sling central portion adjustment mechanism applying pressure to the urethra 58 or the anus 67.
- sling tension adjustment mechanisms are formed in gaps in the sling mesh forming the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing.
- Various mechanisms and techniques are employed to adjust the sling tension adjustment mechanisms to decrease or increase the adjustment spacing between the sling intermediate ends to thereby shorten or lengthen, respectively, the overall length of the sling end portions and to thereby increase or decrease, respectively, the tension applied by the central support portion to the urethra.
- the sling tension adjustment mechanisms are disposed along the sling end portions so as to be disposed at tissue pathway locations that are proximate the patient's skin to enable access to or application of the external adjustment actuator against the skin or through the skin and underlying tissues to operate the sling tension adjustment mechanisms.
- a sling tension adjustment mechanism is incorporated into or on a section of one or preferably both of the sling end portions 42 and 44 proximal to but spaced from the central support portion 40 that can be adjusted at least in the acute post-operative healing phase.
- a first sling end portion tension adjustment mechanism 102 is schematically depicted extending between and coupled to sling intermediate ends 36 and 38 of sling end portion 42.
- the gap or adjustment spacing 162 between sling intermediate ends 36 and 38 is shortened to increase tension or lengthened to decrease tension in sling end portion 42
- a second sling end portion tension adjustment mechanism 104 is schematically depicted extending between and coupled to sling intermediate ends 46 and 48 of sling end portion 44.
- the gap or adjustment spacing 164 between sling intermediate ends 46 and 48 is shortened to increase tension or lengthened to decrease tension in sling end portion 44.
- each sling tension adjustment mechanism 102 and 104 from the central support portion 40 is selected in relation to the anatomy for either male or female fecal or urinary incontinence slings and the implantation route or technique to facilitate access or engagement with an externally applied adjustment actuator or an actuator element extending percutaneously from a skin incision.
- the adjustment mechanisms are generally adjusted to adjust the length and/or tension of the end portions 42 and 44 to thereby tension the center support portion 40 and draw it closer to the urethra 58 or anus 67 to relax tension of the center support portion 40 to release pressure on the urethra 58 or anus 67.
- tissue anchors 92 and 94 may take any of the forms disclosed in the above-referenced U.S. Patent Application Publication No. 2005/0004576, for example. Generally speaking such tissue anchors 92 and 94 can be readily drawn through tissue in the direction away from the sling ends 32 and 34, respectively, but resist retraction back through the tissue.
- the sling tissue anchors 92 and 94 may be extended through and bear against the rectus fascia or the transobturator to stabilize the sling ends 32 and 34 to set sling tension and to resist being drawn toward the sling tension adjustment mechanisms 102 and 104 when tension is increased.
- the end portion tension adjustment mechanisms comprise sliding locks 132 and 134 (FIG. 8) or 142 and 144 (FIG. 9) that engage the end portions 42 and 44 of the sling mesh 30.
- sections of the sling mesh 30 are looped and passed through channels of sliding locks 132 and 134.
- the sling intermediate ends are drawn through channels of the sliding locks 142 and 144. It will be understood that the depicted slings 20 are disposed in the patient's body the manner depicted in FIG. 3 or FIG. 4.
- the loops 136, 138 or free ends 146, 148 function as actuator elements that can be grasped through the skin incisions 82 and 84 (or through a vaginal incision if a single incision approach is chosen) and pulled upon with respect to the sliding locks 132, 134 or 142, 144 to shorten the lengths of the end portions 42, 44 and increase tension on the urethra 58.
- Sliding locks 132, 134 and 142, 144 operate similar to zip-tie locks. It will be understood that the depicted loops 136, 138 and the free ends 146, 148 can comprise sutures or zip-lock tapes fastened to intermediate ends of the sling mesh 30 so that the sutures or zip-lock tapes are drawn through channels of the sliding locks 132, 134 and 142, 144.
- FIG. 10 wherein the end portion 42 is severed at intermediate ends 36 and 38 to form a gap or adjustment spacing 162, and the end portion 44 is severed at intermediate ends 46 and 48 to form a gap or adjustment spacing 164.
- Sutures 156 and 158 are threaded back and forth through mesh pores adjacent the intermediate ends 36,38 and 46, 48, respectively, and across the respective adjustment spacings 162 and 164, to function as draw strings for later adjustment of the adjustment spacings 162 and 164 during the acute healing phase.
- the suture 156 and adjustment spacing 162 comprise sling end portion tension adjustment mechanism 152 of end portion 42
- the suture 158 and adjustment spacing 164 comprise sling end portion tension adjustment mechanism 154 of end portion 44.
- the suture ends 166 and 168 may be grasped and pulled to shorten the adjustment spacings 162 and 164 to thereby shorten the sling end portions 42 and 44 and thereby decrease the sling length and increase tension applied by the center support portion 40 to the urethra 58 (or anus).
- a further adjustment suture 108 (optionally formed of biodegradable material) is optionally placed around the sling mesh 30 and extended through the vaginal skin incision 62 to enable manual tension adjustment.
- the suture ends 106 may be grasped and pulled to function as an actuator element and pull the sling mesh away from the urethra 58 to release tension applied by the center support portion 40 to the urethra 58 (or anus).
- the sling central support portion 40 may be accessed by reopening the vaginal incision 62 to pull on the sling 20 to draw the sutures 156 and 158 back through the mesh pores, thereby increasing the sling length and decreasing tension applied by the center support portion 40 to the urethra 58 (or anus).
- a biodegradable sheath may be placed over the adjustment mechanisms 152 and 154 and at least a portion of the sling mesh to inhibit tissue ingrowth into the mesh pores and adjustment spacings 162 and 164 and thereby ease adjustment of the sling 20 until the sheath is absorbed and tissue ingrowth encapsulates and immobilizes sling mesh 30.
- the suture ends 166, 168, and 106 may be severed at the respective incisions 82, 84, and 62 following final adjustment.
- Certain sling implantation procedures for urethral and fecal slings involve employing implantation instruments having needles that are advanced from a first skin incision to a second skin incision to form first and second or right and left (non-suprapubic) tissue pathways around the urethra 58 or the anus 67. The instruments or other instruments are then employed to push or pull the sling end portions 42 and 44 through the first and second pathways to dispose the sling ends near or through the skin incisions 82 and 84 as shown in FIGs. 3 and 4.
- the above-described embodiments contemplate implantation in such tissue pathways.
- sling ends configured to engage sling implantation tool needle ends to be pushed from a single incision adjacent the urethra 58 (or the anus 67) through first and second tissue pathways to dispose the sling end portions extending away from the urethra 58 (or anus 67).
- the skin incisions 82 and 84 are not necessarily made, and the sling ends are disposed at subcutaneous locations.
- the sutures 156 and 158 are drawn through tissue anchors 96 and 98 that are passed through and bear against subcutaneous tissue layers 72 and 74, respectively.
- the tissue anchors 96 and 98 have channels or bores that one or both of the sutures 116 and 118 are passed though that grip the sutures with sufficient force to maintain sling tension.
- the suture retaining force may be overcome by manipulation of the suture and tissue anchor to increase or decrease sling tension during post-operative recuperation.
- the suture ends extending through the skin incisions 82 and 84 are placed under the skin 52, and the incisions are closed. During chronic implantation, adjustments of sling tension may take place by reopening the skin incisions 82 and 84 to access the suture ends and the tissue anchors 96 and 98.
- the suture 156 passes through a slidable bore of the tissue anchor 96 and through the same skin incision 82 that the tissue pathway is created for the sling 20.
- the suture 158 is depicted extending through a slidable bore of the tissue anchor 98 and through the same skin incision 84 that the tissue pathway is created for the sling 20.
- the tissue pathway may extend through the right and left transobturator membranes (tissue layers 72 and 74) that the tissue anchors 96 and 98 are passed through and bear against.
- FIG. 11B 1 tissue anchors 632 and 634 are coupled to the sling ends 32 and 34, respectively, and the sutures 156 and 158 are passed through the tissue anchors 96 and 98.
- the tissue anchor 632 and the sling end portion 42 are pushed from a single skin incision below the urethra 58 or anus 67 through a first tissue pathway such that the tissue anchor 632 is passed through and bears against tissue layer 72.
- the tissue anchor 634 and the sling end portion 43 are pushed from the skin incision below the urethra 58 or anus 67 through a second tissue pathway such that the tissue anchor 634 is passed through and bears against tissue layer 74.
- the suture 156 and tissue anchor 96 are pushed through a further tissue pathway such that the tissue anchor 96 is passed through and bears against a separate tissue layer 76 and then through a skin incision 86.
- the suture 158 and tissue anchor 98 are pushed through a further tissue pathway such that the tissue anchor 96 is passed through and bears against a separate tissue layer 76 and then through a skin incision 88.
- the sutures 156 and 158 can first be passed by themselves through the skin incisions 86 and 88, respectively, and the tissue anchors 96 and 98 can be applied over the sutures 156 and 158 to bear against the tissue layers 76 and 78, respectively.
- the various sling embodiments can be used without tissue anchors.
- Tension can be applied by pulling on the suture ends of sutures 156 and 158, respectively while applying pressure against the subcutaneous tissue anchors 96 and 98, thereby decreasing the spacings 162 and 164. Tension on sutures 156 and 158 can be release to lengthen spacings 162 and 164 by exposing and manipulating the tissue anchors 96 and 98.
- the tissue layers 72, 74, 76, and 78 may comprise a muscle layer, fascia or transobturator membrane. Tissue layers 72 and 76 may be the same or a different tissue layer, and tissue layers 74 and 78 may be the same or a different tissue layer.
- the particular locations of skin incisions 86 and 88 and the respective tissue anchors 96 and 98 may include obturator, abdominal, pelvic, perineal and rectal regions.
- tissue anchors 632, 634, 96, and 98 may take any of the forms disclosed in the above-referenced ' 002 patent and in U.S. Patent Application Publication Nos. 2005/0004576 and 2006/0089525.
- adjustment actuator acts upon the sling end portion adjustment mechanisms 102 and 104 by percutaneous direct access to an adjustment tool or transcutaneous transmission of adjustment commands to an adjustment control of the adjustment mechanism.
- both shortening and lengthening of the length of the adjustment spacings 162 and 164 for increasing and decreasing sling tension are contemplated by these embodiments.
- adjustment mechanism 202 is disposed across the adjustment spacing 162 and affixed to sling intermediate ends 36 and 38, and adjustment mechanism 204 is disposed across the adjustment spacing 164 and affixed to sling intermediate ends 46 and 48.
- An external adjustment actuator 200 is depicted brought into proximity to or applied against the skin 52 for generating an adjustment command 210 that is communicated transcutaneously through the skin 52 and underlying fat, tissue and fascia to adjustment mechanism 204. It will be understood that the external adjustment actuator 200 may also be brought into proximity to the skin 52 for generating a similar adjustment command communicated transcutaneously through the skin 52 and underlying fat, tissue and fascia to adjustment mechanism 202.
- the adjustment mechanisms 202 and 204 comprise electro-mechanical systems or elements or materials that respond to the transmitted command 210 to effect the adjustment in length of the adjustable spacings 162 and 164.
- mechanisms 202 and 204 are shape memory alloy (e.g. nitinol) elements that contract in size and expand in size depending on the stimulus.
- the external adjustment actuator 200 is an RF signal generator that generates an RF signal 210 through antenna 206 applied to the patient's skin as command 210.
- the adjustment mechanisms 202 and 204 each incorporate an RF antenna 216 that receives the RF signal and apply the received signal to internal electro-mechanical drive mechanism 218 for extending or contracting the length of the adjustment mechanisms 202 and 204.
- the RF signal 210 is a power signal that is received by antenna 216 to generate a current that is applied to resistive heating elements or heat responsive elements forming the electro-mechanical drive mechanism 218 of each of adjustment mechanisms 202 and 204.
- the electro-mechanical drive mechanism 218 of the adjustment mechanisms 202 and 204 may comprise chambers holding a heat responsive fluid that expands as heat is applied, and the expanded fluid drives pistons in the chambers to increase the overall length of the adjustment mechanisms 202 and 204.
- the electro-mechanical drive mechanism 218 may comprise a heat responsive bi-metal strip that is heated by the received current and expands or contracts in length to expand or contract the length of the adjustment mechanisms 202 and 204.
- the external adjustment actuator 200 generates a pulsed or steady magnetic field as the command 210.
- the adjustment mechanisms 202 and 204 incorporate magnetic responsive switches, e.g., reed switches or MAGFETs within the electro-mechanical drive mechanism 218 that switch states and operate the electro-mechanical drive mechanism 218 to extend or contract the length of the adjustment mechanisms 202 and 204.
- the external adjustment actuator 200 is simply a heating or chilling pad that is applied to the skin to locally heat or cool the underlying tissue and the adjustment mechanisms 202 and 204 to expand or contract a heat responsive element or material that is incorporated into the adjustment mechanisms 202 and 204. The heating and/or cooling of the heat responsive element or material extends and/or or contracts the length of the adjustment mechanisms 202 and 204.
- the sling tension adjustment mechanisms 202 and 204 comprise light responsive elements
- the external adjustment actuator 200 comprises a light source (laser or diode) that emits light pulses of a light frequency capable of penetrating the skin and underlying fat layers and fascia as the command 210 that the light responsive elements are capable of detecting.
- An electro-mechanical drive mechanism 218 responds to the output signals of the light detectors to adjust the length of the adjustment mechanisms 202 and 204.
- FIGs. 14 - 17 are schematic illustrations of a serpentine roller that may be incorporated into the adjustment mechanisms 202 and 204 to adjust the length of the adjustment spacings 162 and 164.
- the intermediate ends 36, 38 and 46, 48 are attached to ends of a band 230 that extends through a channel 226 of the housing 220, the channel 226 including two chambers 222 and 224.
- the band 230 extends around roller 232 disposed in chamber 222 and roller 234 disposed in chamber 224.
- the lengths of the adjustment spacings 162, 164 depend on the location of the rollers 232 and 234 in the respective channels 222 and 224.
- a maximum length of the adjustment spacings 162, 164 is obtained with the rollers 232 and 234 disposed substantially out of the respective channels 222 and 224 as shown in FIG 16.
- a minimum length of the adjustment spacings 162, 164 is obtained with the rollers 232 and 234 disposed fully within the respective channels 222 and 224 as shown in FIG 17.
- An intermediate or neutral length of the adjustment spacings 162, 164 is obtained with the roller 232 disposed fully within the respective channels 222 and the roller 234 disposed substantially out of the respective channel 224 as shown in FIG 15.
- the sling 20 would be implanted with the rollers 232 and 234 disposed in the neutral position of FIG. 15, and later adjustments to the position of FIG. 16 or FIG.
- roller 17 would be made with an external adjuster applied to the patient' s skin 52. It is contemplated that movement of the rollers 232 and 234 would be controlled by an electro-mechanical interface between the rollers 232 and 234 and any mechanism responsive to commands 210 generated by the external actuator 200 as described above.
- the external adjustment actuator 310 has an actuator-engaging end 312 at the end of a shaft 314.
- the tension adjustment mechanisms 302 and 304 are shaped with actuator end receptacles 306 and 308, respectively, that can be manually palpated through the skin 52.
- the actuator engaging end 312 and shaft 314 can be inserted percutaneously through skin incisions 64 and 66 to fit the actuator engaging end 312 into the actuator end receptacles 306 and 308.
- the external adjustment actuator 310 is depicted in engagement (at separate times) with both actuator end receptacles 306 and 308 in FIG. 18.
- Various rotatable mechanisms within the tension adjustment mechanisms 302 and 304 are contemplated that can be rotated by manual rotation of the external adjustment actuator 310 in one direction to shorten the sling end portions 42 and 44 together to increase sling tension and that can be rotated by manual rotation of the external adjustment actuator 310 in the other direction to lengthen the sling end portions 42 and 44 to separate apart to decrease sling tension.
- the actuator engaging end 312 is shaped to both penetrate tissue and to have mating surfaces for engaging the end receptacles 306 and 308 to enable rotation in both directions.
- the tension adjustment mechanisms 302 and 304 depicted in FIGs. 19 - 22 each comprise a bobbin 316 mounted for rotation in a receptacle of a housing 320 fixed at one end to the sling intermediate end 36, 46, the bobbin 316 shaped with the actuator end receptacles 306, 308 extending axially into one side of the bobbin 316.
- a band or strand 330 extends from a fixed connection with the other sling intermediate end 38, 48 into a channel 322 in housing 320 and around a groove of the bobbin 316 to a fixed coupling with the bobbin 316.
- the bobbin 316 is formed with three detents 332, 334, 336 spaced apart around its circumference, and the free end of a catch 324 fixed at its other end to housing 320 engages one of the detents 332, 334, 336.
- the actuator end receptacles 306, 308 have a five sided socket shape, and the engaging end 312 of the shaft 314 of external adjustment actuator 310 is also shaped as a mating five-side wrench having a distal point and is shown poised to be inserted into the actuator end receptacle 306, 308 in FIG. 19.
- the neutral position of the bobbin 316 at the time that the sling 20 is implanted is depicted in FIG. 20.
- the external adjustment actuator 310 can be used to engage and rotate the bobbin 316 to either increase or decrease the amount of the band or strand 330 taken up on the bobbin groove and to thereby shorten or extend, respectively, the adjustment spacing 162, 164, and tighten or loosen, respectively, the sling 20 and increase or decrease, respectively, tension applied by the sling central support portion 40 to the urethra 58 (or anus).
- a minimum length of the adjustment spacing 162, 164 is obtained by clockwise rotation of the bobbin 316 to move the catch end 324 out of detent 334 and along the outer edge of the bobbin 316 until the catch end engages detent 336.
- a maximum length of the adjustment spacing 162, 164 is obtained by counter-clockwise rotation of the bobbin 316 to move the catch end 324 out of detent 334 and along the outer edge of the bobbin 316 until the catch end engages detent 332.
- FIG. 23 An alternative detent arrangement of the bobbin and housing is depicted in FIG. 23.
- the housing 340 supports a rotatable bobbin 346 surrounded by a fixed detent ring 342.
- the actuator-engaging receptacle 348 is shaped to receive an actuator end shaped like a three-sided Keith needle.
- a first band or strand 350 extends from a fixed end about a portion of the circumference of the bobbin 346 and is coupled at its other end to the intermediate end 36, 46 of the sling 20 formed of mesh 30.
- a second band or strand 352 extends from a fixed end about a portion of the circumference of the bobbin 346 and is coupled at its other end to the intermediate end 38, 48 of the sling 20.
- the rotatable bobbin 346 and fixed detent ring 342 further comprise a plurality of flexible tabs or teeth that interlock like gear teeth.
- a neutral position of the bobbin 346 is established at the time that the sling 20 is implanted is depicted.
- the Keith needle style external adjustment actuator 310 can be used to engage the receptacle 348 and rotate the bobbin 346 clockwise to decrease or counterclockwise to increase the amount of the bands or strands 350, 352 taken up on the bobbin grooves.
- the clockwise and counterclockwise bobbin rotations thereby extend or shorten, respectively, the adjustment spacing 162, 164, and loosen or tighten, respectively, the sling 20 and decrease or increase, respectively, tension applied by the sling central support portion 40 to the urethra 58.
- FIGs. 24, 25A - 25D, and 26A - 26D disposed in the adjustable spacings 162, 164.
- the tension adjustment mechanisms 362, 364 each comprise a dual cam assembly 370 comprising a first cam 372 coupled to first tether 374 and a first cam follower 376 and a second cam 382 coupled to a second tether 384 and second cam follower 386.
- the ends of the first and second tethers 374 and 384 are coupled to the sling intermediate ends 36, 46, and 38, 48 respectively.
- the first cam 372 rotated with respect to cam follower 376 operates to decrease the adjustable spacings 162, 164 from the neutral length of FIG. 24 to the contracted length of FIG.
- the second cam 382 rotated with respect to cam follower 38 operates to increase the adjustable spacings 162, 164 from the neutral length of FIG. 24 to the contracted length of FIG. 26A as shown in FIGS. 26B - 26D.
- the external adjustment actuator 310 (FIG. 18) is operated to engage either the first or the second cam 372 or 382 to increase or decrease sling tension, respectively. Any suitable socket and actuator configuration may be employed for effecting selective rotation of the cams.
- the external adjustment actuator is a syringe 410 or the like that is inserted percutaneously through a skin incision to engage a port 406, 408 of a fluid retaining chamber of the sling tension adjustment mechanism 402, 404.
- the port 406, 408 comprises a penetrable, resealable septum, and a needle stop may be included within the fluid chamber opposite the resealable septum to prevent needle perforation of the wall of the fluid retaining chamber within the outer housing 415.
- the port 406, 408 is coupled to sling intermediate end 36, 46, and a rod 420 is coupled at its free end to the sling intermediate end 38, 48.
- the port 406, 408 accesses a cylinder within housing 422 so that the fluid delivered through the septum of the port 406, 408 is also delivered into the cylinder.
- a piston coupled to the rod 420 (which may simply be an enlarged diameter end of rod 420) is also enclosed within the cylinder of housing 422.
- Rod 420 extends through a C-shaped opening 417 in the end of outer housing 415 that guides but does not inhibit movement of rod 420.
- the adjustment spacing 162, 164 is adjusted by injecting or withdrawing fluid from the fluid chamber to laterally extend or retract the piston mounted rod 420 to increase or decrease the adjustment spacing 162, 164 as shown in FIGs. 29 - 31.
- FIGs. 32 - 36 A variation on this embodiment is depicted in FIGs. 32 - 36, wherein a sling tension adjustment mechanism 432, 434 is substituted for the sling tension adjustment mechanism 402, 404 of FIGs. 27 - 31.
- the port 436 is formed with a syringe needle interlock 443, and the syringe 410 has a special interlocking tip 442 that opens and enters the interlock 443 to deliver or withdraw fluid from or to the syringe chamber 416.
- the port 436 is coupled to a housing 446 enclosing a cylinder or fluid chamber 444 that the fluid is delivered into.
- the interlock 443 is spring loaded by spring 440 within the port chamber 445.
- a piston 448 is also enclosed within the housing 446 and coupled to a rod 450 extending from the housing end.
- the port 436 is coupled to sling intermediate end 36, 46, and the rod 450 is coupled at its free end to the sling intermediate end 38, 48.
- the volume of fluid delivered into the fluid chamber 444 dictates the position of the cylinder 448 within the chamber 444 and the extension of the rod 450.
- the adjustment spacing 162, 164 is therefore adjusted by injecting or withdrawing fluid from the fluid chamber 444 to laterally extend or retract the piston 448 and rod 450 to increase or decrease the adjustment spacing 162, 164 as shown in FIGs. 35 - 36.
- the sling tension adjustment mechanisms 402, 404 and 432, 434 depicted in FIGs. 27 - 36 comprise single action, hydraulic pistons, wherein the fixed housing is coupled to one sling intermediate end and the movable rod end is coupled to the other intermediate sling end. It will be understood that the sling tension adjustment mechanisms 402, 404 and 432, 434 depicted in FIGs. 27 - 36 may be modified to function as dual action, hydraulic pistons having axially aligned and opposed pistons coupled to respective rods, and the rod free ends of each mechanism coupled to the sling intermediate ends 36, 46 and 38, 48.
- FIGs. 37 - 40 A still further variation on this embodiment of the second category illustrated in FIG. 27 is depicted in FIGs. 37 - 40, wherein a sling tension adjustment mechanism 462, 464 is substituted for the sling tension adjustment mechanism 402, 404 of FIGs. 27 - 31.
- the external adjustment actuator is the syringe 410 or the like that is inserted percutaneously through a skin incision to engage a port 406, 408 of a fluid chamber 470 of the sling tension adjustment mechanism 462, 464.
- the port 406, 408 comprises a penetrable, resealable septum, and a needle stop may be included within the fluid chamber opposite the resealable septum to prevent needle perforation of the wall of the fluid chamber 470.
- the S-shaped chamber housing 472 enclosing the fluid chamber 470 is shaped with opposed spiral arms 466 and 468 respectively coupled to sling intermediate end 36, 46 and end 38, 48.
- the housing 472 is formed of a material that is expandable as fluid volume and pressure increases as shown in FIG. 39 and contractible as fluid volume and pressure decreases as shown in FIG. 40.
- the adjustment spacing 162, 164 is therefore adjusted by injecting or withdrawing fluid from the fluid chamber 470 to laterally extend or retract the opposed spiral arms 466 and 468 to increase or decrease the adjustment spacing 162, 164 as shown in FIGs. 37 - 40.
- the arms 466 and 468 may be corrugated with one or more corrugation to function in the manner of bellows.
- the arms 466 and 468 may be spiral as depicted or extend in axial alignment and away from one another to increase or decrease the adjustable spacing 162, 164.
- the sling tension adjustment mechanisms 502 and 504 comprise fluid reservoirs 512 and 514, housings 522 and 524, respectively, and tubes 532 and 534 extending between the fluid reservoirs 512 and 514 and housings 522 and 524, respectively, alongside the sling end portions 42 and 44, respectively.
- the housings 522 and 524 are coupled to the sling intermediate ends 36, 38 and 46, 48, respectively, and define the adjustment spacings 162 and 164, respectively.
- the fluid reservoirs 512 and 514 are adapted to be implanted just below the skin 52 adjacent the skin incisions 82 and 84, respectively.
- the tubes 532 and 534 may extend through the skin incisions 82 and 84 to dispose the fluid reservoirs 512 and 514 outside the skin during the healing phase.
- the tubes 532 and 534 may be pulled upon to detach their distal ends from tube fittings on the housings 522 and 524 after tissue ingrowth into the mesh pores has secured the sling 20 in position. Tissue ingrowth should maintain the adjustment spacings 162, 164 even if the hydraulic fluid (saline) then escapes from fluid cylinders and chambers within the housings 522 and 524.
- the fluid reservoirs 512 and 514 have respective fluid delivery/withdrawal ports 516 and 518 that may be percutaneously accessed by needle tip 412 of syringe 410 to introduce fluid into the fluid reservoir 512, 514 or to withdraw fluid from the fluid reservoir 512, 514 following implantation of the sling 20 to thereby adjust the amount of fluid in the fluid chambers of housings 522 and 524 and adjust the length of the adjustable spacings 162 and 164.
- housings 522, 524 may incorporate any of the adjustment mechanisms 402, 404 or 432, 434 or 462, 464 and variations thereof described above with the tubes 532, 534 and fluid reservoirs 512 and 514 substituted for the above-described fluid delivery/withdrawal ports.
- FIGs. 42 - 45 alternative forms of adjustment housings 522 and 524 of the adjustment mechanisms 502, 504 and 502', 504' containing fluid chambers, pistons, and connecting rods are depicted in greater detail.
- the housing 522, 524 encloses a fluid chamber 526, a piston 528 and a rod 530 extending axially from one end of the housing 522, 524.
- FIGs. 42 - 45 alternative forms of adjustment housings 522 and 524 of the adjustment mechanisms 502, 504 and 502', 504' containing fluid chambers, pistons, and connecting rods are depicted in greater detail.
- the housing 522, 524 encloses a fluid chamber 526, a piston 528 and a rod 530 extending axially from one end of the housing 522, 524.
- the housing 522, 524 is elliptical in lateral cross-section having a major ellipse axis corresponding generally to the width of the mesh 30 of sling 20 so that the minor ellipse axis minimizes overall thickness of the sling 20.
- the housing wall 542, fluid chamber 526, and piston 528 may be shaped more oblong than elliptic as shown in FIG. 46.
- the sling intermediate end 36, 46 is coupled by thermoplastic rivets or sutures or the like to the stationary end of housing 522, 524, and the sling intermediate end 38, 48 is coupled by thermoplastic rivets or sutures or the like to the movable free end of rod 530 in each housing 522, 524.
- the piston 528 is formed with a ring or rings that provide a tight seal with the housing wall 542 defining the fluid chamber 526 to minimize fluid loss.
- the tubes 532 and 534 extend from the end of the housing 522, 524 opposite the rod 530 and centrally along the axes of the mesh 30 of each of the end portions 42 and 44, respectively, to the fluid reservoirs 512 and 514, respectively, to supply fluid to or withdraw fluid from the chamber portion defined by the housing interior wall 536 and the piston head 538.
- the tube 532, 534 extends offset from the axis of the sling mesh 30.
- FIG. 46 A dual action hydraulic cylinder form of an adjustment mechanism 552 similar to adjustment mechanisms 502, 504 and 502', 504' is depicted in FIG. 46.
- An oblong shape of the piston 558, the housing 562, and fluid chamber 556 is also depicted in FIG. 46 that may be substituted for the elliptical shapes of the piston 528, housing 522, 524, and fluid chamber 526, respectively, of FIGs. 42 - 45.
- the dual action adjustment mechanism 552 requires two subcutaneously implantable fluid reservoirs (not shown) or a dual action fluid reservoir and tubes 572 and 574 extending alongside the sling mesh to subcutaneous implantation sites.
- the housing 562 encloses a fluid chamber 556, piston 558 and rod 560 extending through an opening in one end of the housing 562.
- the fluid chamber 556 comprises a contracting chamber 568 coupled to tube 572 on one side of piston 558 and an extending chamber 570 coupled to tube 574 on the other side of the piston 558.
- the adjustment mechanism 552 is substituted for the adjustment mechanisms 502 and 504 of FIG. 41 to define the adjustment spacings 162 and 164 as a function of the position of the piston 558 in the fluid chamber 556.
- the adjustment spacing 162, 164 is lengthened if fluid is introduced into chamber portion 570 from the first fluid reservoir through tube 574 while fluid is simultaneously withdrawn from chamber portion 568 into the second fluid reservoir through tube 572.
- adjustment spacing 162, 164 is shortened if fluid is introduced into chamber portion 568 from the second fluid reservoir through tube 572 while fluid is simultaneously withdrawn from chamber portion 570 into the first fluid reservoir through tube 574.
- any of the above-described single action hydraulic adjustment mechanisms can be modified in this fashion to function as a dual action hydraulic adjustment mechanism. It may be desirable to provide a locking mechanism to maintain the adjusted position of the piston and rod of the single or dual action hydraulic adjustment mechanisms disclosed herein after setting the adjustment spacing. Leakage and blow-by of the pressurized hydraulic fluid may occur causing the adjustment spacing to change before tissue ingrowth into the sling mesh pores stabilizes the sling.
- FIGs. 47 and 48 illustrate one form of locking mechanism 405 incorporated into a single action hydraulic cylinder adjustment mechanism 402, 404 of the type shown in FIGs. 28 - 31.
- hydraulic cylinder, adjustment mechanism 402', 404', upper and lower lines of serrations, or teeth 421 and 423 extend along the rod 420.
- the rod 420 extends from the cylinder 455 within housing 422 and passes through a locking ring 425 mounted to slightly rock or pivot on axle 427 supported by the outer housing 415.
- a counterweight rod 429 also extends from the axle within the outer housing 415.
- Serrations or teeth are also formed on the inner wall of the locking ring 425 in alignment and engagement with the upper and lower lines of serrations or teeth 421 and 423.
- FIGs. 49 and 50 illustrate another form of locking mechanism 435 incorporated into a single action hydraulic cylinder adjustment mechanism 402, 404 of the type shown in FIGs. 28 - 31.
- the locking mechanism 435 comprises modifications to the rod 420 providing reduced diameter sections 437, 439, and a laterally extending pin 441 , a pair of springs 447, 449 disposed around rod sections 437, 439, and a rotatable sleeve 457 disposed over the rod 420.
- the rotatable sleeve 457 surrounding rod 420 extends through the C-shaped opening 417 in housing 415.
- a spiral slot 451 with a plurality of notches 453 is formed in the rotatable sleeve 457, and the pin 441 extends through the spiral slot 451 and can be engaged in a notch 453.
- the adjustment spacing 162, 164 is adjusted by injecting or withdrawing fluid from the fluid chamber to laterally extend or retract the piston mounted rod 420 to increase or decrease the adjustment spacing 162, 164.
- rod 420 is moved within cylinder 455 against the spring force of one or the other of the springs 447, 449 and the outwardly extending pin 441 travels along the spiral slot 447, rotating the sleeve 457.
- the spring force functions as a detent by lodging the pin 441 into engagement with the closest notch 453.
- the engagement resists any change in rod position that might otherwise occur due to loss of fluid from the cylinder. However, the engagement force can be overcome when fluid is added to or removed from the cylinder. It will be understood that the outer housing 415 may extend completely around the pin 441 and the housing 422 to isolate them from body tissue.
- FIGs. 51 - 53 A further miniaturized single action hydraulic cylinder adjustment mechanism 402", 404" is depicted in FIGs. 51 - 53 that may be substituted for the above-described adjustment mechanism 502, 504 of FIG. 41.
- the width and height or diameter of the modified housing 415' is sized to correspond generally to the width of the sling mesh 30 of sling 20.
- the locking mechanism 405 described above is incorporated into the modified housing 415' although locking mechanism 435 may be substituted for locking mechanism 405.
- the cylinder 455 is directly coupled to a tube coupling 419 that the end of the tube 532, 534 is affixed to.
- the syringe 410 is employed to penetrate the septum of the fill port 512, 514 to add or remove fluid from cylinder 455 and adjust the rod 420 to adjust the adjustable spacing as described above with respect to FIG. 41.
- the tube distal end may be detached from the fluid coupling 419 when tissue ingrowth immobilizes the sling mesh 30.
- the outer housing 415' may extend completely around the locking ring 425 and the housing 422' to isolate them from body tissue.
- the adjustable mechanism of the second aspect of the sling 20 of the present invention may also comprise miniaturized mechanical mechanisms that are adjustable outside the patient's skin or percutaneously through the patient's skin during the healing phase.
- the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin.
- the adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing.
- a miniaturized gear driven adjustment mechanism 802, 804 is depicted in FIGs. 54 and 55 that may be substituted for the above-described adjustment mechanisms 502 and 504 of FIG. 41.
- An adjustment mechanism housing 822 is attached at one end to the intermediate sling end 36, 46 and encloses a gear chamber 826 and a rod chamber 824.
- a driven gear 828 is enclosed within the gear chamber 826, and a rod 820 having a spiral thread 834 extending around its circumference extends through the rod chamber 824 and out of housing end opening 832.
- the spiral thread 834 engages gear threads within the bore of the driven gear 828.
- One end of the rod 820 is coupled to the intermediate sling end 38, 48.
- a gear drive 810 comprises an elongated drive shaft 812 extending through a sheath lumen 814 of a drive sheath 816 to a drive gear 830 within the gear chamber 826 of an outer housing 822.
- the teeth of the drive gear 830 and the driven gear 828 are in engagement.
- the drive sheath 816 extends through the skin incisions following implantation to enable adjustment of the length of the rod 820 within the rod chamber 824.
- the gear drive handle 818 may be grasped and rotated to rotate the drive shaft 812 and the drive gear 830.
- the distal end of drive shaft 812 may be shaped to detachably engage axially with the drive gear 830 so that the drive sheath 816 and shaft 812 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 822 and drive gear 830, respectively, and be drawn out through the skin incision after tissue ingrowth into the mesh pores has secured the sling 20 in position.
- FIG. 56 An alternative, miniaturized, gear driven adjustment mechanism 852, 854 is depicted in FIG. 56 that may be substituted for the above-described adjustment mechanisms 302 and 304 of FIG. 18.
- An adjustment mechanism housing 872 is attached at one end to the intermediate sling end 36, 46 and encloses a gear chamber 876 and a rod chamber 874.
- a driven gear 878 is enclosed within the gear chamber 876, and a rod 870 having a spiral thread 884 extending around its circumference extends through the rod chamber 874 and out of housing end opening 832.
- the spiral thread 884 engages gear threads within the bore of the driven gear 878.
- One end of the rod 870 is coupled to the intermediate sling end 38, 48.
- a gear driver 860 comprises an elongated drive shaft 866 having a spiral drive gear 880 at the distal end of the drive shaft 866 and a handle 868 at the proximal end of the drive shaft 866.
- the distal end of the gear drive 860 may be shaped to be percutaneously advanced through the patient's intact skin at pre-made incisions to interact with the driven gear 878.
- the distal end of the drive shaft 866 is extended through an opening in the housing 872 and into engagement with the drive gear 880 to adjust of the length of the rod 870 within the rod chamber 874.
- the teeth of the drive gear 880 and the driven gear 878 are depicted in engagement in FIG. 56.
- the gear drive handle 868 may be grasped and rotated to rotate the drive shaft 866 and the drive gear 880.
- Rotation of the driven gear 878 around the rod 870 in one direction drives the rod 870 out of the rod chamber 874 and lengthens the adjustment spacing 164, 166
- rotation of the driven gear 878 around the rod 870 in the other direction drives the rod 870 into the rod chamber 874 and shortens the adjustment spacing 164, 166.
- the gear drive may take the form of gear drive 810 of FIG. 54 that is temporarily left extending through the skin incisions following implantation of the sling.
- drive shaft 812 may be shaped to detachably engage axially with the drive gear 880 so that the drive sheath 816 and shaft 812 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 872 and drive gear 880, respectively, and be drawn out through the skin incision after tissue ingrowth into the mesh pores has secured the sling 20 in position.
- FIG. 57 A still further alternative, miniaturized, mechanical drive mechanism 902, 904 is depicted in FIG. 57 that may be substituted for the above- described adjustment mechanisms 502 and 504 of FIG. 41.
- the adjustment spacing 164, 166 is adjusted by a rack and pinion gear drive 910 extended temporarily through the patient's skin or implanted under the patient's skin and accessed percutaneously with an external adjustment actuator 310 shaped to engage the pinion gear drive 910 similar to external adjustment actuator 310 shown in FIG. 18.
- the gear drive 910 comprises an elongated drive shaft 912 extending through a sheath lumen 914 of a drive sheath 916 from a gear drive housing 918 to the mechanical drive mechanism 902, 904.
- the proximal end of the sheath 916 is coupled to the gear drive housing 918.
- the gear drive housing 918 encloses a gear chamber 926 in which a rack 930, coupled at one end to the proximal end of the drive shaft 912, is disposed for lateral movement, and a pinion 928 is positioned for rotary movement.
- the teeth of the rack 930 and the pinion 928 are in engagement.
- a hex shaped recess 932 is formed in the pinion to be engaged by a hex wrench to rotate the pinion 928 and laterally move the rack 930 within the gear chamber 926.
- the distal ends of the sheath 916 and the drive shaft 912 are coupled to one end of the housing 906 of the drive mechanism 902, 904.
- the housing 906 takes the form of the housing 415' of FIGs. 51 - 53 and is depicted without a cover to expose the rod chamber 908 and the rod 920 and locking mechanism 905 disposed therein.
- Locking mechanism 905 corresponds to locking mechanism 405 described above and may take other forms or may not be provided in this embodiment.
- Rotation of the pinion 928 in one direction drives the rack 930 and the drive shaft 912 in one direction to drive rod 920 out of the rod chamber 908 and lengthen the adjustment spacing 164, 166.
- Rotation of the pinion 928 in the other direction drives the rack 930 and the drive shaft 912 in the other direction to pull rod 920 into the rod chamber 908 and shortens the adjustment spacing 164, 166.
- FIGs. 58A - 58D A still further alternative, miniaturized, mechanical drive mechanism 952, 954 is depicted in FIGs. 58A - 58D that may be substituted for the above- described adjustment mechanisms 502 and 504 of FIG. 41.
- the adjustment spacing 164, 166 is also adjusted by a rack and pinion gear drive 910 extended temporarily through the patient's skin or implanted under the patient's skin and accessed percutaneously with an external adjustment actuator 310 shaped to engage the rack and pinion gear drive 910 as described above with respect to FIG. 57.
- the housing 956 is coupled at one end to the sling intermediate end 36, 46, and encloses a rack chamber 958 and a driven rack 962 within the rack chamber 958.
- the driven rack 962 in rack chamber 958 is coupled at one rack end to the end of the drive shaft 914 and at the other rack end to the sling intermediate end 38, 48.
- a pivotally mounted catch 964 is shaped to engage rack teeth 962 and to guide movement and help maintain rack 960 in a selected position in the rack chamber 958 to define the adjustment spacing 162, 164.
- Rotation of the pinion 928 in one direction drives the drive rack 930 and the drive shaft 912 in one direction to move drive rack 962 out of the rack chamber 958 and lengthen the adjustment spacing 164, 166 as shown in FIG. 58B.
- Rotation of the pinion 928 in the other direction moves the rack 930 and the drive shaft 912 in the other direction to pull rod 920 into the rack chamber 958 and shortens the adjustment spacing 164, 166, as shown in FIG 58D.
- the gear drive housing 918 can be implanted under the skin. It will also be understood that each gear drive housing 918 can be temporarily left extending through the skin incisions following implantation of the sling.
- the distal end of drive shaft 912 may be shaped to detachably engage axially with the rod 920, and the distal end of the sheath 916 may detachably engage with the end of the housing 906 or 956.
- the drive sheath 916 and shaft 912 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 906 or 956 and rod 920 or rack 960, respectively, and be drawn out through the skin incision.
- the drive pinion 928 can alternatively be integrated into the rack chamber 958 in lieu of or alongside the pivoting catch 964.
- the gear drive 910, sheath 916, and the shaft 912 would be eliminated, and the pinion 928 located if the rack chamber 958 could be accessed by the percutaneously inserted hex wrench 310 in the manner described above with respect to FIGs. 18 - 23.
- the above-described embodiments of the second category of the sling of the invention may be modified by substituting other support materials than open pore mesh 30, particularly in the central support portion 40, e.g., homograft or allograft materials or nonporous synthetic materials.
- other materials and structures may be substituted for the mesh 30 in the sections of constituting one or both of the end portions extending from the intermediate ends 38 and 48 to the ends of the central support portion 40.
- one or more straight or spiral suture may be substituted for all or part of such sections.
- adjustable tension slings depict methods and apparatus for adjusting sling tension in each end portion, it will be understood that in each case only one adjustment mechanism may be provided acting on or within one sling end portion (or alternatively on both end portions 1 ).
- all of the above-described embodiments of the urethral or fecal slings may optionally incorporate a sling central portion adjustment mechanism, e.g., suture 108 illustrated in FIGs. 10 and 11 or as otherwise described herein.
- all of the above-described embodiments of the urethral or fecal slings illustrated in FIGs. 12 through 58 may optionally incorporate tissue anchors coupled to the sling ends extending from or incorporated into the sling ends 32 and 34.
- tissue anchors coupled to the sling ends extending from or incorporated into the sling ends 32 and 34.
- the sling anchor 92 illustrated extending from sling end 32 in FIG. 11 could be incorporated into a suture extending from the sling ends 32 and 34 in each such embodiment to assist in tensioning the sling end portions 42 and 44 during adjustment of the tension adjustment mechanisms.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Systems for providing support to body tissue to alleviate incontinence are disclosed that comprise an elongated incontinence sling (20) having a central support portion (40) adapted to be positioned to support any one of the urethra (58) or anus (67) and first and second sling end portions (42,44) extending from the central support portion (40) through body tissue and a tension adjustment mechanism (152,154) acting on or within one or both of the sling end portions (42,44). The sling tension adjustment mechanism (152,154) is attached to and extends through an adjustment spacing (162,164) between sling intermediate ends (36,38,46,48) within at least one sling end portion (42,44). The adjustment spacing (162,164) is lengthened to decrease sling tension and shortened to increase sling tension.
Description
ADJUSTABLE TENSION INCONTINENCE SLING ASSEMBLIES
RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Application Serial No
60/805,544 filed June 22, 2006, and U.S. Provisional Application Serial No 60/806,664 filed July 6, 2006, the entire contents of which are incorporated herein by reference.
TECHNICAL FIELD
[0002] The present invention pertains to improved methods and apparatus providing support to a portion of the urethra or rectum or anus to alleviate urinary or fecal incontinence and particularly to elongated slings having mechanisms for selectively adjusting the tension applied through the sling to body tissue.
BACKGROUND
[0003] Urinary incontinence is a condition characterized by involuntary loss of urine, beyond the individual's control, due to the loss or diminution of the ability to maintain the urethral sphincter closed as the bladder fills with urine. Male or female stress urinary incontinence (SUI) occurs when the patient is physically or emotionally stressed. Such patients may also experience urge incontinence.
[0004] Fecal incontinence is a condition characterized by involuntary defecation or passage of feces through the anal canal due to injury to or weakness of one or more of the internal anal sphincter, the external anal sphincter, and the levator ani.
[0005] Implantable urethral and anal prosthetic sphincter systems have been disclosed in the prior art to treat incontinence that comprise an inflatable balloon that is either pillow or cuff shaped, a balloon reservoir/pressure source filled with a fluid, a pump, and interconnecting tubing. The balloon is implantable beneath or surrounding the urethral tract (at or near the bladder neck in female patients) or around the anal sphincter and is coupled through
tubing to the balloon reservoir/pressure source and pump that are implanted subcutaneously. The pump may be manually actuated to inflate the balloon compress the urethral tract to prevent incontinence and to deflate the balloon to allow voiding. Examples of such prosthetic sphincter systems are disclosed in U.S. Patent Nos. 4,222,377, 4,571 ,749, and 5,562,598, and one such system comprises the AMS-800 Urinary Control System available from American Medical Systems, Inc.
[0006] Urethral tapes or slings have been developed that are implanted in a urethral sling procedure in which the urethral sling is inserted beneath the urethra and advanced in the retro pubic space, perforating the abdominal fascia. In one procedure, peripheral or end portions of the elongated urethral sling are affixed to bone or body tissue, and a central support portion of the elongated urethral sling extends under the urethral or bladder neck to provide a platform that compresses the urethral sphincter, limits urethral distention, and pelvic drop, and thereby improves coaptation. Elongated "self-fixating" slings have also been clinically introduced for implantation in the body that do not require that the end portions be physically attached to tissue or bone and that rely upon tissue ingrowth into sling pores to stabilize the sling as disclosed, for example, in commonly assigned U.S. Patent Nos. 6,382,214, 6,612,977, 6,641 ,524, 6,648,921 , 6,652,450, 6,702,827, 6,802,807, and 6,911 ,003 and publications and patents cited therein.
[0007] The above-described slings comprise a central portion that is adapted to support the urethra, two end portions bracketing the support portion, a protective sheath or sheaths encasing at least the end portions, and connectors at the ends of the sling. Various ways of attaching a sleeve end and sling mesh end to a connector are detailed in the above-referenced *450 patent, for example. Further ways of attaching sling ends to sling implantation tools are disclosed in U.S. Patent Application Publication Nos. 2004/0087970. 2005/0245787, and 2005/0250977. The sling implantation tools are employed to form tissue pathways extending from a vaginal incision to two abdominal skin incisions and to draw the sling end portions through the pathways to dispose the sling free ends out of the skin incisions and the central portion
around the urethra. The connectors are detached from the sling ends, and the sheaths are drawn out of the skin incisions, allowing the incisions to be closed.
[0008] Sling tension is typically adjusted at implantation sufficiently to take up any slack in the sling and impart at least a degree of increased tension to the urethra with the bladder empty. A surgical instrument may be placed between the sling central portion and the urethra, the sling ends drawn to tension and fully close the urethral tract, and the instrument withdrawn so that the uethra is relaxed sufficiently to function. Alternative tension adjustment mechanisms that may be employed during implantation are disclosed in the above- referenced commonly assigned "827 and "921 patents.
[0009] Typically, such urethral tapes or slings are fabricated of a loose weave sling fabric or mesh that acutely engages tissue and encourages tissue ingrowth along the pathway through mesh pores to achieve chronic stabilization or "self-fixation. Tissue ingrowth takes about 2-3 weeks in the typical patient in the absence of any significant intentional or unintentional movement of the mesh. During this post-operative time, the patient monitors the degree of success achieved in ameliorating leakage and any discomfort that might occur if the applied tension is so high as to unduly slow voluntary urination.
[0010] If any such problems occur, it may be necessary to reopen the incisions to access and pull on the sling ends to tighten the sling central portion around the urethra or to reopen the vaginal incision to pull on the sling central portion to loosen the sling central portion around the urethra. Several approaches have been taken to simplify or reduce the need for such postoperative adjustments.
[0011] One tension adjustment complication arises from the fact that the loose weave sling mesh inherently stretches and elongates when tension is applied at the ends or central support portion to overcome resistance of the tissue bearing against the sling mesh along the tissue pathway. It is difficult to judge just how much tension to apply to achieve adequate tightening or loosening in
the central support portion. In one approach to overcoming this complication disclosed, for example, in the above-referenced %450 patent, an elongated repositioning means, e.g., an elongated inextensible tensioning member, is incorporated extending in or along the sling mesh from near the sling ends to or through the sling central portion. Tension applied to the repositioning means is transmitted along the length of the sling so the sling mesh does not substantially stretch during initial positioning and any repositioning during the acute healing phase.
[0012] In another approach disclosed, for example, in U.S. Patent Application
Publication 2006/0058574 (FIGs. 4a - 4f), an expandable member or container is incorporated on or in the sling central support portion that can be inflated or deflated with bulking agent to apply more or less tension to the urethra. As stated therein, optionally, the container has a touchable internal valve element to permit the surgeon to palpate the area prior to injecting or removing the bulking agent. Alternatively, the bulking agent may be injected and removed via a two-way external port. When a bulking agent is injected into the container, the tissue between the mesh and urethra will expand. This results in two effects; a simple vertical lifting due to expansion and a vertical lifting due to stretching the outside of the mesh. A suitable bulking agent may be water or saline. A similar approach is disclosed in U.S. Patent Nos. 4,019,499 and 6,786,861.
[0013] Other approaches that enable increasing tension of the sling central portion against the urethra involve shortening the lengths of the sling end portions as described, for example in the above-referenced, commonly assigned "921 patent. Mesh folds are formed in the sling end portions using filaments that extend through vaginal incisions externally of the body. Depending on the embodiment, the mesh folds can be released to decrease sling tension or be tightened to increase sling tension by pulling on the filament ends following the initial implantation procedure. In other embodiments, filaments are extended substantially through the lengths of the sling end portions and extend from the vaginal incisions. The filaments may
be gripped and pulled to tighten the mesh in the sling end portions to increase overall sling tension.
[0014] In still another approach disclosed, for example, in U.S. Patent
Application Publication 2006/0058574 (FIGs. 5a - 5c), the mesh sling or tape is further modified to include a mechanical adjustment means to adjust the length of the tape in the end portions on either side of the central portion after the tape has been implanted in the tissue pathways. The mechanical adjustment means incorporate a tie-wrap mechanism or sutures and one-way suture retaining devices of the type disclosed in U.S. Patent No. 5,669,935 located along the tape on either side of the central portion. In each case, one suture end is affixed to the tape and extends along it and through a suture retaining device affixed to the tape closer to the central portion. The sutures or tie-wrap are not tensioned at implantation, and the tie-wrap or suture free ends extend through the vaginal incision. If the tension on the urethra is too light as determined during the acute healing phase, the surgeon may grasp and pull on the tie-wrap or suture free ends to shorten the lengths of the tape end portions and thereby increase sling tension. The exposed suture or tie- wrap ends may be severed during chronic implantation.
[0015] In yet another approach, tape or sling ends or the end of a tensioning cable coupled to a urethral support mechanism are coupled to an adjustment mechanism that is chronically implanted subcutaneously and can be accessed to adjust sling tension. See, for example, commonly assigned U.S. Patent No. 4,969,892 and further U.S. Patent Nos. 5,474,518 and 6,117,067 and the REMEEX® readjustable sling by Neomedic, Intl. (www.remeex.com). Ratchet or gear adjustment mechanisms that are accessed using a driver inserted through the skin and thereby rotated to increase or decrease sling tension are disclosed in the '892 and 518 patents. An inflatable/deflatable elastic chamber, adjustment mechanism that incorporates a fill port that is penetrable by a syringe needle advanced through the skin is disclosed in the '067 patent. The adjustment forces are applied to the sling ends and must be transmitted through the sling to effect any change in tension along the sling central portion adjacent the urethra.
[0016] Further sling tension adjustment mechanisms and techniques involve adding tensioning filaments to the sling free ends and extending the elements through the skin incisions and into engagement with buttons or pads implanted subcutaneously engaging a muscle or rectus fascia layer and/or having tissue engaging elements or anchors along the filament or at the sling ends that engage subcutaneous tissues as disclosed, for example, in U.S. Patent No. 6,911 ,002 and in U.S. Patent Application Publication Nos. 2005/0004576 and 2006/0089525.
[0017] Although effective in alleviating SUI, further improvements in urethral and anal slings to post-operatively adjust tension applied to the urethra and anus are desirable.
SUMMARY
[0018] The preferred embodiments of the present invention incorporate a number of inventive features that address the above-described problems that may be combined as illustrated by the preferred embodiments or advantageously separately employed.
[0019] The present invention involves improvements in an elongated incontinence sling, or simply sling, comprising a central support portion and end portions extending from the central portion to sling ends. Herein, use of the term sling or the expression "incontinence sling" without further qualification shall embrace urethral slings adapted to be placed through a tissue pathway disposing the central support portion between the urethra or bladder neck (hereafter collectively referred to as the urethra for convenience) and the vaginal wall to alleviate urethral incontinence and fecal slings adapted to be placed through a tissue pathway disposing the central support portion inferior to the anus, the anal sphincter or the lower rectum (hereafter collectively referred to as the anus for convenience) to alleviate fecal incontinence. Certain embodiments employ tensioning filaments or lines or sutures that are referred to as sutures for convenience.
[0020] In accordance with the present invention, such slings are improved to enhance post-operative sling adjustment of the tension applied to the urethra or anus to enhance efficacy and patient comfort. Several categories of the invention are disclosed herein. The various embodiments disclosed herein are applicable to both males and females, to address issues of incontinence in both, to address issues of prolapse repair in female and perineal floor descent, as well as fecal incontinence in both. Also surgical techniques such as forming suprapubic, retropubic, transobturator, inside out, outside in tissue pathways between two skin incisions, or a tissue pathway formed from a single incision through the vagina or perineal floor (in male or female patients) are also contemplated for passage of a sling therethrough.
[0021] In various embodiments, sling tension adjustment mechanisms join separate sling pieces forming part of the sling mesh with the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing. Various adjustment actuators and techniques are employed to adjust the sling tension adjustment mechanisms to decrease or increase the adjustment spacing between the sling intermediate ends to thereby shorten or lengthen, respectively, the overall length of the sling end portions and to thereby increase or decrease, respectively, the tension applied by the central support portion to the urethra or anus. The sling tension adjustment mechanisms are disposed along the sling end portions so as to be disposed at tissue pathway locations that are proximate the patient's skin to enable application of the external adjustment actuator against the skin or through the skin and underlying tissues to operate the sling tension adjustment mechanisms.
[0022] In one embodiment, sutures are threaded back and forth through mesh pores adjacent the intermediate ends and across the respective adjustment spacings of each sling end portion. The suture ends are adapted to be extended through the skin incisions to function as adjustment actuators in the manner of draw strings for later adjustment of the adjustment spacings during the acute healing phase. The suture ends may be grasped and pulled to pull
the sling intermediate ends closer together to decrease the adjustment spacing and thereby decrease the sling length and increase tension applied by the center support portion to the urethra or anus.
[0023] In a variation of this embodiment, the tensioning sutures are passed through suture or tissue anchors that engage subcutaneous muscle, the rectus fascia or the transobturator membrane and extend through the skin incisions employed to form the tissue pathway that the sling extends through. Alternatively, the tensioning sutures are passed through suture or tissue anchors that engage subcutaneous muscle, the rectus fascia or the transobturator membrane and extend through other skin incisions to be grasped and pulled on to adjust tension. For convenience, such subcutaneous muscle, the rectus fascia or the transobturator membrane or other membranes and fascia are collectively referred to as tissue layers herein.
[0024] In another embodiment, the external adjustment actuator comprises a signal transmitter that is employed to generate a sling adjustment command that passes transcutaneously (through the intact skin), and the adjustment mechanism comprises a receiver for receiving the transmitted commands and increases or decreases the adjustment spacing. In yet further embodiments, the external adjustment actuator is a magnetic field generator or permanent magnet that is employed to generate a magnetic field representing a sling adjustment command that passes transcutaneously through the skin, and the adjustment mechanism comprises a magnetic field responsive element that responds by increasing or decreasing the adjustment spacing. In still further embodiments, the sling tension adjustment mechanism comprises a temperature responsive element responsive to heat or cold applied transcutaneously by an external thermal heater or cooler to heat or cool the adjustment mechanism to thereby increase or decrease the adjustment spacing. In yet further embodiments, the sling tension adjustment mechanism comprises light responsive elements responsive to certain wavelengths of light that can be generated by an external adjustment actuator and
transmitted transcutaneous^ to the sling tension adjustment mechanism to thereby increase or decrease the adjustment spacing.
[0025] In still another embodiment, the external adjustment actuator is inserted percutaneously (penetrating the skin) to engage and operate the sling tension adjustment mechanism to increase or decrease the adjustment spacing. Various sling tension adjustment mechanisms are provided that can be rotated by the external adjustment actuator in one direction to draw the sling intermediate ends together to increase sling tension and that can be rotated in the other direction to allow the sling intermediate ends to separate apart to decrease sling tension.
[0026] In yet another embodiment, the external adjustment actuator is a syringe or the like that is inserted percutaneously to engage a port of a fluid retaining chamber of the sling tension adjustment mechanism, whereby the adjustment spacing is adjusted by injecting or withdrawing fluid from the fluid chamber to increase or decrease the adjustment spacing. In certain variations, the sling tension adjustment mechanism comprises a fluid reservoir to be implanted just below the skin, a fluid chamber disposed in the adjustment spacing and coupled to the intermediate ends, and a tube extending between the fluid reservoir and the fluid chamber in each sling end portion. The fluid reservoir has a fluid delivery/withdrawal port that may be percutaneously accessed to introduce fluid into the fluid reservoir or to withdraw fluid from the fluid reservoir following implantation of the sling to thereby adjust the amount of fluid in the fluid chamber and adjust the length of the adjustable spacing.
[0027] In certain embodiments, the fluid chamber comprises a single action hydraulic cylinder disposed in the adjustment spacing coupled to one sling intermediate end, the cylinder containing a fluid operated piston within an elongated chamber, the cylinder coupled to a sling adjustment rod that is in turn coupled to the other sling intermediate end. The fluid volume introduced into the fluid chamber determines the piston location in the cylinder and the resulting length of the adjustment spacing. In a variation, a dual action hydraulic cylinder having a pair of opposed pistons in the fluid chamber are
each coupled to rods that are in turn coupled to sling intermediate ends governs the adjustment spacing.
[0028] In these embodiments, the fluid chambers are preferably empty of fluid when the sterile sling is supplied in the sterile package from the manufacturer. Implantation of the sling through body pathways may be simpler and easier with the fluid chambers empty. The fluid, e.g., a sterile saline or other biocompatible hydraulic fluid, may be introduced through the fluid delivery port(s) while the port(s) are still accessible. The amount of fluid necessary to effect blockage of the urethral tract may be checked by draining and filling the patient's bladder through the urethral tract, determining efficacy, and adding or withdrawing fluid to adjust the applied urethral pressures in the pressurized and ambient pressure fluid distribution states. Similar procedures may be employed to effect constriction of the anal canal.
[0029] In further embodiments the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin. The adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing^
[0030] Optionally, sling end tissue anchors may be provided on sling ends to engage tissues, e.g., the rectus fascia or the obturator membrane to fix the sling ends and aid in tension adjustment of the sling end portions.
[0031] Optionally, a sling adjustment mechanism may be incorporated into the sling central support portion to enable the separate tensioning of the sling central support portion.
[0032] This summary of the invention has been presented here simply to point out some of the ways that the invention overcomes difficulties presented in the prior art and to distinguish the invention from the prior art and is not intended to operate in any manner as a limitation on the interpretation of
claims that are presented initially in the patent application and that are ultimately granted.
BRIEF DESCRIPTION OF THE DRAWINGS
[0033] These and other advantages and features of the present invention will be more readily understood from the following detailed description of the preferred embodiments thereof, when considered in conjunction with the drawings, in which like reference numerals indicate identical structures throughout the several views, and wherein:
[0034] FIG. 1 is a schematic view of an exemplary sling assembly enclosing a sling adapted to be modified in accordance with the invention to function as an adjustable tension urethral or fecal sling;
[0035] FIG. 2 is a schematic illustration of the sling of FIG. 1 adapted to be modified in accordance with the invention to provide an adjustable tension function;
[0036] FIG. 3 is a schematic illustration of a urethral sling of FIG. 2 implanted in a female patient's body in relation to the urethra or bladder neck;
[0037] FIG. 4 is a schematic illustration of a fecal sling of FIG. 2 implanted in a female patient's body in relation to the anus and rectum;
[0038] FIG. 5 is a schematic illustration of the relation of the sling central support portion and sling end portions to the urethra or anus;
[0039] FIG. 6 is a schematic illustration of a generic embodiment of an adjustable tension sling of the present invention having sling tension adjustment mechanisms formed in gaps or spaces in the sling mesh forming the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing;
[0040] FIG. 7 is a schematic illustration of the generic embodiment of FIG. 6 having optional tissue anchors extending from the sling ends to aid in the operation of the sling tension adjustment mechanisms;
[0041] FIGs. 8 and 9 are schematic illustrations of an embodiment of an adjustable tension sling, wherein sliding locks that engage intermediate ends or loops of the sling mesh are incorporated into the sling end portions to increase and/or decrease the sling tension;
[0042] FIG. 10 is a schematic illustration of a further embodiment of an adjustable tension sling, wherein sling tension adjustment sutures bridge adjustment spacings in the sling end portions and extend through the skin to increase and/or decrease the sling tension;
[0043] FIG. 11A is a schematic illustration of a variation of the adjustable tension sling of FIG. 10, wherein the sling tension adjustment sutures extend through or around tissue anchors and extend through the skin to be available to increase and/or decrease the sling tension;
[0044] FIG. 11B is a schematic illustration of a further variation of the adjustable tension sling of FIG. 10, wherein the sling ends incorporate tissue anchors passed through and engaging tissue layers and the tension adjustment sutures extend through or around further tissue anchors and extend through the skin to be available to increase and/or decrease the sling tension;
[0045] FIGs. 12 and 13 are schematic illustrations of further preferred embodiments of an adjustable tension sling having sling tension adjustment mechanisms bridging adjustment spacings in the sling end portions adapted to be adjusted by commands transcutaneously transmitted from an external adjustment actuator to increase and/or decrease the tension applied locally to the urethra;
[0046] FIGs. 14 - 17 are schematic illustrations of further preferred embodiments of an adjustable tension sling having sling tension adjustment mechanisms bridging adjustment spacings in the sling end portions
comprising serpentine roller adjustment mechanisms that adjusts the length of an adjustment spacing in response to an externally applied command;
[0047] FIG. 18 is a schematic illustration of a further preferred embodiment of an adjustable tension sling, wherein the adjustment mechanism is adjusted by an external adjustment actuator comprising an external adjustment actuator having an engaging end at the end of a shaft adapted to be percutaneously advanced into engagement with the adjustment mechanism to adjust the length of an adjustment spacing between intermediate sling ends in the sling end portions;
[0048] FIG. 19 is a schematic illustration of one embodiment of the sling tension adjustment mechanisms of FIG. 18 employing a rotatable bobbin, a fixed catch and detents around the bobbin circumference;
[0049] FIGs. 20 - 22 are schematic illustrations of the adjustment mechanism of FIG. 19 that adjusts the length of an adjustment spacing in response to an externally applied external adjustment actuator;
[0050] FIG. 23 is a schematic view in section of a variation on the embodiment of FIG. 19, wherein the adjustment mechanism housing supports a rotatable bobbin surrounded by a fixed detent ring providing an increased range of adjustments;
[0051] FIGs. 24 - 26 are schematic plan illustrations of a further embodiment of the adjustment mechanism of FIG. 18, wherein a dual cam assembly having a first cam operates to decrease the adjustable spacings from the neutral length illustrated in FIG. 24 to the contracted length of FIGs. 25A - 25D and a second cam operates to increase the adjustable spacings to the extended length of FIGs. 26A - 26D;
[0052] FIG. 27 is a schematic illustration of a further preferred embodiment of the adjustable tension sling, wherein the adjustment mechanism is adjusted by an external fluid delivery/withdrawal syringe adapted to be percutaneously advanced into engagement with a fluid port of the adjustment mechanism to
adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0053] FIGs. 28 - 31 are schematic plan side or top views illustrating one, single action, hydraulic cylinder, adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0054] FIGs. 32 - 36 are schematic perspective, side or top views in partial section illustrating a further single action, hydraulic cylinder, adjustment mechanism bf FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0055] FIGs. 37 - 40 are schematic perspective or top views illustrating a still further single action, hydraulic adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0056] FIG. 41 is a schematic illustration of a further preferred embodiment of the adjustable tension sling, wherein the adjustment mechanism is adjusted by an external fluid delivery/withdrawal syringe adapted to be percutaneously advanced into engagement with a fluid port of a subcutaneously implantable fluid reservoir coupled to the adjustment mechanism to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0057] FIGs. 42 - 44 are schematic perspective views in partial section illustrating a single action, hydraulic cylinder, adjustment mechanisms of FIG. 41 having fluid chambers adapted to be filled or be emptied of fluid using the syringe of FIG. 41 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0058] FIG. 45 is a perspective view in partial section of a further single action, hydraulic cylinder, adjustment mechanism adapted to be employed as depicted in FIG. 41 having fluid chamber portions adapted to be filled or be emptied of fluid using a syringe to add or withdraw fluid from subcutaneously implanted fluid reservoirs coupled to the fluid chamber portions to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0059] FIG. 46 is a perspective view in partial section of a dual action, hydraulic cylinder, adjustment mechanism adapted to be employed as depicted in FIG. 41 having fluid chamber portions adapted to be filled or be emptied of fluid using a syringe to add or withdraw fluid from subcutaneously implanted fluid reservoirs coupled to the fluid chamber portions to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;
[0060] FIGs. 47 and 48 are schematic plan views in partial section illustrating one form of locking mechanism incorporated into the single action hydraulic cylinder adjustment mechanism of FIGs. 28 - 31 ;
[0061] FIGs. 49 and 50 are schematic plan views in partial section illustrating another form of locking mechanism incorporated into the single action hydraulic cylinder adjustment mechanism of FIGs. 28 - 31 ;
[0062] FIG. 51 is a schematic Illustration of a miniaturized, single action, hydraulic cylinder, adjustment mechanism incorporating the locking mechanism illustrated in FIGs. 47 and 48;
[0063] FIG. 52 is a side plan view of the miniaturized, single action, hydraulic cylinder, adjustment mechanism of FIG. 51 ;
[0064] FIG. 53 is a top plan view in partial section of the miniaturized, single action, hydraulic cylinder, adjustment mechanism of FIG. 51 ;
[0065] FIG. 54 is a schematic Illustration of a miniaturized, mechanical gear, adjustment mechanism that is adjusted by a gear drive extended temporarily through the patient's skin;
[0066] FiG. 55 is a schematic expanded view in partial section illustrating the gear drive components within the adjustment mechanism of FIG. 54;
[0067] FIG. 56 is a schematic Illustration of a further miniaturized, mechanical gear, adjustment mechanism that is adjusted by a gear drive external adjustment actuator extended percutaneously through the patient's skin to engage the gear drive and adjust sling tension;
[0068] FIG. 57 is a schematic Illustration of a still further miniaturized, mechanical gear, adjustment mechanism that is adjusted by a rack and pinion gear drive extended temporarily through the patient's skin; and
[0069] FIGs. 58A - 58D are schematic views in partial section illustrating adjustment of sling tension through use of the rack and pinion gear drive extended temporarily through the patient's skin to adjust the miniaturized, mechanical gear, adjustment mechanism of FIG. 57.
[0070] The drawing figures are not necessarily to scale.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0071] The various embodiments of the present invention are implemented in slings suitable for and methods of implanting such slings in the treatment of male and female urinary and fecal incontinence and to effect pelvic floor, perineal floor, and pelvic proplapse repairs employing a variety of surgical approaches. For example, female pelvic floor repair slings may be implanted by techniques that involve transvaginal, transobturator, suprapubic, pre-pubic, or transperineal exposures or pathways, and male urinary incontinence slings may be implanted by techniques that involve transobturator, suprapubic, or transperineal pathways. Any of the disclosed embodiments can be used as fecal incontinence slings which may be implanted by techniques that involve transvaginal, transobturator, suprapubic or via perineal floor pathways. In
fecal incontinence applications, the disclosed embodiments can be used to correct the anorectal angle in the rectum to re-establish continence in patients. The above methods can, but are not necessarily limited to, utilize helical needles of the type described in U.S. Patent No. 6,911 ,003 or C- shaped needles or elongate needles of the type used to perform suprapubic procedures.
[0072] Referring to FIG. 1 , an exemplary embodiment of an elongated sling assembly 10 is depicted in which the embodiments of the present invention may be advantageously implemented. The elongated sling assembly 10 contains a sling 20 that may be implanted in any of the above-described manners and pathways pathways through which at least end portions of the elongated sling assembly 10 is drawn to dispose a central support portion 40 of sling 20 in operative relation to the urethral or bladder neck or around the anal sphincter or elsewhere in the pelvic region. The sling assembly 10 comprises the sling 20 coupled to sling end connectors 12 and 14 and encased in protective sheaths 22 and 24.
[0073] The depicted exemplary sling assembly 10 thus extends between sling end connectors 12 and 14 that engage with the free ends of right hand and left hand sling implantation tools of the types described above, for example. The sling end connectors 12 and 14 are shaped to dilate the right and left passages or pathways through body tissue formed by the curved needles of the right and left hand implantation tools in the above-described trans-vaginal or transobturator procedures, for example.
[0074] In this example, the sling 20 is enclosed within protective sheaths 22 and 24 extending from the sling end connectors, 12 and 14, respectively, to respective free and open sheath ends 26 and 28. Preferably, the protective sheaths 22 and 24 are constructed of a flexible thin transparent plastic film that enables visual examination of the sling 20 and is sufficiently lubricious that it passes easily through the tissue pathways of the patient formed using the right hand and left hand sling implantation tools of the types described above or otherwise created. The sheaths 22 and 24 can include sheath indicia or tear scores, perforations or holes for assisting the surgeon in
properly orienting sling 20 relative to the urethra. Embodiments of the present invention are contemplated that involve modifying the sheaths 22 and 24.
[0075] The sling 20 that is left in place chronically (following implantation and removal of sheaths 22 and 24 and end connectors 12 and 14) comprises an elongated, rectangular (in this depicted embodiment) braided or preferably knitted, mesh strip or simply mesh 30 as shown in FIG. 2. The sling 20 and mesh 30 are subdivided into a central support portion 40 that is adapted to be placed through a pathway extending between the urethra or bladder neck and the vaginal wall. Proximal end portions 42 and 44 of sling 20 extend from the central support portion 40 to the mesh ends 32 and 34. In FIGs. 1 — 5, the mesh 30 extends between mesh ends 32 and 34 and may be continuous throughout the length of the sling 20 between mesh ends 32 and 34. However, it will be understood that the central portion 40 of sling 20 may be formed of other materials such that the central portion 40 is physically attached to the end portions 42 and 44. In certain embodiments, the central portion 40 may be formed of any tissue-compatible synthetic material or any natural biocompatible material, including, but not limited to, treated autologous, allograft, or xenograft tissues, procine dermis, a tissue engineered matrix, or a combination thereof.
[0076] The sling 20 of sling assembly 10 is therefore similar to those the disclosed in the above-referenced "450 and '003 patents but is modified herein to incorporate one or more of the aspects of the present invention. It will be understood that the mesh 30 may be dimensioned shaped in a variety of ways known in the art for implantation in the treatment of male and female urinary and fecal incontinence and to effect pelvic floor, perineal floor, and pelvic proplapse repairs employing a variety of surgical approaches. For example, the sling 20 may comprise more than two end portions 42 and 44 coupled to connectors and extending at a variety of angles from a particularly shaped center portion 40.
[0077] In the implantation procedures described in the above-referenced '214,
"450, and "524 patents and U.S. Patent Application Publication Nos. 2005/0043580 and 2005/0065395, the sling connector ends 12 and 14 are
fitted to the implantation tools and the proximal end portions 42 and 44 are drawn through the body passageway or pathway. The central support portion 40 is adapted to drawn against tissue to support the urethra or bladder neck or the anal sphincter or elsewhere in the pelvic region after the proximal end portions 42 and 44 are drawn through body pathways. The sling connector ends 12, and 14 are drawn out of the skin incision and detached from the implantation tool needle ends. The mesh 30 and sheaths 22 and 24 are severed just proximate to the connector ends 12 and 14, respectively. The remaining portions of the protective sheaths 22 and 24 are withdrawn over the mesh 30 and through the skin incisions. The sling 20 then remains in place, and tension adjustments are made to provide sufficient urethral or anal resistance to leakage. The incisions are closed upon completion of the tests, and tissue ingrowth into the pores of the mesh 30 takes place in a matter of weeks. Before describing the embodiments of the invention, attention is directed to a step illustrated in FIG. 3 of one such sling implantation procedure that results in the sling 20 extending through a tissue pathway created in a female (for example) patient 50 extending around the urethra 58. In preceding steps, the tissue pathway was formed by passing needles through a vaginal skin incision 62 just adjacent to the vagina 60 through soft tissue between urethra 58 and vagina 60 and along each side of urethra 58 through layers of fat, muscle, and fascia and between pubic bone 54 and bladder 56 to first and second skin incisions through skin 52. Any of the known tissue pathways may be formed in this generally described manner. In a related embodiment, a sling is implanted via a single incision (vaginal incision 62) with the sling being pushed up into the transobturator or retro pubic space. The end connectors 12 and 14 of the sling assembly 10 were attached to the same or other needles to draw the sling assembly 10 through the tissue pathway to dispose the end connectors outside the patient's skin 52. As shown in FIG. 3, the connectors 12 and 14 and sheaths 22 and 24 were removed after being drawn out of the skin incisions, leaving the sling 20 in place. In a related embodiment, connectors 12 and 14 are eliminated.
[0079] Referring to FIG. 4, a schematic illustration of an incontinence sling implanted in a female (for example) patient's body for treating fecal incontinence is depicted. In this illustration, the sling central portion 40 extends underneath the anus or anal sphincter 67 or inferior portion of the rectum 65 (hereafter collectively referred to as the anus 67 for convenience) to correct the anorectal angle in the patient. Various surgical approaches can be used to implant sling 20 to correct fecal incontinence including suprapubic, transobturator, retropubic, prepubic, transperineal and transvaginal (including a single incision approach transvaginal^ or transperineally).
[0080] At this point, the tension T that sling 20 applies against the urethra 58 or anus 67 is adjusted as schematically illustrated in FIG. 5. Since the procedure may be performed using a local anesthesia, the patient 50 is able to provide feedback to the surgeon during adjustment of sling tension. In the procedure illustrated in FIG. 3, typically, the bladder 56 is filled with saline using a catheter, and the patient is requested to cough. The surgeon is able to determine whether leakage occurs and may adjust the tension on the sling 20 by pulling on the exposed sling ends 32 and 34 to increase tension of the center support portion 40 against the urethra 58 or by pulling on center support portion through the vaginal incision to decrease the tension of the center support portion 40 against the urethra 58. The exposed end sections of the end portions 42 and 44 are trimmed away, and the abdominal incisions and the vaginal incision (as well as the labia fold incisions for the transobturator approach) are closed. In the various embodiments of the present invention, such slings as sling 20 are improved to enhance postoperative sling adjustment of the tension T applied to the urethra 58 or the anus 67 to enhance efficacy and patient comfort.
[0081] While not essential to the practice of the present invention, it may be desirable to provide mechanisms incorporated into or that act on the sling central support portion 40 to facilitate the adjustment of the tension T applied to the urethra 58 or the anus 67. For example, a sling central portion adjustment mechanism may be provided to increase and/or decrease the tension applied locally to the urethra 58 or the anus 67. The sling central
portion adjustment mechanism is associated directly or indirectly with the sling central support portion 40 and is distinct from the sling tension adjustment mechanisms incorporated in the sling end portion or portions.
[0082] For example, as shown in FIG. 10, the sling central portion tension adjustment may simply comprise a suture 108 extending around the sling central portion and passing through the skin incision to provide post-operative tension adjustment of the sling central portion 40 by pulling on sling ends 106. Adjustments may be made until the suture is withdrawn through the skin 52 or is absorbed by the body.
[0083] Longer-term post-operative adjustment of the sling central portion tension may be accomplished with sling central portion adjustment mechanisms that remain in place. In one approach, the mechanism may be accessed for tension adjustment employing an external adjustment actuator that is percutaneously advanced through the skin 52 to engage the sling central portion adjustment mechanism. For example, one such approach involves injecting or withdrawing fluid from a fluid chamber of a pillow of the sling central portion adjustment mechanism applying pressure to the urethra 58 or the anus 67.
[0084] In certain more complex embodiments of the second category, sling tension adjustment mechanisms are formed in gaps in the sling mesh forming the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing. Various mechanisms and techniques are employed to adjust the sling tension adjustment mechanisms to decrease or increase the adjustment spacing between the sling intermediate ends to thereby shorten or lengthen, respectively, the overall length of the sling end portions and to thereby increase or decrease, respectively, the tension applied by the central support portion to the urethra. The sling tension adjustment mechanisms are disposed along the sling end portions so as to be disposed at tissue pathway locations that are proximate the patient's skin to enable access to or application of the external adjustment actuator against the
skin or through the skin and underlying tissues to operate the sling tension adjustment mechanisms.
[0085] Turning to FIGs. 6 and 7, in accordance with embodiments of the present invention, a sling tension adjustment mechanism is incorporated into or on a section of one or preferably both of the sling end portions 42 and 44 proximal to but spaced from the central support portion 40 that can be adjusted at least in the acute post-operative healing phase. A first sling end portion tension adjustment mechanism 102 is schematically depicted extending between and coupled to sling intermediate ends 36 and 38 of sling end portion 42. The gap or adjustment spacing 162 between sling intermediate ends 36 and 38 is shortened to increase tension or lengthened to decrease tension in sling end portion 42 Similarly, a second sling end portion tension adjustment mechanism 104 is schematically depicted extending between and coupled to sling intermediate ends 46 and 48 of sling end portion 44. The gap or adjustment spacing 164 between sling intermediate ends 46 and 48 is shortened to increase tension or lengthened to decrease tension in sling end portion 44. The spacing of each sling tension adjustment mechanism 102 and 104 from the central support portion 40 is selected in relation to the anatomy for either male or female fecal or urinary incontinence slings and the implantation route or technique to facilitate access or engagement with an externally applied adjustment actuator or an actuator element extending percutaneously from a skin incision. The adjustment mechanisms are generally adjusted to adjust the length and/or tension of the end portions 42 and 44 to thereby tension the center support portion 40 and draw it closer to the urethra 58 or anus 67 to relax tension of the center support portion 40 to release pressure on the urethra 58 or anus 67.
[0086] As shown in FIG. 7, it may be desirable to stabilize the sling ends 32 and 34 in tissue by optionally providing sling tissue anchors 92 and 94 extending from the sling ends 32 and 34. The anchors 92 may take any of the forms disclosed in the above-referenced U.S. Patent Application Publication No. 2005/0004576, for example. Generally speaking such tissue anchors 92 and 94 can be readily drawn through tissue in the direction away from the
sling ends 32 and 34, respectively, but resist retraction back through the tissue. Advantageously, the sling tissue anchors 92 and 94 may be extended through and bear against the rectus fascia or the transobturator to stabilize the sling ends 32 and 34 to set sling tension and to resist being drawn toward the sling tension adjustment mechanisms 102 and 104 when tension is increased.
[0087] In certain particular embodiments of the invention depicted in FIGs. 8 and 9, the end portion tension adjustment mechanisms comprise sliding locks 132 and 134 (FIG. 8) or 142 and 144 (FIG. 9) that engage the end portions 42 and 44 of the sling mesh 30. In one variation shown in FIG. 16, sections of the sling mesh 30 are looped and passed through channels of sliding locks 132 and 134. In the other variation shown in FIG. 9, the sling intermediate ends are drawn through channels of the sliding locks 142 and 144. It will be understood that the depicted slings 20 are disposed in the patient's body the manner depicted in FIG. 3 or FIG. 4. The loops 136, 138 or free ends 146, 148 function as actuator elements that can be grasped through the skin incisions 82 and 84 (or through a vaginal incision if a single incision approach is chosen) and pulled upon with respect to the sliding locks 132, 134 or 142, 144 to shorten the lengths of the end portions 42, 44 and increase tension on the urethra 58.
[0088] Sliding locks 132, 134 and 142, 144 operate similar to zip-tie locks. It will be understood that the depicted loops 136, 138 and the free ends 146, 148 can comprise sutures or zip-lock tapes fastened to intermediate ends of the sling mesh 30 so that the sutures or zip-lock tapes are drawn through channels of the sliding locks 132, 134 and 142, 144.
[0089] A further specific embodiment of the present invention is depicted in
FIG. 10, wherein the end portion 42 is severed at intermediate ends 36 and 38 to form a gap or adjustment spacing 162, and the end portion 44 is severed at intermediate ends 46 and 48 to form a gap or adjustment spacing 164. Sutures 156 and 158 are threaded back and forth through mesh pores adjacent the intermediate ends 36,38 and 46, 48, respectively, and across the respective adjustment spacings 162 and 164, to function as draw strings for
later adjustment of the adjustment spacings 162 and 164 during the acute healing phase. The suture 156 and adjustment spacing 162 comprise sling end portion tension adjustment mechanism 152 of end portion 42, and the suture 158 and adjustment spacing 164 comprise sling end portion tension adjustment mechanism 154 of end portion 44.
[0090] In this embodiment, the suture ends 166 and 168 of respective sutures
156 and 158 extending from the skin incisions 82 and 84 during implantation of the sling 20 function as the adjustment actuators. The suture ends 166 and 168 may be grasped and pulled to shorten the adjustment spacings 162 and 164 to thereby shorten the sling end portions 42 and 44 and thereby decrease the sling length and increase tension applied by the center support portion 40 to the urethra 58 (or anus).
[0091] A further adjustment suture 108 (optionally formed of biodegradable material) is optionally placed around the sling mesh 30 and extended through the vaginal skin incision 62 to enable manual tension adjustment. The suture ends 106 may be grasped and pulled to function as an actuator element and pull the sling mesh away from the urethra 58 to release tension applied by the center support portion 40 to the urethra 58 (or anus).
[0092] In the absence of adjustment suture 108, the sling central support portion 40 may be accessed by reopening the vaginal incision 62 to pull on the sling 20 to draw the sutures 156 and 158 back through the mesh pores, thereby increasing the sling length and decreasing tension applied by the center support portion 40 to the urethra 58 (or anus).
[0093] Optionally, a biodegradable sheath may be placed over the adjustment mechanisms 152 and 154 and at least a portion of the sling mesh to inhibit tissue ingrowth into the mesh pores and adjustment spacings 162 and 164 and thereby ease adjustment of the sling 20 until the sheath is absorbed and tissue ingrowth encapsulates and immobilizes sling mesh 30.
[0094] The suture ends 166, 168, and 106 may be severed at the respective incisions 82, 84, and 62 following final adjustment.
[0095] Certain sling implantation procedures for urethral and fecal slings involve employing implantation instruments having needles that are advanced from a first skin incision to a second skin incision to form first and second or right and left (non-suprapubic) tissue pathways around the urethra 58 or the anus 67. The instruments or other instruments are then employed to push or pull the sling end portions 42 and 44 through the first and second pathways to dispose the sling ends near or through the skin incisions 82 and 84 as shown in FIGs. 3 and 4. The above-described embodiments contemplate implantation in such tissue pathways.
[0096] Other sling implantation procedures for urethral and fecal slings have sling ends configured to engage sling implantation tool needle ends to be pushed from a single incision adjacent the urethra 58 (or the anus 67) through first and second tissue pathways to dispose the sling end portions extending away from the urethra 58 (or anus 67). The skin incisions 82 and 84 are not necessarily made, and the sling ends are disposed at subcutaneous locations.
[0097] In a variation of this embodiment of the invention depicted in FIG. 11A1 the sutures 156 and 158 are drawn through tissue anchors 96 and 98 that are passed through and bear against subcutaneous tissue layers 72 and 74, respectively. Generally speaking, the tissue anchors 96 and 98 have channels or bores that one or both of the sutures 116 and 118 are passed though that grip the sutures with sufficient force to maintain sling tension. The suture retaining force may be overcome by manipulation of the suture and tissue anchor to increase or decrease sling tension during post-operative recuperation. The suture ends extending through the skin incisions 82 and 84 are placed under the skin 52, and the incisions are closed. During chronic implantation, adjustments of sling tension may take place by reopening the skin incisions 82 and 84 to access the suture ends and the tissue anchors 96 and 98.
[0098] In this embodiment, the suture 156 passes through a slidable bore of the tissue anchor 96 and through the same skin incision 82 that the tissue pathway is created for the sling 20. Similarly, the suture 158 is depicted extending through a slidable bore of the tissue anchor 98 and through the
same skin incision 84 that the tissue pathway is created for the sling 20. For example, the tissue pathway may extend through the right and left transobturator membranes (tissue layers 72 and 74) that the tissue anchors 96 and 98 are passed through and bear against.
[0099] In a further variation of this embodiment of the invention depicted in
FIG. 11B1 tissue anchors 632 and 634 are coupled to the sling ends 32 and 34, respectively, and the sutures 156 and 158 are passed through the tissue anchors 96 and 98. In the implantation procedure, the tissue anchor 632 and the sling end portion 42 are pushed from a single skin incision below the urethra 58 or anus 67 through a first tissue pathway such that the tissue anchor 632 is passed through and bears against tissue layer 72. Similarly, the tissue anchor 634 and the sling end portion 43 are pushed from the skin incision below the urethra 58 or anus 67 through a second tissue pathway such that the tissue anchor 634 is passed through and bears against tissue layer 74.
[00100] The suture 156 and tissue anchor 96 are pushed through a further tissue pathway such that the tissue anchor 96 is passed through and bears against a separate tissue layer 76 and then through a skin incision 86. Similarly, the suture 158 and tissue anchor 98 are pushed through a further tissue pathway such that the tissue anchor 96 is passed through and bears against a separate tissue layer 76 and then through a skin incision 88. Alternatively, the sutures 156 and 158 can first be passed by themselves through the skin incisions 86 and 88, respectively, and the tissue anchors 96 and 98 can be applied over the sutures 156 and 158 to bear against the tissue layers 76 and 78, respectively. In a related embodiment, the various sling embodiments can be used without tissue anchors.
[00101] Tension can be applied by pulling on the suture ends of sutures 156 and 158, respectively while applying pressure against the subcutaneous tissue anchors 96 and 98, thereby decreasing the spacings 162 and 164. Tension on sutures 156 and 158 can be release to lengthen spacings 162 and 164 by exposing and manipulating the tissue anchors 96 and 98.
[00102] It will be understood that the tissue layers 72, 74, 76, and 78 may comprise a muscle layer, fascia or transobturator membrane. Tissue layers 72 and 76 may be the same or a different tissue layer, and tissue layers 74 and 78 may be the same or a different tissue layer. The particular locations of skin incisions 86 and 88 and the respective tissue anchors 96 and 98 may include obturator, abdominal, pelvic, perineal and rectal regions.
[00103] The tissue anchors 632, 634, 96, and 98 may take any of the forms disclosed in the above-referenced '002 patent and in U.S. Patent Application Publication Nos. 2005/0004576 and 2006/0089525.
[00104] A wide variety of other specific embodiments of the invention employing adjustment mechanisms bridging a gap between the sling intermediate ends 36, 38 and 46, 48 to adjust spacings 162 and 164 are contemplated. In the following embodiments, the adjustment actuator acts upon the sling end portion adjustment mechanisms 102 and 104 by percutaneous direct access to an adjustment tool or transcutaneous transmission of adjustment commands to an adjustment control of the adjustment mechanism. In these embodiments, both shortening and lengthening of the length of the adjustment spacings 162 and 164 for increasing and decreasing sling tension are contemplated by these embodiments.
[00105] Referring to FIG. 12, adjustment mechanism 202 is disposed across the adjustment spacing 162 and affixed to sling intermediate ends 36 and 38, and adjustment mechanism 204 is disposed across the adjustment spacing 164 and affixed to sling intermediate ends 46 and 48. An external adjustment actuator 200 is depicted brought into proximity to or applied against the skin 52 for generating an adjustment command 210 that is communicated transcutaneously through the skin 52 and underlying fat, tissue and fascia to adjustment mechanism 204. It will be understood that the external adjustment actuator 200 may also be brought into proximity to the skin 52 for generating a similar adjustment command communicated transcutaneously through the skin 52 and underlying fat, tissue and fascia to adjustment mechanism 202. The adjustment mechanisms 202 and 204 comprise electro-mechanical
systems or elements or materials that respond to the transmitted command 210 to effect the adjustment in length of the adjustable spacings 162 and 164. In a related embodiment, mechanisms 202 and 204 are shape memory alloy (e.g. nitinol) elements that contract in size and expand in size depending on the stimulus.
[00106] In one variation of this embodiment depicted in FIG. 13, the external adjustment actuator 200 is an RF signal generator that generates an RF signal 210 through antenna 206 applied to the patient's skin as command 210. The adjustment mechanisms 202 and 204 each incorporate an RF antenna 216 that receives the RF signal and apply the received signal to internal electro-mechanical drive mechanism 218 for extending or contracting the length of the adjustment mechanisms 202 and 204.
[00107] Alternatively, the RF signal 210 is a power signal that is received by antenna 216 to generate a current that is applied to resistive heating elements or heat responsive elements forming the electro-mechanical drive mechanism 218 of each of adjustment mechanisms 202 and 204. For example, the electro-mechanical drive mechanism 218 of the adjustment mechanisms 202 and 204 may comprise chambers holding a heat responsive fluid that expands as heat is applied, and the expanded fluid drives pistons in the chambers to increase the overall length of the adjustment mechanisms 202 and 204. Or, the electro-mechanical drive mechanism 218 may comprise a heat responsive bi-metal strip that is heated by the received current and expands or contracts in length to expand or contract the length of the adjustment mechanisms 202 and 204.
[00108] Alternatively, the external adjustment actuator 200 generates a pulsed or steady magnetic field as the command 210. The adjustment mechanisms 202 and 204 incorporate magnetic responsive switches, e.g., reed switches or MAGFETs within the electro-mechanical drive mechanism 218 that switch states and operate the electro-mechanical drive mechanism 218 to extend or contract the length of the adjustment mechanisms 202 and 204.
[00109] Alternatively, the external adjustment actuator 200 is simply a heating or chilling pad that is applied to the skin to locally heat or cool the underlying tissue and the adjustment mechanisms 202 and 204 to expand or contract a heat responsive element or material that is incorporated into the adjustment mechanisms 202 and 204. The heating and/or cooling of the heat responsive element or material extends and/or or contracts the length of the adjustment mechanisms 202 and 204.
[00110] Alternatively, the sling tension adjustment mechanisms 202 and 204 comprise light responsive elements, and the external adjustment actuator 200 comprises a light source (laser or diode) that emits light pulses of a light frequency capable of penetrating the skin and underlying fat layers and fascia as the command 210 that the light responsive elements are capable of detecting. An electro-mechanical drive mechanism 218 responds to the output signals of the light detectors to adjust the length of the adjustment mechanisms 202 and 204.
[00111] FIGs. 14 - 17 are schematic illustrations of a serpentine roller that may be incorporated into the adjustment mechanisms 202 and 204 to adjust the length of the adjustment spacings 162 and 164. The intermediate ends 36, 38 and 46, 48 are attached to ends of a band 230 that extends through a channel 226 of the housing 220, the channel 226 including two chambers 222 and 224. The band 230 extends around roller 232 disposed in chamber 222 and roller 234 disposed in chamber 224. The lengths of the adjustment spacings 162, 164 depend on the location of the rollers 232 and 234 in the respective channels 222 and 224.
[00112] A maximum length of the adjustment spacings 162, 164 is obtained with the rollers 232 and 234 disposed substantially out of the respective channels 222 and 224 as shown in FIG 16. A minimum length of the adjustment spacings 162, 164 is obtained with the rollers 232 and 234 disposed fully within the respective channels 222 and 224 as shown in FIG 17. An intermediate or neutral length of the adjustment spacings 162, 164 is obtained with the roller 232 disposed fully within the respective channels 222 and the roller 234 disposed substantially out of the respective channel 224 as
shown in FIG 15. The sling 20 would be implanted with the rollers 232 and 234 disposed in the neutral position of FIG. 15, and later adjustments to the position of FIG. 16 or FIG. 17 would be made with an external adjuster applied to the patient' s skin 52. It is contemplated that movement of the rollers 232 and 234 would be controlled by an electro-mechanical interface between the rollers 232 and 234 and any mechanism responsive to commands 210 generated by the external actuator 200 as described above.
[00113] In further embodiments illustrated schematically in FIG. 18, the external adjustment actuator 310 has an actuator-engaging end 312 at the end of a shaft 314. The tension adjustment mechanisms 302 and 304 are shaped with actuator end receptacles 306 and 308, respectively, that can be manually palpated through the skin 52. The actuator engaging end 312 and shaft 314 can be inserted percutaneously through skin incisions 64 and 66 to fit the actuator engaging end 312 into the actuator end receptacles 306 and 308. The external adjustment actuator 310 is depicted in engagement (at separate times) with both actuator end receptacles 306 and 308 in FIG. 18. Various rotatable mechanisms within the tension adjustment mechanisms 302 and 304 are contemplated that can be rotated by manual rotation of the external adjustment actuator 310 in one direction to shorten the sling end portions 42 and 44 together to increase sling tension and that can be rotated by manual rotation of the external adjustment actuator 310 in the other direction to lengthen the sling end portions 42 and 44 to separate apart to decrease sling tension. The actuator engaging end 312 is shaped to both penetrate tissue and to have mating surfaces for engaging the end receptacles 306 and 308 to enable rotation in both directions.
[00114] The tension adjustment mechanisms 302 and 304 depicted in FIGs. 19 - 22 each comprise a bobbin 316 mounted for rotation in a receptacle of a housing 320 fixed at one end to the sling intermediate end 36, 46, the bobbin 316 shaped with the actuator end receptacles 306, 308 extending axially into one side of the bobbin 316. A band or strand 330 extends from a fixed connection with the other sling intermediate end 38, 48 into a channel 322 in housing 320 and around a groove of the bobbin 316 to a fixed coupling with
the bobbin 316. The bobbin 316 is formed with three detents 332, 334, 336 spaced apart around its circumference, and the free end of a catch 324 fixed at its other end to housing 320 engages one of the detents 332, 334, 336.
[00115] In this embodiment, the actuator end receptacles 306, 308 have a five sided socket shape, and the engaging end 312 of the shaft 314 of external adjustment actuator 310 is also shaped as a mating five-side wrench having a distal point and is shown poised to be inserted into the actuator end receptacle 306, 308 in FIG. 19. The neutral position of the bobbin 316 at the time that the sling 20 is implanted is depicted in FIG. 20. At a later date, the external adjustment actuator 310 can be used to engage and rotate the bobbin 316 to either increase or decrease the amount of the band or strand 330 taken up on the bobbin groove and to thereby shorten or extend, respectively, the adjustment spacing 162, 164, and tighten or loosen, respectively, the sling 20 and increase or decrease, respectively, tension applied by the sling central support portion 40 to the urethra 58 (or anus).
[00116] As shown in FIG. 21 , a minimum length of the adjustment spacing 162, 164 is obtained by clockwise rotation of the bobbin 316 to move the catch end 324 out of detent 334 and along the outer edge of the bobbin 316 until the catch end engages detent 336. As shown in FIG. 22, a maximum length of the adjustment spacing 162, 164 is obtained by counter-clockwise rotation of the bobbin 316 to move the catch end 324 out of detent 334 and along the outer edge of the bobbin 316 until the catch end engages detent 332.
[00117] An alternative detent arrangement of the bobbin and housing is depicted in FIG. 23. In this variation, the housing 340 supports a rotatable bobbin 346 surrounded by a fixed detent ring 342. The actuator-engaging receptacle 348 is shaped to receive an actuator end shaped like a three-sided Keith needle. A first band or strand 350 extends from a fixed end about a portion of the circumference of the bobbin 346 and is coupled at its other end to the intermediate end 36, 46 of the sling 20 formed of mesh 30. A second band or strand 352 extends from a fixed end about a portion of the circumference of the bobbin 346 and is coupled at its other end to the intermediate end 38, 48 of the sling 20. The rotatable bobbin 346 and fixed
detent ring 342 further comprise a plurality of flexible tabs or teeth that interlock like gear teeth.
[00118] Again, a neutral position of the bobbin 346 is established at the time that the sling 20 is implanted is depicted. At a later date, the Keith needle style external adjustment actuator 310 can be used to engage the receptacle 348 and rotate the bobbin 346 clockwise to decrease or counterclockwise to increase the amount of the bands or strands 350, 352 taken up on the bobbin grooves. The clockwise and counterclockwise bobbin rotations thereby extend or shorten, respectively, the adjustment spacing 162, 164, and loosen or tighten, respectively, the sling 20 and decrease or increase, respectively, tension applied by the sling central support portion 40 to the urethra 58.
[00119] An alternative dual cam adjustment mechanism 362, 364 is depicted in FIGs. 24, 25A - 25D, and 26A - 26D disposed in the adjustable spacings 162, 164. The tension adjustment mechanisms 362, 364 each comprise a dual cam assembly 370 comprising a first cam 372 coupled to first tether 374 and a first cam follower 376 and a second cam 382 coupled to a second tether 384 and second cam follower 386. The ends of the first and second tethers 374 and 384 are coupled to the sling intermediate ends 36, 46, and 38, 48 respectively. The first cam 372 rotated with respect to cam follower 376 operates to decrease the adjustable spacings 162, 164 from the neutral length of FIG. 24 to the contracted length of FIG. 25A as shown in FIGS. 25B - 25D. The second cam 382 rotated with respect to cam follower 38 operates to increase the adjustable spacings 162, 164 from the neutral length of FIG. 24 to the contracted length of FIG. 26A as shown in FIGS. 26B - 26D. The external adjustment actuator 310 (FIG. 18) is operated to engage either the first or the second cam 372 or 382 to increase or decrease sling tension, respectively. Any suitable socket and actuator configuration may be employed for effecting selective rotation of the cams.
[00120] In yet further embodiments of the second category depicted schematically in FIG. 27, the external adjustment actuator is a syringe 410 or the like that is inserted percutaneously through a skin incision to engage a
port 406, 408 of a fluid retaining chamber of the sling tension adjustment mechanism 402, 404.
[00121] In the embodiment depicted in FIGs. 28 - 31 , the port 406, 408 comprises a penetrable, resealable septum, and a needle stop may be included within the fluid chamber opposite the resealable septum to prevent needle perforation of the wall of the fluid retaining chamber within the outer housing 415. The port 406, 408 is coupled to sling intermediate end 36, 46, and a rod 420 is coupled at its free end to the sling intermediate end 38, 48. The port 406, 408 accesses a cylinder within housing 422 so that the fluid delivered through the septum of the port 406, 408 is also delivered into the cylinder. A piston coupled to the rod 420 (which may simply be an enlarged diameter end of rod 420) is also enclosed within the cylinder of housing 422. Rod 420 extends through a C-shaped opening 417 in the end of outer housing 415 that guides but does not inhibit movement of rod 420. The adjustment spacing 162, 164 is adjusted by injecting or withdrawing fluid from the fluid chamber to laterally extend or retract the piston mounted rod 420 to increase or decrease the adjustment spacing 162, 164 as shown in FIGs. 29 - 31.
[00122] A variation on this embodiment is depicted in FIGs. 32 - 36, wherein a sling tension adjustment mechanism 432, 434 is substituted for the sling tension adjustment mechanism 402, 404 of FIGs. 27 - 31. In this variation, the port 436 is formed with a syringe needle interlock 443, and the syringe 410 has a special interlocking tip 442 that opens and enters the interlock 443 to deliver or withdraw fluid from or to the syringe chamber 416. The port 436 is coupled to a housing 446 enclosing a cylinder or fluid chamber 444 that the fluid is delivered into. The interlock 443 is spring loaded by spring 440 within the port chamber 445. A piston 448 is also enclosed within the housing 446 and coupled to a rod 450 extending from the housing end. The port 436 is coupled to sling intermediate end 36, 46, and the rod 450 is coupled at its free end to the sling intermediate end 38, 48.
[00123] The volume of fluid delivered into the fluid chamber 444 dictates the position of the cylinder 448 within the chamber 444 and the extension of the rod 450. The adjustment spacing 162, 164 is therefore adjusted by injecting
or withdrawing fluid from the fluid chamber 444 to laterally extend or retract the piston 448 and rod 450 to increase or decrease the adjustment spacing 162, 164 as shown in FIGs. 35 - 36.
[00124] The sling tension adjustment mechanisms 402, 404 and 432, 434 depicted in FIGs. 27 - 36 comprise single action, hydraulic pistons, wherein the fixed housing is coupled to one sling intermediate end and the movable rod end is coupled to the other intermediate sling end. It will be understood that the sling tension adjustment mechanisms 402, 404 and 432, 434 depicted in FIGs. 27 - 36 may be modified to function as dual action, hydraulic pistons having axially aligned and opposed pistons coupled to respective rods, and the rod free ends of each mechanism coupled to the sling intermediate ends 36, 46 and 38, 48.
[00125] A still further variation on this embodiment of the second category illustrated in FIG. 27 is depicted in FIGs. 37 - 40, wherein a sling tension adjustment mechanism 462, 464 is substituted for the sling tension adjustment mechanism 402, 404 of FIGs. 27 - 31. In this dual action variation, the external adjustment actuator is the syringe 410 or the like that is inserted percutaneously through a skin incision to engage a port 406, 408 of a fluid chamber 470 of the sling tension adjustment mechanism 462, 464. The port 406, 408 comprises a penetrable, resealable septum, and a needle stop may be included within the fluid chamber opposite the resealable septum to prevent needle perforation of the wall of the fluid chamber 470.
[00126] The S-shaped chamber housing 472 enclosing the fluid chamber 470 is shaped with opposed spiral arms 466 and 468 respectively coupled to sling intermediate end 36, 46 and end 38, 48. The housing 472 is formed of a material that is expandable as fluid volume and pressure increases as shown in FIG. 39 and contractible as fluid volume and pressure decreases as shown in FIG. 40. The adjustment spacing 162, 164 is therefore adjusted by injecting or withdrawing fluid from the fluid chamber 470 to laterally extend or retract the opposed spiral arms 466 and 468 to increase or decrease the adjustment spacing 162, 164 as shown in FIGs. 37 - 40.
100127] In a further alternative variation (not shown), the arms 466 and 468 may be corrugated with one or more corrugation to function in the manner of bellows. In such case, the arms 466 and 468 may be spiral as depicted or extend in axial alignment and away from one another to increase or decrease the adjustable spacing 162, 164.
[00128] In certain further embodiments of the second category of the invention depicted schematically in FIG. 41 , the sling tension adjustment mechanisms 502 and 504 comprise fluid reservoirs 512 and 514, housings 522 and 524, respectively, and tubes 532 and 534 extending between the fluid reservoirs 512 and 514 and housings 522 and 524, respectively, alongside the sling end portions 42 and 44, respectively. The housings 522 and 524 are coupled to the sling intermediate ends 36, 38 and 46, 48, respectively, and define the adjustment spacings 162 and 164, respectively.
[00129] The fluid reservoirs 512 and 514 are adapted to be implanted just below the skin 52 adjacent the skin incisions 82 and 84, respectively. Alternatively, the tubes 532 and 534 may extend through the skin incisions 82 and 84 to dispose the fluid reservoirs 512 and 514 outside the skin during the healing phase. In that case, the tubes 532 and 534 may be pulled upon to detach their distal ends from tube fittings on the housings 522 and 524 after tissue ingrowth into the mesh pores has secured the sling 20 in position. Tissue ingrowth should maintain the adjustment spacings 162, 164 even if the hydraulic fluid (saline) then escapes from fluid cylinders and chambers within the housings 522 and 524.
[00130] The fluid reservoirs 512 and 514 have respective fluid delivery/withdrawal ports 516 and 518 that may be percutaneously accessed by needle tip 412 of syringe 410 to introduce fluid into the fluid reservoir 512, 514 or to withdraw fluid from the fluid reservoir 512, 514 following implantation of the sling 20 to thereby adjust the amount of fluid in the fluid chambers of housings 522 and 524 and adjust the length of the adjustable spacings 162 and 164.
[00131] It will be understood that the housings 522, 524 may incorporate any of the adjustment mechanisms 402, 404 or 432, 434 or 462, 464 and variations thereof described above with the tubes 532, 534 and fluid reservoirs 512 and 514 substituted for the above-described fluid delivery/withdrawal ports.
[00132] In FIGs. 42 - 45, alternative forms of adjustment housings 522 and 524 of the adjustment mechanisms 502, 504 and 502', 504' containing fluid chambers, pistons, and connecting rods are depicted in greater detail. The housing 522, 524 encloses a fluid chamber 526, a piston 528 and a rod 530 extending axially from one end of the housing 522, 524. In the particular single action cylinder designs depicted in FIGs. 42 - 45, the housing 522, 524 is elliptical in lateral cross-section having a major ellipse axis corresponding generally to the width of the mesh 30 of sling 20 so that the minor ellipse axis minimizes overall thickness of the sling 20. The housing wall 542, fluid chamber 526, and piston 528 may be shaped more oblong than elliptic as shown in FIG. 46. The sling intermediate end 36, 46 is coupled by thermoplastic rivets or sutures or the like to the stationary end of housing 522, 524, and the sling intermediate end 38, 48 is coupled by thermoplastic rivets or sutures or the like to the movable free end of rod 530 in each housing 522, 524. It will be understood that the piston 528 is formed with a ring or rings that provide a tight seal with the housing wall 542 defining the fluid chamber 526 to minimize fluid loss.
[00133] In the variation of this embodiment of adjustment mechanism 502, 504 depicted in FIGs. 42 - 44, the tubes 532 and 534 extend from the end of the housing 522, 524 opposite the rod 530 and centrally along the axes of the mesh 30 of each of the end portions 42 and 44, respectively, to the fluid reservoirs 512 and 514, respectively, to supply fluid to or withdraw fluid from the chamber portion defined by the housing interior wall 536 and the piston head 538. In the variation of adjustment mechanism 502', 504' depicted in FIG. 45, the tube 532, 534 extends offset from the axis of the sling mesh 30.
[00134] A dual action hydraulic cylinder form of an adjustment mechanism 552 similar to adjustment mechanisms 502, 504 and 502', 504' is depicted in FIG. 46. An oblong shape of the piston 558, the housing 562, and fluid chamber
556 is also depicted in FIG. 46 that may be substituted for the elliptical shapes of the piston 528, housing 522, 524, and fluid chamber 526, respectively, of FIGs. 42 - 45.
[00135] The dual action adjustment mechanism 552 requires two subcutaneously implantable fluid reservoirs (not shown) or a dual action fluid reservoir and tubes 572 and 574 extending alongside the sling mesh to subcutaneous implantation sites. The housing 562 encloses a fluid chamber 556, piston 558 and rod 560 extending through an opening in one end of the housing 562. The fluid chamber 556 comprises a contracting chamber 568 coupled to tube 572 on one side of piston 558 and an extending chamber 570 coupled to tube 574 on the other side of the piston 558.
[00136] In use, the adjustment mechanism 552 is substituted for the adjustment mechanisms 502 and 504 of FIG. 41 to define the adjustment spacings 162 and 164 as a function of the position of the piston 558 in the fluid chamber 556. The adjustment spacing 162, 164 is lengthened if fluid is introduced into chamber portion 570 from the first fluid reservoir through tube 574 while fluid is simultaneously withdrawn from chamber portion 568 into the second fluid reservoir through tube 572. Conversely, adjustment spacing 162, 164 is shortened if fluid is introduced into chamber portion 568 from the second fluid reservoir through tube 572 while fluid is simultaneously withdrawn from chamber portion 570 into the first fluid reservoir through tube 574.
[00137] Any of the above-described single action hydraulic adjustment mechanisms can be modified in this fashion to function as a dual action hydraulic adjustment mechanism. It may be desirable to provide a locking mechanism to maintain the adjusted position of the piston and rod of the single or dual action hydraulic adjustment mechanisms disclosed herein after setting the adjustment spacing. Leakage and blow-by of the pressurized hydraulic fluid may occur causing the adjustment spacing to change before tissue ingrowth into the sling mesh pores stabilizes the sling.
[00138] FIGs. 47 and 48 illustrate one form of locking mechanism 405 incorporated into a single action hydraulic cylinder adjustment mechanism
402, 404 of the type shown in FIGs. 28 - 31. In the depicted single action, hydraulic cylinder, adjustment mechanism 402', 404', upper and lower lines of serrations, or teeth 421 and 423 extend along the rod 420. The rod 420 extends from the cylinder 455 within housing 422 and passes through a locking ring 425 mounted to slightly rock or pivot on axle 427 supported by the outer housing 415. A counterweight rod 429 also extends from the axle within the outer housing 415. Serrations or teeth are also formed on the inner wall of the locking ring 425 in alignment and engagement with the upper and lower lines of serrations or teeth 421 and 423.
[00139] The frictional engagement of the serrations of the locking ring 425 and the upper and lower lines of serrations or teeth 421 and 423 function as the locking mechanism 405 and tend to inhibit movement of the rod 420, but the engagement force is overcome when fluid is added to or removed from the cylinder. The piston and rod 420 can therefore move between its limits due to the change in fluid pressure. If fluid pressure gradually decreases due to leakage, the counterweight rod 429 tends to cause the locking ring 425 to pivot on axle 427 to engage the teeth together to resist movement of the rod 420. It will be understood that the outer housing 415 may extend completely around the locking ring 425 and the housing 422 to isolate them from body tissue.
[00140] FIGs. 49 and 50 illustrate another form of locking mechanism 435 incorporated into a single action hydraulic cylinder adjustment mechanism 402, 404 of the type shown in FIGs. 28 - 31. In the depicted single action hydraulic cylinder adjustment mechanism 402", 404", the locking mechanism 435 comprises modifications to the rod 420 providing reduced diameter sections 437, 439, and a laterally extending pin 441 , a pair of springs 447, 449 disposed around rod sections 437, 439, and a rotatable sleeve 457 disposed over the rod 420. The rotatable sleeve 457 surrounding rod 420 extends through the C-shaped opening 417 in housing 415. A spiral slot 451 with a plurality of notches 453 is formed in the rotatable sleeve 457, and the pin 441 extends through the spiral slot 451 and can be engaged in a notch 453.
[00141] The adjustment spacing 162, 164 is adjusted by injecting or withdrawing fluid from the fluid chamber to laterally extend or retract the piston mounted rod 420 to increase or decrease the adjustment spacing 162, 164. In the process, rod 420 is moved within cylinder 455 against the spring force of one or the other of the springs 447, 449 and the outwardly extending pin 441 travels along the spiral slot 447, rotating the sleeve 457. The spring force functions as a detent by lodging the pin 441 into engagement with the closest notch 453. The engagement resists any change in rod position that might otherwise occur due to loss of fluid from the cylinder. However, the engagement force can be overcome when fluid is added to or removed from the cylinder. It will be understood that the outer housing 415 may extend completely around the pin 441 and the housing 422 to isolate them from body tissue.
[00142] These locking mechanisms may be incorporated into the various single and dual action hydraulic cylinder adjustment mechanisms disclosed herein.
[00143] A further miniaturized single action hydraulic cylinder adjustment mechanism 402", 404" is depicted in FIGs. 51 - 53 that may be substituted for the above-described adjustment mechanism 502, 504 of FIG. 41. In this embodiment, the width and height or diameter of the modified housing 415' is sized to correspond generally to the width of the sling mesh 30 of sling 20. The locking mechanism 405 described above is incorporated into the modified housing 415' although locking mechanism 435 may be substituted for locking mechanism 405. The cylinder 455 is directly coupled to a tube coupling 419 that the end of the tube 532, 534 is affixed to. The syringe 410 is employed to penetrate the septum of the fill port 512, 514 to add or remove fluid from cylinder 455 and adjust the rod 420 to adjust the adjustable spacing as described above with respect to FIG. 41. As noted above, the tube distal end may be detached from the fluid coupling 419 when tissue ingrowth immobilizes the sling mesh 30. It will be understood that the outer housing 415' may extend completely around the locking ring 425 and the housing 422' to isolate them from body tissue.
[00144] The adjustable mechanism of the second aspect of the sling 20 of the present invention may also comprise miniaturized mechanical mechanisms that are adjustable outside the patient's skin or percutaneously through the patient's skin during the healing phase. In certain embodiments the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin. The adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing.
[00145] A miniaturized gear driven adjustment mechanism 802, 804 is depicted in FIGs. 54 and 55 that may be substituted for the above-described adjustment mechanisms 502 and 504 of FIG. 41. An adjustment mechanism housing 822 is attached at one end to the intermediate sling end 36, 46 and encloses a gear chamber 826 and a rod chamber 824. A driven gear 828 is enclosed within the gear chamber 826, and a rod 820 having a spiral thread 834 extending around its circumference extends through the rod chamber 824 and out of housing end opening 832. The spiral thread 834 engages gear threads within the bore of the driven gear 828. One end of the rod 820 is coupled to the intermediate sling end 38, 48.
[00146] A gear drive 810 comprises an elongated drive shaft 812 extending through a sheath lumen 814 of a drive sheath 816 to a drive gear 830 within the gear chamber 826 of an outer housing 822. The teeth of the drive gear 830 and the driven gear 828 are in engagement. The drive sheath 816 extends through the skin incisions following implantation to enable adjustment of the length of the rod 820 within the rod chamber 824. The gear drive handle 818 may be grasped and rotated to rotate the drive shaft 812 and the drive gear 830. Rotation of the driven gear 828 around the rod 820 in one direction drives the rod 820 out of the rod chamber 824 and lengthens the adjustment spacing 164, 166, whereas rotation of the driven gear 828 around the rod 820 in the other direction drives the rod 820 into the rod chamber 824 and shortens the adjustment spacing 164, 166.
[00147] The distal end of drive shaft 812 may be shaped to detachably engage axially with the drive gear 830 so that the drive sheath 816 and shaft 812 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 822 and drive gear 830, respectively, and be drawn out through the skin incision after tissue ingrowth into the mesh pores has secured the sling 20 in position.
[00148] An alternative, miniaturized, gear driven adjustment mechanism 852, 854 is depicted in FIG. 56 that may be substituted for the above-described adjustment mechanisms 302 and 304 of FIG. 18. An adjustment mechanism housing 872 is attached at one end to the intermediate sling end 36, 46 and encloses a gear chamber 876 and a rod chamber 874. A driven gear 878 is enclosed within the gear chamber 876, and a rod 870 having a spiral thread 884 extending around its circumference extends through the rod chamber 874 and out of housing end opening 832. The spiral thread 884 engages gear threads within the bore of the driven gear 878. One end of the rod 870 is coupled to the intermediate sling end 38, 48.
[00149] A gear driver 860 comprises an elongated drive shaft 866 having a spiral drive gear 880 at the distal end of the drive shaft 866 and a handle 868 at the proximal end of the drive shaft 866. The distal end of the gear drive 860 may be shaped to be percutaneously advanced through the patient's intact skin at pre-made incisions to interact with the driven gear 878. The distal end of the drive shaft 866 is extended through an opening in the housing 872 and into engagement with the drive gear 880 to adjust of the length of the rod 870 within the rod chamber 874. The teeth of the drive gear 880 and the driven gear 878 are depicted in engagement in FIG. 56. The gear drive handle 868 may be grasped and rotated to rotate the drive shaft 866 and the drive gear 880. Rotation of the driven gear 878 around the rod 870 in one direction drives the rod 870 out of the rod chamber 874 and lengthens the adjustment spacing 164, 166, whereas rotation of the driven gear 878 around the rod 870 in the other direction drives the rod 870 into the rod chamber 874 and shortens the adjustment spacing 164, 166.
[00150] It will be understood that alternatively, the gear drive may take the form of gear drive 810 of FIG. 54 that is temporarily left extending through the skin incisions following implantation of the sling. In that case, the distal end of drive shaft 812 may be shaped to detachably engage axially with the drive gear 880 so that the drive sheath 816 and shaft 812 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 872 and drive gear 880, respectively, and be drawn out through the skin incision after tissue ingrowth into the mesh pores has secured the sling 20 in position.
[00151] A still further alternative, miniaturized, mechanical drive mechanism 902, 904 is depicted in FIG. 57 that may be substituted for the above- described adjustment mechanisms 502 and 504 of FIG. 41. In this embodiment, the adjustment spacing 164, 166 is adjusted by a rack and pinion gear drive 910 extended temporarily through the patient's skin or implanted under the patient's skin and accessed percutaneously with an external adjustment actuator 310 shaped to engage the pinion gear drive 910 similar to external adjustment actuator 310 shown in FIG. 18.
[00152] In the embodiment depicted in FIG. 57, the gear drive 910 comprises an elongated drive shaft 912 extending through a sheath lumen 914 of a drive sheath 916 from a gear drive housing 918 to the mechanical drive mechanism 902, 904. The proximal end of the sheath 916 is coupled to the gear drive housing 918. The gear drive housing 918 encloses a gear chamber 926 in which a rack 930, coupled at one end to the proximal end of the drive shaft 912, is disposed for lateral movement, and a pinion 928 is positioned for rotary movement. The teeth of the rack 930 and the pinion 928 are in engagement. A hex shaped recess 932 is formed in the pinion to be engaged by a hex wrench to rotate the pinion 928 and laterally move the rack 930 within the gear chamber 926.
[00153] The distal ends of the sheath 916 and the drive shaft 912 are coupled to one end of the housing 906 of the drive mechanism 902, 904. The housing 906 takes the form of the housing 415' of FIGs. 51 - 53 and is depicted without a cover to expose the rod chamber 908 and the rod 920 and locking mechanism 905 disposed therein. Locking mechanism 905 corresponds to
locking mechanism 405 described above and may take other forms or may not be provided in this embodiment.
[00154] Rotation of the pinion 928 in one direction drives the rack 930 and the drive shaft 912 in one direction to drive rod 920 out of the rod chamber 908 and lengthen the adjustment spacing 164, 166. Rotation of the pinion 928 in the other direction drives the rack 930 and the drive shaft 912 in the other direction to pull rod 920 into the rod chamber 908 and shortens the adjustment spacing 164, 166.
[00155] A still further alternative, miniaturized, mechanical drive mechanism 952, 954 is depicted in FIGs. 58A - 58D that may be substituted for the above- described adjustment mechanisms 502 and 504 of FIG. 41. In this embodiment, the adjustment spacing 164, 166 is also adjusted by a rack and pinion gear drive 910 extended temporarily through the patient's skin or implanted under the patient's skin and accessed percutaneously with an external adjustment actuator 310 shaped to engage the rack and pinion gear drive 910 as described above with respect to FIG. 57.
[00156] In this embodiment, the housing 956 is coupled at one end to the sling intermediate end 36, 46, and encloses a rack chamber 958 and a driven rack 962 within the rack chamber 958. The driven rack 962 in rack chamber 958 is coupled at one rack end to the end of the drive shaft 914 and at the other rack end to the sling intermediate end 38, 48. A pivotally mounted catch 964 is shaped to engage rack teeth 962 and to guide movement and help maintain rack 960 in a selected position in the rack chamber 958 to define the adjustment spacing 162, 164.
[00157] Rotation of the pinion 928 in one direction drives the drive rack 930 and the drive shaft 912 in one direction to move drive rack 962 out of the rack chamber 958 and lengthen the adjustment spacing 164, 166 as shown in FIG. 58B. Rotation of the pinion 928 in the other direction moves the rack 930 and the drive shaft 912 in the other direction to pull rod 920 into the rack chamber 958 and shortens the adjustment spacing 164, 166, as shown in FIG 58D.
[00158] It will be understood that the gear drive housing 918 can be implanted under the skin. It will also be understood that each gear drive housing 918 can be temporarily left extending through the skin incisions following implantation of the sling. In this case, the distal end of drive shaft 912 may be shaped to detachably engage axially with the rod 920, and the distal end of the sheath 916 may detachably engage with the end of the housing 906 or 956. After tissue ingrowth into the mesh pores has secured the sling 20 in position, the drive sheath 916 and shaft 912 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 906 or 956 and rod 920 or rack 960, respectively, and be drawn out through the skin incision.
[00159] With respect to the embodiment of FIGs. 58A - 58D, it will be understood that the drive pinion 928 can alternatively be integrated into the rack chamber 958 in lieu of or alongside the pivoting catch 964. In this variation, the gear drive 910, sheath 916, and the shaft 912 would be eliminated, and the pinion 928 located if the rack chamber 958 could be accessed by the percutaneously inserted hex wrench 310 in the manner described above with respect to FIGs. 18 - 23.
[00160] It will be understood that the above-described embodiments of the second category of the sling of the invention may be modified by substituting other support materials than open pore mesh 30, particularly in the central support portion 40, e.g., homograft or allograft materials or nonporous synthetic materials. Moreover, other materials and structures may be substituted for the mesh 30 in the sections of constituting one or both of the end portions extending from the intermediate ends 38 and 48 to the ends of the central support portion 40. For example, one or more straight or spiral suture may be substituted for all or part of such sections.
[00161] While the above-described embodiments of adjustable tension slings depict methods and apparatus for adjusting sling tension in each end portion, it will be understood that in each case only one adjustment mechanism may be provided acting on or within one sling end portion (or alternatively on both end portions 1 ).
[00162] It will also be understood that all of the above-described embodiments of the urethral or fecal slings may optionally incorporate a sling central portion adjustment mechanism, e.g., suture 108 illustrated in FIGs. 10 and 11 or as otherwise described herein.
[00163] Furthermore, it will be understood that all of the above-described embodiments of the urethral or fecal slings illustrated in FIGs. 12 through 58 may optionally incorporate tissue anchors coupled to the sling ends extending from or incorporated into the sling ends 32 and 34. For example the sling anchor 92 illustrated extending from sling end 32 in FIG. 11 could be incorporated into a suture extending from the sling ends 32 and 34 in each such embodiment to assist in tensioning the sling end portions 42 and 44 during adjustment of the tension adjustment mechanisms.
[00164] Many of the embodiments described herein can be used in connection with prolapse and pelvic floor repairs (men and women) that may require postoperative adjustment of the implanted mesh or graft or sling. They may also be used in connection with prostatectomies or hysterectomies and to support any other body tissue within the pelvic area or other parts of the body including but not limited to, hernia repair, and shoulder and abdominal repairs. Examples of meshes, grafts and prolapse repairs are described in U.S. Publication Nos. 2004-0039453 A1 , 2005-0250977 A1 , and 2005-0245787 A1 , which are hereby incorporated by reference in their entirety.
[00165] All patents and publications referenced herein are hereby incorporated by reference in their entireties.
[00166] It will be understood that certain of the above-described structures, functions and operations of the above-described preferred embodiments are not necessary to practice the present invention and are included in the description simply for completeness of an exemplary embodiment or embodiments. It will also be understood that there may be other structures, functions and operations ancillary to the typical surgical procedures that are not disclosed and are not necessary to the practice of the present invention.
] In addition, it will be understood that specifically described structures, functions and operations set forth in the above-referenced patents can be practiced in conjunction with the present invention, but they are not essential to its practice. It is therefore to be understood, that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described without actually departing from the spirit and scope of the present invention.
Claims
1. A system for providing support to body tissue to alleviate incontinence comprising:
an elongated incontinence sling having a central support portion adapted to be positioned to support any one of the urethra or anus having first and second sling end portions extending from the central support portion through body tissue;
a tension adjustment mechanism acting on or within one or both of the sling end portions, wherein the sling tension adjustment mechanism is attached to and extends through an adjustment spacing between sling intermediate ends within the sling end portion intermediate the sling end and the sling central portion and comprises spacing adjustment means for changing the adjustment spacing; and
external adjustment actuator means for actuating the sling tension adjustment mechanism to change the adjustment spacing between the sling intermediate ends and thereby change tension in the sling central portion applied to the urethra or anus.
2. The system of Claim 1 , wherein the external adjustment actuator means extends through the patient's skin for adjustment.
3. The system of Claim 1, further comprising at least one tissue anchor coupled to at least one sling end adapted to be passed through body tissue to anchor the sling end against the body tissue to stabilize the sling end and facilitate adjustment of sling tension.
4. The system of Claim 1 , wherein:
the tension adjustment mechanism comprises a portion of a suture extending across the adjustment spacing between the sling intermediate ends within the sling end portion intermediate the sling end and the sling central portion to form the spacing adjustment means; and
the external adjustment actuator means comprises a portion of the suture extending from the spacing adjustment means between the sling intermediate ends and adapted to be extended through a skin incision for manipulation to change the adjustment spacing between the sling intermediate ends and thereby change tension in the sling central portion applied to the urethra or anus.
5. The system of Claim 1 , wherein:
the sling tension adjustment mechanism comprises a portion of a suture extending the across the adjustment spacing between the sling intermediate ends within the sling end portion intermediate the sling end and the sling central portion to form the spacing adjustment means; and
the external adjustment actuator means comprises:
a portion of the suture extending from the spacing adjustment means between the sling intermediate ends and adapted to be extended through a tissue pathway through body tissue; and
a tissue anchor having a bore receiving the portion of the suture extending through body tissue, the tissue anchor adapted to be manipulated to anchor against the body tissue and to the change the adjustment spacing between the sling intermediate ends and thereby change tension in the sling central portion applied to the urethra or anus.
6. The system of Claim 5, wherein the sling further comprises at least one tissue anchor coupled to at least one sling end adapted to be passed through body tissue to anchor the sling end against the body tissue to stabilize the sling end and facilitate adjustment of sling tension.
7. The system of Claim 1 , wherein:
the external adjustment actuator comprises a transmitter adapted to be brought into proximity to or applied against the skin and operated to generate a spacing adjustment command that is communicated transcutaneously through the skin and body tissue to the adjustment mechanism; and
the adjustment mechanism comprises means responsive to the transcutaneously communicated commands for operating the spacing adjustment means to increase or decrease the adjustment spacing.
8. The system of Claim 7, wherein:
the external adjustment actuator comprises a RF signal transmitter that is employed to generate a RF sling adjustment command transmitted through the patient's skin; and
the adjustment mechanism comprises a RF receiver for receiving the transmitted commands, and the spacing adjustment means is responsive to the received RF signal to increase or decrease the adjustment spacing.
9. The system of Claim 7, wherein:
the external adjustment actuator comprises is a magnetic field generator or permanent magnet that is employed to generate a magnetic field representing a sling adjustment command that passes transcutaneously through the patient's skin; and the spacing adjustment means comprises a magnetic field responsive element that responds to the magnetic field by increasing or decreasing the adjustment spacing.
10. The system of Claim 7, wherein:
the external adjustment actuator comprises an external thermal heater or cooler adapted to be applied to the patient's skin; and
the spacing adjustment means comprises a temperature responsive element responsive to heat or cold applied transcutaneously through the patient's skin to heat or cool the adjustment mechanism to thereby increase or decrease the adjustment spacing.
11. The system of Claim 7, wherein:
the external adjustment actuator comprises an external light source adapted to be applied to the patient's skin and to generated a light wavelength that is transmittable through skin and body tissue; and
the spacing adjustment means comprises light responsive elements responsive to the wavelength of light generated by the external adjustment actuator and transmitted transcutaneously to the sling tension adjustment mechanism to thereby increase or decrease the adjustment spacing.
12. The system of Claim 1 , wherein:
the external adjustment actuator comprises an elongated instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin; and the adjustment mechanism comprises means engageable by the engaging end the external adjustment actuator for operating the spacing adjustment means to increase or decrease the adjustment spacing.
13. The system of Claim 12, wherein:
the engageable means comprises:
a housing coupled to one sling intermediate end; and
a rotatable bobbin supported by the housing having a receptacle shaped to receive the engaging end of the elongated instrument to enable rotation of the bobbin; and
the spacing adjustment means comprises a strand coupled to the other sling intermediate end and extending around the bobbin that is adapted to be wound onto the bobbin to decrease the adjustment spacing or to be unwound from the bobbin to increase the adjustment spacing.
14. The system of Claim 12, wherein:
the engageable means comprises:
a housing having a chamber bounded by a fixed detent ring of tabs extending into the chamber; and
a rotatable bobbin supported by the housing within the chamber having a receptacle shaped to receive the engaging end of the elongated instrument to enable rotation of the bobbin and an array of flexible tabs extending radially outward of the bobbin in engagement with the tabs of the fixed detent ring; and
the spacing adjustment means comprises a first strand coupled to the first sling intermediate end and extending around the bobbin in a first direction and a second strand coupled to the second sling intermediate end and extending around the bobbin in an opposite direction,
whereby the first and second strands are wound onto the bobbin by rotation of the bobbin in a first direction to shorten the adjustment spacing and the first and second strands are unwound from the bobbin by rotation of the bobbin in a second direction to shorten the adjustment spacing.
15. The system of Claim 12, wherein:
the engageable means comprises:
a housing having a chamber;
a dual cam assembly supported by the housing within the chamber comprising a first cam having a first receptacle shaped to receive the engaging end of the elongated instrument and a second cam having a second receptacle shaped to receive the engaging end of the elongated instrument;
a first cam follower mounted to the housing and bearing on the first cam; and
a second cam follower mounted to the housing and bearing on the second cam; and
the spacing adjustment means comprises a first tether coupled to the first sling intermediate end and extending around the first cam in a first direction and a second tether coupled to the second sling intermediate end and extending around the second cam in an opposite direction,
whereby the first tether is wound onto the first cam by rotation of the first cam in a first direction into engagement with the first cam follower to shorten the adjustment spacing and the second tether is unwound from the second cam by rotation of the second cam in the first direction into engagement with the second cam follower to shorten the adjustment spacing.
16. The system of Claim 1 , wherein:
the external adjustment actuator comprises a syringe having a syringe chamber adapted to be filled with fluid and a syringe needle having a needle bore extending from the syringe chamber to the needle tip, the syringe needle adapted to be percutaneously passed through the patient's skin;
the tension adjustment mechanism comprises a housing enclosing a fluid retaining chamber having a port penetrable by the syringe needle tip enabling adding or withdrawing fluid from the fluid retaining chamber; and
the spacing adjustment means is coupled to the fluid retaining chamber,
whereby the adjustment spacing is adjusted by passing the syringe needle tip through the port and injecting or withdrawing fluid from the fluid retaining chamber to increase or decrease the adjustment spacing.
17. The system of Claim 16, wherein:
the housing comprises a piston chamber, a piston within the chamber, and a piston rod extending from the piston chamber;
the housing is coupled to the first intermediate end; and
the piston rod is coupled to the second intermediate end,
whereby the piston is moved within the piston chamber to increase the adjustment spacing upon adding fluid through the port to the piston chamber and to decrease the adjustment spacing upon withdrawing fluid through the port to the piston chamber.
18. The system of Claim 16, wherein:
the housing is formed of a flexible material in having opposed first and second spiral arms extending away from the port;
the first intermediate end is coupled to the first spiral arm; and
the second intermediate end is coupled to the second spiral arm,
whereby the arcuate arms straighten to increase the adjustment spacing upon adding fluid through the port.
19. The system of Claim 1 , further comprising
a fluid reservoir adapted to be subcutaneously implanted having a penetrable port and enclosing a reservoir chamber and further comprising a tube extending from the reservoir chamber to a tube end; and wherein:
the external adjustment actuator comprises a syringe having a syringe chamber adapted to be filled with fluid and a syringe needle having a needle bore extending from the syringe chamber to the needle tip, the syringe needle adapted to be percutaneously passed through the patient's skin and through the port into the reservoir chamber;
the tension adjustment mechanism comprises a housing enclosing a fluid retaining chamber coupled to the tube end; and
the spacing adjustment means is coupled to the fluid retaining chamber,
whereby the adjustment spacing is adjusted by passing the syringe needle tip through the port and injecting or withdrawing fluid from the reservoir chamber and the fluid retaining chamber to increase or decrease the adjustment spacing.
20. The system of Claim 19, wherein:
the housing comprises a piston chamber, a piston within the chamber, and a piston rod extending from the piston chamber;
the housing is coupled to the first intermediate end; and
the piston rod is coupled to the second intermediate end,
whereby the piston is moved within the piston chamber to increase the adjustment spacing upon adding fluid through the port to the piston chamber and to decrease the adjustment spacing upon withdrawing fluid through the port to the piston chamber.
21. The system of Claim 20, wherein the fluid retaining chamber comprises a single action hydraulic cylinder or a dual action hydraulic cylinder.
22. The system of Claim 1 , wherein:
the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin; and
the adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing.
23. The system of Claim 22, wherein:
the driven gear means comprises: a housing coupled to the first sling intermediate end enclosing a gear chamber and a rod chamber;
a threaded rod extending through the rod chamber and attached at one end to the second sling intermediate end; and
a rotatable driven gear supported by the housing and in engagement with the threaded rod,
whereby the driven gear is rotatable by engagement with and rotation of the drive gear in a first direction to extend the threaded rod from the rod chamber to increase the adjustment spacing and is rotatable by engagement with and rotation of the drive gear in a second direction to draw the threaded rod into the rod chamber to decrease the adjustment spacing
24. The system of Claim 22, further comprising:
a gear drive adapted to be subcutaneously implanted having a receptacle, and an elongated drive shaft extending through a sheath lumen of a drive sheath to a drive shaft end, and wherein:
the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin into engagement with the receptacle; and
the adjustment mechanism comprises a driven gear means engageable by the drive shaft end for operating the spacing adjustment means to increase or decrease the adjustment spacing.
25. A method of. providing support to body tissue to alleviate incontinence comprising: providing an elongated incontinence sling having a central support portion adapted to be positioned to support any one of the urethra or anus having first and second sling end portions extending from the central support portion through body tissue and a tension adjustment mechanism acting on or within one or both of the sling end portions, wherein the sling tension adjustment mechanism is attached to and extends through an adjustment spacing between sling intermediate ends within the sling end portion intermediate the sling end and the sling central portion and comprises spacing adjustment means for changing the adjustment spacing;
implanting the incontinence sling disposing the central support portion in operative relation to the one of the urethra or anus; and
actuating the sling tension adjustment mechanism to change the adjustment spacing between the sling intermediate ends and thereby change tension in the sling central portion applied to the urethra or anus.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/305,874 US8460169B2 (en) | 2006-06-22 | 2007-06-22 | Adjustable tension incontinence sling assemblies |
US12/467,762 US20090259092A1 (en) | 2006-06-22 | 2009-05-18 | Adjustable Sling and Method of Treating Pelvic Conditions |
US14/266,791 US9980801B2 (en) | 2006-06-22 | 2014-04-30 | Adjustable sling and method of treating pelvic conditions |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80554406P | 2006-06-22 | 2006-06-22 | |
US60/805,544 | 2006-06-22 | ||
US80666406P | 2006-07-06 | 2006-07-06 | |
US60/806,664 | 2006-07-06 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/305,874 A-371-Of-International US8460169B2 (en) | 2006-06-22 | 2007-06-22 | Adjustable tension incontinence sling assemblies |
US12/467,762 Continuation-In-Part US20090259092A1 (en) | 2006-06-22 | 2009-05-18 | Adjustable Sling and Method of Treating Pelvic Conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007149555A2 true WO2007149555A2 (en) | 2007-12-27 |
WO2007149555A3 WO2007149555A3 (en) | 2008-04-10 |
Family
ID=38596654
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/014553 WO2007149555A2 (en) | 2006-06-22 | 2007-06-22 | Adjustable tension incontinence sling assemblies |
PCT/US2007/014780 WO2007149593A2 (en) | 2006-06-22 | 2007-06-22 | Adjustable tension incontinence sling assemblies |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/014780 WO2007149593A2 (en) | 2006-06-22 | 2007-06-22 | Adjustable tension incontinence sling assemblies |
Country Status (8)
Country | Link |
---|---|
US (4) | US8628463B2 (en) |
EP (1) | EP2049039A2 (en) |
JP (2) | JP2009540937A (en) |
KR (1) | KR101424564B1 (en) |
AU (1) | AU2007261254B2 (en) |
BR (1) | BRPI0712370A2 (en) |
CA (2) | CA2654294C (en) |
WO (2) | WO2007149555A2 (en) |
Cited By (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009017680A2 (en) * | 2007-07-27 | 2009-02-05 | Ams Research Corporation | Pelvic floor treatments and related tools and implants |
WO2009106878A1 (en) | 2008-02-28 | 2009-09-03 | Gyne Ideas Limited | Urethral support system |
WO2010042010A1 (en) * | 2008-10-10 | 2010-04-15 | Milux Holding Sa | Variable sling for urinary incontinence |
EP2001398B1 (en) * | 2007-03-07 | 2010-05-26 | Assut Europe S.P.A. | Prosthesis for the treatment of urinary incontinence |
WO2010088917A1 (en) * | 2009-02-05 | 2010-08-12 | Coloplast A/S | Implantable devices, tools and methods for anatomical support |
WO2010099327A1 (en) * | 2009-02-25 | 2010-09-02 | Scott J Stephen | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
WO2010142294A1 (en) * | 2009-06-08 | 2010-12-16 | Coloplast A/S | Anatomical augmentation device |
EP2308383A2 (en) * | 2009-10-09 | 2011-04-13 | Tyco Healthcare Group LP | Internal retractor systems |
WO2011060788A1 (en) * | 2009-11-19 | 2011-05-26 | Coloplast A/S | Implantable anatomical support |
WO2011150938A1 (en) | 2010-06-03 | 2011-12-08 | Coloplast A/S | Sacrocolpopexy support and method of implantation |
WO2011157274A1 (en) | 2010-06-14 | 2011-12-22 | Coloplast A/S | Incontinence treatment device and method of treating incontinence |
US8100924B2 (en) | 2001-03-30 | 2012-01-24 | Coloplast A/S | Surgical implant |
US8118727B2 (en) | 2000-10-12 | 2012-02-21 | Coloplast A/S | Method for supporting pelvic anatomy |
US8128554B2 (en) | 2000-10-12 | 2012-03-06 | Coloplast A/S | System for introducing a pelvic implant |
US8215310B2 (en) | 2004-05-21 | 2012-07-10 | Coloplast A/S | Implant for treatment of vaginal and/or uterine prolapse |
US20120253107A1 (en) * | 2011-03-28 | 2012-10-04 | Gindele Paul J | Implants, tools, and methods for treatment of pelvic conditions |
EP2510903A3 (en) * | 2007-06-29 | 2012-12-05 | AMS Research Corporation | Non-continuous pelvic implant |
US20130006049A1 (en) * | 2011-06-30 | 2013-01-03 | Alexander James A | Implants, tools, and methods for treatments of pelvic conditions |
US8430826B2 (en) | 2009-03-04 | 2013-04-30 | Covidien Lp | Specimen retrieval apparatus |
US20130109910A1 (en) * | 2009-12-30 | 2013-05-02 | James A. Alexander | Systems, implants, tools, and methods for treatments of pelvic conditions |
US8460169B2 (en) | 2006-06-22 | 2013-06-11 | Ams Research Corporation | Adjustable tension incontinence sling assemblies |
US8535217B2 (en) | 2005-07-26 | 2013-09-17 | Ams Research Corporation | Methods and systems for treatment of prolapse |
US8585578B2 (en) | 2009-02-05 | 2013-11-19 | Coloplast A/S | Implantable devices, tools and methods for anatomical support |
US8709471B2 (en) | 2003-03-27 | 2014-04-29 | Coloplast A/S | Medicament delivery device and a method of medicament delivery |
US8727963B2 (en) | 2008-07-31 | 2014-05-20 | Ams Research Corporation | Methods and implants for treating urinary incontinence |
US8834350B2 (en) | 2006-06-16 | 2014-09-16 | Ams Research Corporation | Surgical implants, tools, and methods for treating pelvic conditions |
US8874215B2 (en) | 2008-10-10 | 2014-10-28 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
US8920304B2 (en) | 2000-07-05 | 2014-12-30 | Coloplast A/S | Method and device for treating urinary incontinence |
USD721175S1 (en) | 2011-09-08 | 2015-01-13 | Ams Research Corporation | Backers for surgical indicators |
USD721807S1 (en) | 2011-09-08 | 2015-01-27 | Ams Research Corporation | Surgical indicators |
US8961448B2 (en) | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
US9005222B2 (en) | 2002-08-02 | 2015-04-14 | Coloplast A/S | Self-anchoring sling and introducer system |
US9017243B2 (en) | 2008-08-25 | 2015-04-28 | Ams Research Corporation | Minimally invasive implant and method |
US9060771B2 (en) | 2008-01-29 | 2015-06-23 | Peter Forsell | Method and instrument for treating obesity |
US9072907B2 (en) | 2008-10-10 | 2015-07-07 | Peter Forsell | Heart help device, system, and method |
US9084664B2 (en) | 2006-05-19 | 2015-07-21 | Ams Research Corporation | Method and articles for treatment of stress urinary incontinence |
US9089393B2 (en) | 2011-03-28 | 2015-07-28 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
USD736382S1 (en) | 2011-09-08 | 2015-08-11 | Ams Research Corporation | Surgical indicator with backers |
US9125717B2 (en) | 2011-02-23 | 2015-09-08 | Ams Research Corporation | Implant tension adjustment system and method |
US9144426B2 (en) | 2006-02-16 | 2015-09-29 | Ams Research Corporation | Surgical articles and methods for treating pelvic conditions |
US9233238B2 (en) | 2011-02-23 | 2016-01-12 | Ams Research Corporation | Drug releasing pelvic treatment system and method |
US9351723B2 (en) | 2011-06-30 | 2016-05-31 | Astora Women's Health, Llc | Implants, tools, and methods for treatments of pelvic conditions |
US9364308B2 (en) | 2009-12-30 | 2016-06-14 | Astora Women's Health, Llc | Implant systems with tensioning feedback |
US9370363B2 (en) | 2009-02-05 | 2016-06-21 | Coloplast A/S | Anchor assembly for an implantable, pelvic support device |
US9414903B2 (en) | 2011-07-22 | 2016-08-16 | Astora Women's Health, Llc | Pelvic implant system and method |
US9480546B2 (en) | 2013-08-05 | 2016-11-01 | Coloplast A/S | Hysteropexy mesh apparatuses and methods |
US9492259B2 (en) | 2011-03-30 | 2016-11-15 | Astora Women's Health, Llc | Expandable implant system |
US9492191B2 (en) | 2011-08-04 | 2016-11-15 | Astora Women's Health, Llc | Tools and methods for treatment of pelvic conditions |
US9572648B2 (en) | 2010-12-21 | 2017-02-21 | Justin M. Crank | Implantable slings and anchor systems |
FR3047408A1 (en) * | 2016-02-09 | 2017-08-11 | Cl Medical | DEVICE FOR TREATING URINARY INCONTINENCE OF EFFORT IN A HUMAN PATIENT |
US9782245B2 (en) | 2011-03-30 | 2017-10-10 | James R. Mujwid | Implants, tools, and methods for treatment of pelvic conditions |
US9918816B2 (en) | 2008-08-25 | 2018-03-20 | Boston Scientific Scimed, Inc. | Minimally invasive implant and method |
US9949812B2 (en) | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
US9949814B2 (en) | 2010-09-29 | 2018-04-24 | Boston Scientific Scimed, Inc. | Systems, tools, and methods for treatments of pelvic conditions |
US9968346B2 (en) | 2010-09-29 | 2018-05-15 | Boston Scientific Scimed, Inc. | Systems, tools, and methods for treatments of pelvic conditions |
US10028813B2 (en) | 2010-07-22 | 2018-07-24 | Boston Scientific Scimed, Inc. | Coated pelvic implant device and method |
US10039661B2 (en) | 2006-10-20 | 2018-08-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US10058240B2 (en) | 2011-06-29 | 2018-08-28 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US10098721B2 (en) | 2011-09-01 | 2018-10-16 | Boston Scientific Scimed, Inc. | Pelvic implant needle system and method |
US10219898B2 (en) | 2008-10-10 | 2019-03-05 | Peter Forsell | Artificial valve |
WO2019058180A3 (en) * | 2017-09-25 | 2019-05-02 | Marian Devonec | Readjustable and reversible tensioning means for urinary incontinence |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US10390813B2 (en) | 2011-08-05 | 2019-08-27 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US10426586B2 (en) | 2017-01-16 | 2019-10-01 | Coloplast A/S | Sacrocolpopexy support |
US10583234B2 (en) | 2008-10-10 | 2020-03-10 | Peter Forsell | Heart help device, system and method |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
US10952836B2 (en) | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
US11123171B2 (en) | 2008-10-10 | 2021-09-21 | Peter Forsell | Fastening means for implantable medical control assembly |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11284983B2 (en) | 2011-07-22 | 2022-03-29 | Boston Scientific Scimed, Inc. | Pelvic implant system and method |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6641525B2 (en) | 2001-01-23 | 2003-11-04 | Ams Research Corporation | Sling assembly with secure and convenient attachment |
EP2085049B1 (en) * | 2003-08-11 | 2019-06-19 | Cook Medical Technologies LLC | Surgical implant with penetrating tip |
US8088130B2 (en) | 2006-02-03 | 2012-01-03 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US8298262B2 (en) | 2006-02-03 | 2012-10-30 | Biomet Sports Medicine, Llc | Method for tissue fixation |
US8118836B2 (en) | 2004-11-05 | 2012-02-21 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US8303604B2 (en) | 2004-11-05 | 2012-11-06 | Biomet Sports Medicine, Llc | Soft tissue repair device and method |
US9017381B2 (en) | 2007-04-10 | 2015-04-28 | Biomet Sports Medicine, Llc | Adjustable knotless loops |
US8361113B2 (en) | 2006-02-03 | 2013-01-29 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US7909851B2 (en) | 2006-02-03 | 2011-03-22 | Biomet Sports Medicine, Llc | Soft tissue repair device and associated methods |
US7749250B2 (en) | 2006-02-03 | 2010-07-06 | Biomet Sports Medicine, Llc | Soft tissue repair assembly and associated method |
US8128658B2 (en) | 2004-11-05 | 2012-03-06 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to bone |
US7905904B2 (en) | 2006-02-03 | 2011-03-15 | Biomet Sports Medicine, Llc | Soft tissue repair device and associated methods |
US8137382B2 (en) | 2004-11-05 | 2012-03-20 | Biomet Sports Medicine, Llc | Method and apparatus for coupling anatomical features |
US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
US7909753B1 (en) | 2005-10-05 | 2011-03-22 | Ams Research Corporation | Connector for mesh support insertion |
WO2007059199A2 (en) | 2005-11-14 | 2007-05-24 | C.R. Bard, Inc. | Sling anchor system |
US8801783B2 (en) | 2006-09-29 | 2014-08-12 | Biomet Sports Medicine, Llc | Prosthetic ligament system for knee joint |
US9468433B2 (en) | 2006-02-03 | 2016-10-18 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US8562645B2 (en) * | 2006-09-29 | 2013-10-22 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US10517587B2 (en) | 2006-02-03 | 2019-12-31 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US8597327B2 (en) | 2006-02-03 | 2013-12-03 | Biomet Manufacturing, Llc | Method and apparatus for sternal closure |
US8562647B2 (en) | 2006-09-29 | 2013-10-22 | Biomet Sports Medicine, Llc | Method and apparatus for securing soft tissue to bone |
US8652171B2 (en) | 2006-02-03 | 2014-02-18 | Biomet Sports Medicine, Llc | Method and apparatus for soft tissue fixation |
US11311287B2 (en) | 2006-02-03 | 2022-04-26 | Biomet Sports Medicine, Llc | Method for tissue fixation |
US11259792B2 (en) | 2006-02-03 | 2022-03-01 | Biomet Sports Medicine, Llc | Method and apparatus for coupling anatomical features |
US9078644B2 (en) | 2006-09-29 | 2015-07-14 | Biomet Sports Medicine, Llc | Fracture fixation device |
US8968364B2 (en) | 2006-02-03 | 2015-03-03 | Biomet Sports Medicine, Llc | Method and apparatus for fixation of an ACL graft |
ITTO20060413A1 (en) * | 2006-06-07 | 2007-12-08 | Arrigo Lessana | REPLACEMENT DEVICE OF THE TENDONE ROPES OF AN ATRIOVENTRICULAR VALVE |
US20110021868A1 (en) * | 2006-07-11 | 2011-01-27 | James Browning | Tissue Repair Device |
WO2008033950A2 (en) | 2006-09-13 | 2008-03-20 | C. R. Bard, Inc. | Urethral support system |
FR2906131B1 (en) | 2006-09-21 | 2009-04-24 | Cl Medical Sarl | SURGICAL TREATMENT FOR TREATMENT OF URINARY INCONTINENCE IN MAN |
US8672969B2 (en) | 2006-09-29 | 2014-03-18 | Biomet Sports Medicine, Llc | Fracture fixation device |
US11259794B2 (en) | 2006-09-29 | 2022-03-01 | Biomet Sports Medicine, Llc | Method for implanting soft tissue |
CA2686136A1 (en) * | 2007-04-28 | 2008-11-06 | The Board Of Trustees Of The Leland Stanford Junior University | Dynamic and adjustable support devices |
US8439979B2 (en) * | 2007-07-04 | 2013-05-14 | Myopowers Medical Technologies Sa | Artificial contractile structure and apparatus comprising such structure |
WO2009023256A2 (en) * | 2007-08-14 | 2009-02-19 | Curant, Inc. | Devices for supporting, elevating, or compressing internal structures |
FR2919996B1 (en) * | 2007-08-17 | 2010-09-10 | Cl Medical | IMPLANT FOR SUPPORTING THE URETRE OF A MAN AND SURGICAL ASSEMBLY FOR TREATMENT OF URINARY INCONTINENCE IN A MAN COMPRISING SUCH AN IMPLANT |
CN101842060B (en) | 2007-09-21 | 2014-07-16 | Ams研究公司 | Pelvic floor treatments and related tools and implants |
US8206280B2 (en) | 2007-11-13 | 2012-06-26 | C. R. Bard, Inc. | Adjustable tissue support member |
US20090171141A1 (en) * | 2007-12-27 | 2009-07-02 | Chu Michael S H | Anterior Repair - Needle Path and Incision Sites |
US9282958B2 (en) * | 2007-12-28 | 2016-03-15 | Boston Scientific Scimed, Inc. | Devices and method for treating pelvic dysfunctions |
US8216124B2 (en) * | 2008-11-03 | 2012-07-10 | Goldman Ian L | Systems and methods for treating stress urinary incontinence |
US20110092839A1 (en) * | 2008-11-17 | 2011-04-21 | Toronto Rehabilitation Institute | Mask and method for use in respiratory monitoring and diagnostics |
FR2939025B1 (en) * | 2008-11-28 | 2012-04-20 | Chru Lille | IMPLANT FOR THE TREATMENT OF A GENITAL PROLAPSE AND METHOD OF TREATMENT THEREFOR |
CN105395296B (en) * | 2009-11-23 | 2017-09-22 | Ams研究股份有限公司 | Pattern implant and method |
WO2011072148A1 (en) * | 2009-12-09 | 2011-06-16 | Ams Reseaech Corporation | Patterned sling implant |
EP2519185A4 (en) | 2009-12-30 | 2018-01-24 | Boston Scientific Scimed, Inc. | Elongate implant system and method for treating pelvic conditions |
US9393091B2 (en) * | 2009-12-31 | 2016-07-19 | Astora Women's Health, Llc | Suture-less tissue fixation for implantable device |
JP5625164B2 (en) * | 2010-04-01 | 2014-11-19 | 国立大学法人 宮崎大学 | Puncture needle |
US9402706B2 (en) * | 2010-07-29 | 2016-08-02 | Boston Scientific Scimed, Inc. | Bodily implants and methods of adjusting the same |
US9421076B2 (en) | 2010-07-29 | 2016-08-23 | Boston Scientific Scimed, Inc | Implants and methods of implanting the same |
BR112013008254A2 (en) | 2010-10-06 | 2017-12-12 | Ams Res Corp | implant configured for transvaginal insertion in a female patient to treat a pelvic disorder, and method for surgically implanting a mesh in a female patient |
WO2012134689A1 (en) | 2011-03-28 | 2012-10-04 | Ams Research Corporation | Implants, tools, and methods for treatments of pelvic conditions |
AU2012236277B2 (en) * | 2011-03-30 | 2016-03-03 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatment of pelvic conditions |
FR2975585B1 (en) | 2011-05-23 | 2013-05-31 | Mdb Texinov Sa | TEXTILE IMPLANT AND METHOD FOR PRODUCING THE SAME |
US9333062B2 (en) * | 2011-06-10 | 2016-05-10 | Boston Scientific Scimed, Inc. | Bodily implants and methods of treating fecal incontinence using bodily implants |
US9168035B2 (en) * | 2011-07-07 | 2015-10-27 | Caldera Medical, Inc. | Adjustable implant |
CA2846497C (en) | 2011-08-25 | 2017-06-27 | Mis Solutions, Inc. | Apparatus and method for intra-abdominal movement of internal organs |
US9402704B2 (en) | 2011-08-30 | 2016-08-02 | Boston Scientific Scimed, Inc. | Fecal incontinence treatment device and method |
US9808330B2 (en) * | 2011-09-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Bodily implant with tension indicator |
US10265152B2 (en) | 2011-10-13 | 2019-04-23 | Boston Scientific Scimed, Inc. | Pelvic implant sizing systems and methods |
US9357991B2 (en) | 2011-11-03 | 2016-06-07 | Biomet Sports Medicine, Llc | Method and apparatus for stitching tendons |
US9381013B2 (en) | 2011-11-10 | 2016-07-05 | Biomet Sports Medicine, Llc | Method for coupling soft tissue to a bone |
US9192458B2 (en) | 2012-02-09 | 2015-11-24 | Ams Research Corporation | Implants, tools, and methods for treatments of pelvic conditions |
KR101337465B1 (en) * | 2012-02-15 | 2013-12-06 | 백승준 | Mesh assembly for plastic surgery |
WO2013144729A2 (en) * | 2012-03-28 | 2013-10-03 | Tomc John | Vaginal vault suspension system and method |
US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
US9554886B2 (en) | 2012-04-23 | 2017-01-31 | Boston Scientific Scimed, Inc. | Medical assembly with tactile feedback |
CA2877865C (en) | 2012-06-29 | 2020-09-01 | Jeffrey Smith | Apparatus and method for delivering surgical tissue connectors into an abdominal cavity and removing the surgical tissue connectors from the abdominal cavity |
US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
WO2014010086A1 (en) * | 2012-07-13 | 2014-01-16 | テルモ株式会社 | Implant |
CA2880380C (en) * | 2012-09-28 | 2020-09-15 | Sofradim Production | Packaging for a hernia repair device |
US9872753B2 (en) * | 2012-12-11 | 2018-01-23 | Innoventions Ltd. | Medical sling with detachable sling elements |
US9949813B2 (en) * | 2013-03-08 | 2018-04-24 | Boston Scientific Scimed, Inc. | Incontinence implant assembly |
US9918827B2 (en) | 2013-03-14 | 2018-03-20 | Biomet Sports Medicine, Llc | Scaffold for spring ligament repair |
WO2014162428A1 (en) * | 2013-04-01 | 2014-10-09 | テルモ株式会社 | Indwelling anchor device |
WO2015006729A2 (en) * | 2013-07-11 | 2015-01-15 | Shifamed Holdings, Llc | Devices and methods for lung volume reduction |
US9724493B2 (en) * | 2013-08-27 | 2017-08-08 | Catheter Precision, Inc. | Components and methods for balancing a catheter controller system with a counterweight |
US9713518B2 (en) | 2013-12-09 | 2017-07-25 | Boston Scientific Scimed, Inc. | Sacrocolopopexy implants and related methods of use |
US9918732B2 (en) * | 2013-12-10 | 2018-03-20 | Boston Scientific Scimed, Inc. | Sacrocolopopexy implants and methods of using and manufacturing thereof |
US10245039B2 (en) * | 2014-05-30 | 2019-04-02 | Children's Medical Center Corporation | Methods and apparatuses for applying tensile force to tissue |
KR101589376B1 (en) * | 2014-05-30 | 2016-01-28 | 두재균 | Sling procedure for urinary incontinence |
WO2016039810A1 (en) * | 2014-09-11 | 2016-03-17 | Aprevent Medical Inc. | Methods and apparatus for treating glottic insufficiency |
US10675016B2 (en) | 2015-10-30 | 2020-06-09 | New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery | Suture sleeve patch and methods of delivery within an existing arthroscopic workflow |
EP4218632A1 (en) | 2017-12-23 | 2023-08-02 | Teleflex Life Sciences Limited | Expandable tissue engagement apparatus |
US11944527B2 (en) * | 2018-11-13 | 2024-04-02 | Soranus Arge Ve Danismanlik Hizmetleri Sanayi Ticaret A.S. | Readjustable midurethral sling |
CN115361991A (en) | 2020-01-30 | 2022-11-18 | 兰巴姆医疗技术有限公司 | Catheter prosthesis |
CN117838222A (en) | 2020-08-03 | 2024-04-09 | 泰利福生命科学有限公司 | Handle and cassette system for medical intervention |
CN113907914B (en) * | 2021-12-15 | 2022-03-25 | 德宝恒生科技服务有限公司 | Device for regulating and controlling urethral pressure |
Family Cites Families (373)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3124136A (en) | 1964-03-10 | Method of repairing body tissue | ||
US6008A (en) * | 1849-01-09 | Pkoto-litho | ||
US4001A (en) * | 1845-04-16 | Carriage- wheel | ||
US638704A (en) | 1899-02-10 | 1899-12-12 | John J Tower | Sliding ram for tools. |
US2738790A (en) | 1954-08-12 | 1956-03-20 | George P Pilling & Son Company | Suturing instrument |
US3182662A (en) | 1962-07-25 | 1965-05-11 | Vithal N Shirodkar | Plastic prosthesis useful in gynaecological surgery |
US3384073A (en) | 1964-04-21 | 1968-05-21 | Ethicon Inc | Surgical device for correction of urinary incontinence |
US3311110A (en) | 1964-07-15 | 1967-03-28 | American Cyanamid Co | Flexible composite suture having a tandem linkage |
US3472232A (en) | 1967-05-31 | 1969-10-14 | Abbott Lab | Catheter insertion device |
US3580313A (en) | 1969-01-07 | 1971-05-25 | Mcknight Charles A | Surgical instrument |
US3763860A (en) | 1971-08-26 | 1973-10-09 | H Clarke | Laparoscopy instruments and method for suturing and ligation |
US3789828A (en) | 1972-09-01 | 1974-02-05 | Heyer Schulte Corp | Urethral prosthesis |
US3858783A (en) | 1972-11-20 | 1975-01-07 | Nikolai Nikolaevich Kapitanov | Surgical instrument for stitching up tissues with lengths of suture wire |
US3815576A (en) | 1973-01-26 | 1974-06-11 | D Balaban | Artificial sphincter |
DE2305815A1 (en) | 1973-02-07 | 1974-08-08 | Kurt Seuberth | DEVICE FOR SEPARATING SURGICAL FEEDS |
US3924633A (en) | 1974-01-31 | 1975-12-09 | Cook Inc | Apparatus and method for suprapubic catheterization |
US4037603A (en) | 1975-05-13 | 1977-07-26 | Wendorff Erwin R | Metallic surgical suture |
US3995619A (en) | 1975-10-14 | 1976-12-07 | Glatzer Stephen G | Combination subcutaneous suture remover, biopsy sampler and syringe |
US4019499A (en) | 1976-04-22 | 1977-04-26 | Heyer-Schulte Corporation | Compression implant for urinary incontinence |
US4128100A (en) | 1976-10-08 | 1978-12-05 | Wendorff Erwin R | Suture |
US5633286B1 (en) | 1977-03-17 | 2000-10-10 | Applied Elastomerics Inc | Gelatinous elastomer articles |
US4172458A (en) | 1977-11-07 | 1979-10-30 | Pereyra Armand J | Surgical ligature carrier |
US4235238A (en) | 1978-05-11 | 1980-11-25 | Olympus Optical Co., Ltd. | Apparatus for suturing coeliac tissues |
US4246660A (en) | 1978-12-26 | 1981-01-27 | Queen's University At Kingston | Artificial ligament |
SU1342486A1 (en) | 1982-06-29 | 1987-10-07 | М.А. Мороз | Needle holder |
US4441497A (en) | 1982-10-21 | 1984-04-10 | Paudler Franklin T | Universal suture passer |
US4509516A (en) | 1983-02-24 | 1985-04-09 | Stryker Corporation | Ligament tunneling instrument |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4873976A (en) | 1984-02-28 | 1989-10-17 | Schreiber Saul N | Surgical fasteners and method |
SU1225547A1 (en) | 1984-08-03 | 1986-04-23 | Московский Городской Ордена Ленина И Ордена Трудового Красного Знамени Научно-Исследовательский Институт Скорой Помощи Им.Н.В.Склифосовского | Surgical instrument |
US4865031A (en) | 1985-07-12 | 1989-09-12 | Keeffe Paul J O | Fabric and method of use for treatment of scars |
US4632100A (en) | 1985-08-29 | 1986-12-30 | Marlowe E. Goble | Suture anchor assembly |
GB8525565D0 (en) | 1985-10-17 | 1985-11-20 | Speedhom B B | Surgical replacement of ligaments |
US5032508A (en) | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
GB8611129D0 (en) | 1986-05-07 | 1986-06-11 | Annis D | Prosthetic materials |
US4920986A (en) | 1986-10-14 | 1990-05-01 | Zedlani Pty. Limited | Urinary incontinence device |
US5386836A (en) | 1986-10-14 | 1995-02-07 | Zedlani Pty Limited | Urinary incontinence device |
EP0314412B1 (en) | 1987-10-30 | 1993-10-06 | Howmedica Inc. | Device for tendon and ligament repair |
WO1990003766A1 (en) | 1988-10-04 | 1990-04-19 | Peter Emanuel Petros | Surgical instrument prosthesis and method of utilisation of such |
US5012822A (en) | 1988-10-11 | 1991-05-07 | Schwarz Gerald R | Method for controlling urinary incontinence |
US5123428A (en) | 1988-10-11 | 1992-06-23 | Schwarz Gerald R | Laparoscopically implanting bladder control apparatus |
US5007894A (en) | 1989-02-10 | 1991-04-16 | Goran Enhorning | Female incontinence device |
US5013292A (en) | 1989-02-24 | 1991-05-07 | R. Laborie Medical Corporation | Surgical correction of female urinary stress incontinence and kit therefor |
US4938760A (en) | 1989-03-29 | 1990-07-03 | American Medical Systems, Inc. | Female suspension procedure |
US4932962A (en) | 1989-05-16 | 1990-06-12 | Inbae Yoon | Suture devices particularly useful in endoscopic surgery and methods of suturing |
GB8924806D0 (en) | 1989-11-03 | 1989-12-20 | Neoligaments Ltd | Prosthectic ligament system |
US5013316A (en) | 1990-03-26 | 1991-05-07 | Marlowe Goble E | Soft tissue anchor system |
US5019032A (en) | 1990-04-03 | 1991-05-28 | Robertson Jack R | Refined suspension procedure with implement for treating female stress incontinence |
US5256133A (en) | 1990-09-05 | 1993-10-26 | Spitz Robert M | Device for correcting stress urinary incontinence |
US5368595A (en) | 1990-09-06 | 1994-11-29 | United States Surgical Corporation | Implant assist apparatus |
US5725529A (en) | 1990-09-25 | 1998-03-10 | Innovasive Devices, Inc. | Bone fastener |
CA2092400A1 (en) | 1990-09-25 | 1992-03-26 | James E. Nicholson | Bone fastener |
US5053043A (en) | 1990-09-28 | 1991-10-01 | Vance Products Incorporated | Suture guide and method of placing sutures through a severed duct |
US5085661A (en) | 1990-10-29 | 1992-02-04 | Gerald Moss | Surgical fastener implantation device |
JPH06506366A (en) | 1990-12-06 | 1994-07-21 | ダブリュ.エル.ゴア アンド アソシエーツ,インコーポレイティド | Implantable bioabsorbable components |
US5149329A (en) | 1990-12-12 | 1992-09-22 | Wayne State University | Surgical suture carrier and method for urinary bladder neck suspension |
FI95351C (en) | 1990-12-18 | 1996-01-25 | Instrumentarium Oy Datex | Device for evaporating liquid |
US5203864A (en) | 1991-04-05 | 1993-04-20 | Phillips Edward H | Surgical fastener system |
US5269783A (en) | 1991-05-13 | 1993-12-14 | United States Surgical Corporation | Device and method for repairing torn tissue |
US5141520A (en) | 1991-10-29 | 1992-08-25 | Marlowe Goble E | Harpoon suture anchor |
US5439467A (en) | 1991-12-03 | 1995-08-08 | Vesica Medical, Inc. | Suture passer |
WO1993010715A2 (en) | 1991-12-03 | 1993-06-10 | Vesitec Medical, Inc. | Surgical treatment of stress urinary incontinence |
EP0633748B1 (en) | 1991-12-03 | 1998-03-04 | Boston Scientific Ireland Limited | Bone Anchor Implantation Device |
US5935122A (en) | 1991-12-13 | 1999-08-10 | Endovascular Technologies, Inc. | Dual valve, flexible expandable sheath and method |
CA2090000A1 (en) | 1992-02-24 | 1993-08-25 | H. Jonathan Tovey | Articulating mesh deployment apparatus |
WO1993017635A1 (en) | 1992-03-04 | 1993-09-16 | C.R. Bard, Inc. | Composite prosthesis and method for limiting the incidence of postoperative adhesions |
US5403328A (en) | 1992-04-22 | 1995-04-04 | United States Surgical Corporation | Surgical apparatus and method for suturing body tissue |
US5188636A (en) | 1992-05-07 | 1993-02-23 | Ethicon, Inc. | Purse string suture instrument |
US5501695A (en) | 1992-05-27 | 1996-03-26 | The Anspach Effort, Inc. | Fastener for attaching objects to bones |
DE4220283C2 (en) | 1992-06-20 | 1994-05-19 | Singer Spezialnadelfab | Surgical needle-thread combination |
DK84193A (en) | 1992-07-15 | 1994-01-16 | Francisco Garcia Lopez | Vaginal autosuture instrument for the prevention of urinary incontinence in women |
US6048351A (en) | 1992-09-04 | 2000-04-11 | Scimed Life Systems, Inc. | Transvaginal suturing system |
US5281237A (en) | 1992-09-25 | 1994-01-25 | Gimpelson Richard J | Surgical stitching device and method of use |
US5362294A (en) | 1992-09-25 | 1994-11-08 | Seitzinger Michael R | Sling for positioning internal organ during laparoscopic surgery and method of use |
US5337736A (en) | 1992-09-30 | 1994-08-16 | Reddy Pratap K | Method of using a laparoscopic retractor |
ES2049653B1 (en) | 1992-10-05 | 1994-12-16 | Velazquez Francisco Farrer | CORRECTIVE DEVICE FOR FEMALE URINARY INCONTINENCE. |
US5383904A (en) | 1992-10-13 | 1995-01-24 | United States Surgical Corporation | Stiffened surgical device |
US5250033A (en) | 1992-10-28 | 1993-10-05 | Interventional Thermodynamics, Inc. | Peel-away introducer sheath having proximal fitting |
IL127978A0 (en) | 1999-01-08 | 1999-11-30 | Influence Med Tech Ltd | Incontinence device |
US5972000A (en) | 1992-11-13 | 1999-10-26 | Influence Medical Technologies, Ltd. | Non-linear anchor inserter device and bone anchors |
US6635058B2 (en) * | 1992-11-13 | 2003-10-21 | Ams Research Corporation | Bone anchor |
US6406480B1 (en) | 1992-11-13 | 2002-06-18 | American Med Syst | Bone anchor inserter with retractable shield |
IL103737A (en) | 1992-11-13 | 1997-02-18 | Technion Res & Dev Foundation | Stapler device particularly useful in medical suturing |
US5328077A (en) | 1992-11-19 | 1994-07-12 | Lou Ek Seng | Method and apparatus for treating female urinary incontinence |
US5540703A (en) | 1993-01-06 | 1996-07-30 | Smith & Nephew Richards Inc. | Knotted cable attachment apparatus formed of braided polymeric fibers |
AU6236794A (en) | 1993-02-22 | 1994-09-14 | Valleylab, Inc. | A laparoscopic dissection tension retractor device and method |
US5354292A (en) | 1993-03-02 | 1994-10-11 | Braeuer Harry L | Surgical mesh introduce with bone screw applicator for the repair of an inguinal hernia |
WO1994021197A1 (en) | 1993-03-25 | 1994-09-29 | C.R. Bard, Inc. | Vascular graft |
US5474543A (en) | 1993-05-17 | 1995-12-12 | Mckay; Hunter A. | Single needle apparatus and method for performing retropublic urethropexy |
US5520703A (en) | 1993-06-07 | 1996-05-28 | Essig; Mitchell N. | Laparoscopic deschamp and associated suturing technique |
US5370662A (en) | 1993-06-23 | 1994-12-06 | Kevin R. Stone | Suture anchor assembly |
US5500000A (en) | 1993-07-01 | 1996-03-19 | United States Surgical Corporation | Soft tissue repair system and method |
BR9302774A (en) | 1993-07-06 | 1995-02-14 | Antoine Jean Henri Robert | Adjustable peri-urethral expander |
CA2124651C (en) | 1993-08-20 | 2004-09-28 | David T. Green | Apparatus and method for applying and adjusting an anchoring device |
US5591206A (en) | 1993-09-30 | 1997-01-07 | Moufarr+E,Gra E+Ee Ge; Richard | Method and device for closing wounds |
EP0725598A1 (en) | 1993-10-28 | 1996-08-14 | Javin Pierce | A suture anchor |
US5527342A (en) | 1993-12-14 | 1996-06-18 | Pietrzak; William S. | Method and apparatus for securing soft tissues, tendons and ligaments to bone |
US5518504A (en) | 1993-12-28 | 1996-05-21 | American Medical Systems, Inc. | Implantable sphincter system utilizing lifting means |
AU1011595A (en) | 1994-01-13 | 1995-07-20 | Ethicon Inc. | Spiral surgical tack |
DE4410129A1 (en) | 1994-03-24 | 1995-09-28 | Kleinewefers Gmbh | Press device for sheet material |
US5584880A (en) | 1994-04-28 | 1996-12-17 | Martinez; Miguel | Orbital implant |
FR2720266B1 (en) | 1994-05-27 | 1996-12-20 | Cogent Sarl | Prosthetic fabric. |
SE506164C2 (en) | 1995-10-09 | 1997-11-17 | Medscand Medical Ab | Instruments for the treatment of urinary incontinence in women |
US5899909A (en) | 1994-08-30 | 1999-05-04 | Medscand Medical Ab | Surgical instrument for treating female urinary incontinence |
AU3683995A (en) | 1994-09-28 | 1996-04-19 | Innovasive Devices, Inc. | Suture tensioning device |
IL111985A (en) | 1994-12-14 | 1999-04-11 | Medical Influence Technologies | Staple and thread assembly particularly for use in power-driven staplers for medical suturing |
US5584860A (en) | 1995-02-15 | 1996-12-17 | Mitek Surgical Products, Inc. | Suture anchor loader and driver |
US5643320A (en) | 1995-03-13 | 1997-07-01 | Depuy Inc. | Soft tissue anchor and method |
US5571139A (en) | 1995-05-19 | 1996-11-05 | Jenkins, Jr.; Joseph R. | Bidirectional suture anchor |
US6042583A (en) | 1995-06-14 | 2000-03-28 | Medworks Corporation | Bone anchor-insertion tool and surgical method employing same |
US5997554A (en) | 1995-06-14 | 1999-12-07 | Medworks Corporation | Surgical template and surgical method employing same |
US5591163A (en) | 1995-06-14 | 1997-01-07 | Incont, Inc. | Apparatus and method for laparoscopic urethropexy |
US6451024B1 (en) | 1995-06-14 | 2002-09-17 | Dexterity Surgical, Inc. | Surgical method for treating urinary incontinence, and apparatus for use in same |
US5697931A (en) | 1995-06-14 | 1997-12-16 | Incont, Inc. | Apparatus and method for laparoscopic urethopexy |
US5669935A (en) | 1995-07-28 | 1997-09-23 | Ethicon, Inc. | One-way suture retaining device for braided sutures |
AUPN562295A0 (en) | 1995-09-26 | 1995-10-19 | Compton, Jeffrey Spencer Dr | Easy load device for raney style scalp clips |
US5647836A (en) | 1995-09-28 | 1997-07-15 | Blake, Iii; Joseph W. | Method and means for treating female urinary incontinence |
WO1997016121A1 (en) | 1995-10-31 | 1997-05-09 | Karl Christopher Texler | Surgical instruments |
DE19544162C1 (en) | 1995-11-17 | 1997-04-24 | Ethicon Gmbh | Implant for suspension of the bladder in urinary incontinence in women |
JP2000503559A (en) | 1995-12-14 | 2000-03-28 | ゴア エンタープライズ ホールディングス,インコーポレイティド | Apparatus and method for deploying a stent-graft |
DE19601477C2 (en) | 1996-01-17 | 1999-12-16 | Axel Kirsch | Fastening nail |
US5725541A (en) | 1996-01-22 | 1998-03-10 | The Anspach Effort, Inc. | Soft tissue fastener device |
US5741282A (en) | 1996-01-22 | 1998-04-21 | The Anspach Effort, Inc. | Soft tissue fastener device |
US5785640A (en) | 1996-05-23 | 1998-07-28 | Kresch; Arnold J. | Method for treating female incontinence |
US5893856A (en) | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US5782862A (en) | 1996-07-01 | 1998-07-21 | Bonutti; Peter M. | Suture anchor inserter assembly and method |
US5782916A (en) | 1996-08-13 | 1998-07-21 | Galt Laboratories, Inc. | Device for maintaining urinary continence |
US6264676B1 (en) | 1996-11-08 | 2001-07-24 | Scimed Life Systems, Inc. | Protective sheath for transvaginal anchor implantation devices |
US6053935A (en) | 1996-11-08 | 2000-04-25 | Boston Scientific Corporation | Transvaginal anchor implantation device |
US5709708A (en) | 1997-01-31 | 1998-01-20 | Thal; Raymond | Captured-loop knotless suture anchor assembly |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5954057A (en) | 1997-02-12 | 1999-09-21 | Li Medical Technologies, Inc. | Soft tissue suspension clip, clip assembly, emplacement tool and method |
DE69808614T2 (en) | 1997-02-13 | 2003-06-18 | Boston Scientific Ltd., St. Michael | STABILIZATION SLING FOR USE IN MINIMALLY INVASIVE PELVIC SURGERY |
US6099547A (en) | 1997-02-13 | 2000-08-08 | Scimed Life Systems, Inc. | Method and apparatus for minimally invasive pelvic surgery |
DE69821127T2 (en) | 1997-02-13 | 2004-06-09 | Boston Scientific Ltd., St. Michael | PERCUTANEOUS AND HIATAL DEVICES FOR USE IN MINIMALLY INVASIVE PELVIC SURGERY |
DE69839051T2 (en) | 1997-03-07 | 2009-01-15 | Disc-O-Tech Medical Technologies, Ltd. | PERCUT BONE SYSTEMS AND SPINAL STABILIZATION, MOUNTING AND REPAIR |
US6599235B2 (en) * | 1997-03-18 | 2003-07-29 | American Medical Systems Inc. | Transvaginal bone anchor implantation device |
US6039686A (en) | 1997-03-18 | 2000-03-21 | Kovac; S. Robert | System and a method for the long term cure of recurrent urinary female incontinence |
US5782866A (en) | 1997-03-25 | 1998-07-21 | Ethicon, Inc. | System for anchoring tissue to bone |
US5904692A (en) | 1997-04-14 | 1999-05-18 | Mitek Surgical Products, Inc. | Needle assembly and method for passing suture |
US5934283A (en) | 1997-04-15 | 1999-08-10 | Uroplasty, Inc. | Pubovaginal sling device |
US5922026A (en) | 1997-05-01 | 1999-07-13 | Origin Medsystems, Inc. | Surgical method and prosthetic strip therefor |
DE69807329T2 (en) | 1997-06-02 | 2003-04-24 | Martello, Jeanette M. | FIXING ANCHOR FOR SOFT TISSUE |
US6419624B1 (en) | 1999-10-11 | 2002-07-16 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
US5988171A (en) | 1997-06-26 | 1999-11-23 | Influence Medical Technologies, Ltd. | Methods and devices for the treatment of airway obstruction, sleep apnea and snoring |
US5944732A (en) | 1997-08-27 | 1999-08-31 | Medical Components, Inc. | Subcutaneous tunnelling device and methods of forming a subcutaneous tunnel |
US5980558A (en) | 1997-09-30 | 1999-11-09 | Biomet Inc. | Suture anchor system |
US6197036B1 (en) | 1997-10-01 | 2001-03-06 | Scimed Life Systems, Inc. | Pelvic floor reconstruction |
US6027523A (en) | 1997-10-06 | 2000-02-22 | Arthrex, Inc. | Suture anchor with attached disk |
US6099552A (en) | 1997-11-12 | 2000-08-08 | Boston Scientific Corporation | Gastrointestinal copression clips |
US6019768A (en) | 1997-11-18 | 2000-02-01 | Ethicon, Inc, | Suture anchor retriever and method for retrieving an implanted suture anchor |
WO1999037216A1 (en) | 1998-01-27 | 1999-07-29 | Scimed Life Systems, Inc. | Protective sheath for transvaginal anchor implantation device |
US6096041A (en) | 1998-01-27 | 2000-08-01 | Scimed Life Systems, Inc. | Bone anchors for bone anchor implantation device |
US6660010B2 (en) * | 1998-01-27 | 2003-12-09 | Scimed Life Systems, Inc. | Bone anchor placement device with recessed anchor mount |
US6221005B1 (en) | 1998-02-17 | 2001-04-24 | Norman I. Bruckner | Pubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence with urethal hypemobility |
US6068591A (en) | 1998-02-17 | 2000-05-30 | Bruckner; Norman I. | Pubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence |
US5984927A (en) | 1998-03-03 | 1999-11-16 | Ethicon, Inc. | Device for sutureless attachment of soft tissue to bone |
ES2149091B1 (en) * | 1998-03-10 | 2001-05-16 | Gil Vernet Vila Jose Maria | DEVICE FOR FIXING AND ADJUSTABLE SUPPORT AT HEIGHT OF INTERNAL ANATOMICAL ORGANS. |
US6099551A (en) | 1998-03-12 | 2000-08-08 | Shelhigh, Inc. | Pericardial strip and stapler assembly for dividing and sealing visceral tissues and method of use thereof |
CA2529951C (en) | 1998-03-20 | 2007-11-13 | Boston Scientific Limited | Endoscopic suture systems |
US6106545A (en) | 1998-04-16 | 2000-08-22 | Axya Medical, Inc. | Suture tensioning and fixation device |
IT1299162B1 (en) | 1998-04-17 | 2000-02-29 | Mauro Cervigni | PROSTHETIC ASSEMBLY TO BE USED IN SURGICAL THERAPY OF UROGENITAL PROLAPSE |
FR2777442B1 (en) | 1998-04-21 | 2000-07-28 | Tornier Sa | REVERSIBLE EXPANSION SUTURE ANCHOR |
US6382214B1 (en) | 1998-04-24 | 2002-05-07 | American Medical Systems, Inc. | Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele |
EP1077653B1 (en) | 1998-05-12 | 2004-03-31 | Boston Scientific Limited | Manual bone anchor placement devices |
EP1079740B1 (en) | 1998-05-21 | 2007-08-29 | Christopher J. Walshe | A tissue anchor system |
US6074341A (en) | 1998-06-09 | 2000-06-13 | Timm Medical Technologies, Inc. | Vessel occlusive apparatus and method |
US6010447A (en) | 1998-07-31 | 2000-01-04 | Kardjian; Paul M. | Bladder sling |
US6042536A (en) | 1998-08-13 | 2000-03-28 | Contimed, Inc. | Bladder sling |
US6648903B1 (en) | 1998-09-08 | 2003-11-18 | Pierson, Iii Raymond H. | Medical tensioning system |
US6030393A (en) | 1998-09-15 | 2000-02-29 | Corlew; Earvin L. | Needle and procedure for relieving urinary incontinence |
US6302840B1 (en) | 1998-09-21 | 2001-10-16 | Theodore V. Benderev | Surgical monitor |
US6050937A (en) | 1998-09-21 | 2000-04-18 | Benderev; Theodore V. | Surgical tension/pressure monitor |
US6786861B1 (en) | 1998-10-01 | 2004-09-07 | Nicolaas Daniel Lombard Burger | Distensible sling for urinary incontinence |
US5925047A (en) | 1998-10-19 | 1999-07-20 | Third Millennium Engineering, Llc | Coupled rod, anterior vertebral body screw, and staple assembly |
FR2785521B1 (en) | 1998-11-10 | 2001-01-05 | Sofradim Production | SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES |
US7410460B2 (en) | 1998-11-23 | 2008-08-12 | Benderev Theodore V | System for securing sutures, grafts and soft tissue to bone and periosteum |
US20050004576A1 (en) * | 1998-11-23 | 2005-01-06 | Benderev Theodore V. | System for securing sutures, grafts and soft tissue to bone and periosteum |
US7387634B2 (en) | 1998-11-23 | 2008-06-17 | Benderev Theodore V | System for securing sutures, grafts and soft tissue to bone and periosteum |
US6200330B1 (en) | 1998-11-23 | 2001-03-13 | Theodore V. Benderev | Systems for securing sutures, grafts and soft tissue to bone and periosteum |
FR2787990B1 (en) | 1998-12-30 | 2001-04-27 | Medical Res & Man Llc | PROSTHESIS FOR CORRECTING URINARY INCONTINENCE IN WOMEN |
WO2000040158A2 (en) | 1999-01-08 | 2000-07-13 | Influence Medical Technologies, Ltd. | Surgical tack |
US6099538A (en) | 1999-02-02 | 2000-08-08 | T.A.G. Medical Products | Set of surgical tools and surgical method for connecting soft bone parts to one another or to connective tissue |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US6981983B1 (en) | 1999-03-31 | 2006-01-03 | Rosenblatt Peter L | System and methods for soft tissue reconstruction |
WO2000057796A1 (en) | 1999-03-31 | 2000-10-05 | Rosenblatt Peter L | Systems and methods for soft tissue reconstruction |
US20050283189A1 (en) * | 1999-03-31 | 2005-12-22 | Rosenblatt Peter L | Systems and methods for soft tissue reconstruction |
FR2792824B1 (en) | 1999-04-27 | 2001-06-22 | Sofradim Production | DEVICE FOR TREATING PROLAPSUS BY VAGINAL SUSPENSION |
WO2000066030A1 (en) | 1999-04-30 | 2000-11-09 | Uromedica, Inc. | Method and apparatus for adjustable sling for treatment of urinary stress incontinence |
US6423072B1 (en) | 1999-05-19 | 2002-07-23 | Stephen M. Zappala | Bone anchor delivery device with an articulating head |
IL130307A0 (en) | 1999-06-04 | 2000-06-01 | Influence Med Tech Ltd | Bone suturing device |
ES2269069T3 (en) | 1999-06-08 | 2007-04-01 | Ethicon, Inc. | WOVEN SURGICAL MESH. |
US6273852B1 (en) | 1999-06-09 | 2001-08-14 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
US6932759B2 (en) | 1999-06-09 | 2005-08-23 | Gene W. Kammerer | Surgical instrument and method for treating female urinary incontinence |
DK1581162T3 (en) | 1999-06-09 | 2011-08-01 | Ethicon Inc | Device for adjusting polymer implants on soft surfaces |
US6475139B1 (en) | 1999-06-09 | 2002-11-05 | Ethicon, Inc. | Visually-directed surgical instrument and method for treating female urinary incontinence |
US7226407B2 (en) | 1999-06-09 | 2007-06-05 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
US7121997B2 (en) | 1999-06-09 | 2006-10-17 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
IT1313574B1 (en) | 1999-07-27 | 2002-09-09 | Angiologica B M S R L | CORRECTIVE NETWORK FOR BODY FABRICS. |
US6168611B1 (en) | 1999-09-08 | 2001-01-02 | Syed Rizvi | Suturing needle assemblies and methods of use thereof |
AUPQ362199A0 (en) | 1999-10-22 | 1999-11-18 | Kaladelfos, George | Intra-vaginal sling placement device |
US6599318B1 (en) | 1999-11-30 | 2003-07-29 | Shlomo Gabbay | Implantable support apparatus and method of using same |
US6306079B1 (en) | 1999-12-07 | 2001-10-23 | Arnaldo F. Trabucco | Mesh pubovaginal sling |
DE19961218A1 (en) | 1999-12-15 | 2001-07-05 | Ethicon Gmbh | Surgical needle for implanting a band |
FR2802798B1 (en) | 1999-12-22 | 2002-02-01 | Promedon S A | PAD STRAP FOR THE TREATMENT OF URINARY INCONTINENCE |
US6406423B1 (en) | 2000-01-21 | 2002-06-18 | Sofradim Production | Method for surgical treatment of urinary incontinence and device for carrying out said method |
GB2359256B (en) * | 2000-01-21 | 2004-03-03 | Sofradim Production | Percutaneous device for treating urinary stress incontinence in women using a sub-urethral tape |
DE10004832A1 (en) | 2000-01-31 | 2001-08-16 | Ethicon Gmbh | Flat implant with X-ray visible elements |
US6414179B1 (en) | 2000-02-18 | 2002-07-02 | Bristol-Myers Squibb Company | Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors |
US7131943B2 (en) | 2000-03-09 | 2006-11-07 | Ethicon, Inc. | Surgical instrument and method for treating organ prolapse conditions |
US6837846B2 (en) | 2000-04-03 | 2005-01-04 | Neo Guide Systems, Inc. | Endoscope having a guide tube |
US20020007222A1 (en) | 2000-04-11 | 2002-01-17 | Ashvin Desai | Method and apparatus for supporting a body organ |
US6908473B2 (en) | 2000-04-14 | 2005-06-21 | Jeffry B. Skiba | Tissue anchoring devices, biological vessel suspending devices and systems and methods utilizing same |
US6482214B1 (en) | 2000-04-27 | 2002-11-19 | Medtronic, Inc. | Intravascular seal with mesh reinforcement and method for using same |
US6596001B2 (en) | 2000-05-01 | 2003-07-22 | Ethicon, Inc. | Aiming device for surgical instrument and method for use for treating female urinary incontinence |
US6638211B2 (en) * | 2000-07-05 | 2003-10-28 | Mentor Corporation | Method for treating urinary incontinence in women and implantable device intended to correct urinary incontinence |
US6494906B1 (en) | 2000-07-25 | 2002-12-17 | Advanced Cardiovascular Systems, Inc. | Stent fold clip |
US7025063B2 (en) | 2000-09-07 | 2006-04-11 | Ams Research Corporation | Coated sling material |
US6592515B2 (en) | 2000-09-07 | 2003-07-15 | Ams Research Corporation | Implantable article and method |
DE10046840A1 (en) | 2000-09-20 | 2002-07-04 | Goodrich Hella Aerospace Ls | Reading light for a vehicle interior |
EP1333774B1 (en) * | 2000-09-26 | 2009-12-23 | Ethicon, Inc. | Surgical apparatus for delivery of a sling in the treatment of female urinary incontinence |
DE20016866U1 (en) | 2000-09-30 | 2000-12-14 | Wendt, Adalbert, 50127 Bergheim | Tool to unlock a lock cylinder |
FR2814939B1 (en) | 2000-10-05 | 2002-12-20 | Sofradim Production | SUB-URETRAL SUPPORT KIT FOR THE TREATMENT OF URINARY INCONTINENCE OF FEMALE EXERCISE |
US6702827B1 (en) * | 2000-10-06 | 2004-03-09 | American Medical Systems | Sling adjustment and tensioning accessory |
US7299803B2 (en) | 2000-10-09 | 2007-11-27 | Ams Research Corporation | Pelvic surgery drape |
GB0025068D0 (en) | 2000-10-12 | 2000-11-29 | Browning Healthcare Ltd | Apparatus and method for treating female urinary incontinence |
US6605097B1 (en) | 2000-10-18 | 2003-08-12 | Jorn Lehe | Apparatus and method for treating female urinary incontinence |
US6638209B2 (en) | 2000-10-20 | 2003-10-28 | Ethicon Gmbh | System with a surgical needle and a handle |
KR20080022238A (en) | 2000-10-23 | 2008-03-10 | 에디컨인코포레이티드 | Apparatus and method for measurement and assessment of sling-tension for treatment of female urinary incontinence |
DE10056169C2 (en) | 2000-11-13 | 2003-07-03 | Ethicon Gmbh | Implant for holding the female bladder |
AU2002217880A1 (en) | 2000-11-15 | 2002-05-27 | Scimed Life Systems, Inc. | Device and method for treating female urinary incontinence |
DE60137964D1 (en) | 2000-11-20 | 2009-04-23 | Ethicon Inc | OPERATING INSTRUMENT FOR THE TREATMENT OF FEMALE HARNINE CONTINENCE |
US20020128670A1 (en) | 2000-11-22 | 2002-09-12 | Ulf Ulmsten | Surgical instrument and method for treating female urinary incontinence |
US6726703B2 (en) * | 2000-11-27 | 2004-04-27 | Scimed Life Systems, Inc. | Distal protection device and method |
US6599323B2 (en) | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
US7267845B2 (en) | 2000-12-22 | 2007-09-11 | Basf Corporation | Coating systems containing modified crosslinkers |
US6582443B2 (en) | 2000-12-27 | 2003-06-24 | Ams Research Corporation | Apparatus and methods for enhancing the functional longevity and for facilitating the implantation of medical devices |
US6612977B2 (en) * | 2001-01-23 | 2003-09-02 | American Medical Systems Inc. | Sling delivery system and method of use |
US20020147382A1 (en) | 2001-01-23 | 2002-10-10 | Neisz Johann J. | Surgical articles and methods |
US7229453B2 (en) | 2001-01-23 | 2007-06-12 | Ams Research Corporation | Pelvic floor implant system and method of assembly |
US7070556B2 (en) | 2002-03-07 | 2006-07-04 | Ams Research Corporation | Transobturator surgical articles and methods |
US6641525B2 (en) | 2001-01-23 | 2003-11-04 | Ams Research Corporation | Sling assembly with secure and convenient attachment |
US6802807B2 (en) | 2001-01-23 | 2004-10-12 | American Medical Systems, Inc. | Surgical instrument and method |
US20020161382A1 (en) | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
US6602260B2 (en) | 2001-02-02 | 2003-08-05 | Ams Research Corporation | Powered bone screw device |
US20050131393A1 (en) * | 2001-03-09 | 2005-06-16 | Scimed Life Systems, Inc. | Systems, methods and devices relating to delivery of medical implants |
US6936052B2 (en) * | 2001-03-09 | 2005-08-30 | Boston Scientific Scimed, Inc. | System for implanting an implant and method thereof |
US7364541B2 (en) | 2001-03-09 | 2008-04-29 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to delivery of medical implants |
US7025772B2 (en) | 2001-03-09 | 2006-04-11 | Scimed Life Systems, Inc. | System for implanting an implant and method thereof |
US9149261B2 (en) * | 2001-03-09 | 2015-10-06 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to delivery of medical implants |
AUPR406501A0 (en) * | 2001-03-28 | 2001-04-26 | Kaladelfos, George | Treatment of vault prolapse |
FR2824257B1 (en) | 2001-05-07 | 2004-01-30 | Bernard Guerquin | INTRA-VAGINAL DEVICE FOR PREVENTING FEMALE URINARY INCONTINENCE DURING EXERCISE |
US20030004581A1 (en) | 2001-06-27 | 2003-01-02 | Rousseau Robert A. | Implantable prosthetic mesh system |
ITMI20011376A1 (en) | 2001-06-29 | 2002-12-29 | Siemens Inf & Comm Networks | PROCEDURE FOR THE CONTROL OF PACKAGE SWITCHING TRAFFIC IN NUMERICAL MOBILE COMMUNICATION SYSTEMS |
US7407480B2 (en) | 2001-07-27 | 2008-08-05 | Ams Research Corporation | Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele |
US7037255B2 (en) | 2001-07-27 | 2006-05-02 | Ams Research Corporation | Surgical instruments for addressing pelvic disorders |
US6755781B2 (en) * | 2001-07-27 | 2004-06-29 | Scimed Life Systems, Inc. | Medical slings |
ATE332674T1 (en) | 2001-08-03 | 2006-08-15 | Aesculap Ag & Co Kg | INCONTINENCE BAND FOR THE TREATMENT OF URINARY INCONTINENCE |
DE10141234A1 (en) | 2001-08-23 | 2003-03-13 | Ethicon Gmbh | System with a surgical needle and a handle |
US20040073235A1 (en) * | 2001-10-01 | 2004-04-15 | Lund Robert E. | Surgical article |
US6830052B2 (en) | 2001-10-03 | 2004-12-14 | Solarant Medical, Inc. | Urethral support for incontinence |
US6648921B2 (en) * | 2001-10-03 | 2003-11-18 | Ams Research Corporation | Implantable article |
US7087065B2 (en) | 2001-10-04 | 2006-08-08 | Ethicon, Inc. | Mesh for pelvic floor repair |
US6666817B2 (en) * | 2001-10-05 | 2003-12-23 | Scimed Life Systems, Inc. | Expandable surgical implants and methods of using them |
US6673010B2 (en) | 2001-10-22 | 2004-01-06 | T. A. G. Medical Products Ltd. | Biological vessel suspending assembly and systems and methods utilizing same |
FR2831051B1 (en) | 2001-10-22 | 2004-07-30 | Johnson & Johnson Internat | MINI SUPPORT UNDER URETHRO-CERVICAL |
DE10153334B4 (en) | 2001-10-29 | 2004-04-29 | Ethicon Gmbh | Flat implant |
DE10155842A1 (en) | 2001-11-14 | 2003-05-28 | Ethicon Gmbh | Flat implant |
DE10159181A1 (en) | 2001-12-03 | 2003-06-26 | Ethicon Gmbh | Surgical auxiliary instrument |
US6974462B2 (en) | 2001-12-19 | 2005-12-13 | Boston Scientific Scimed, Inc. | Surgical anchor implantation device |
JP4241389B2 (en) | 2002-03-01 | 2009-03-18 | エチコン、インコーポレイテッド | Method and apparatus for treatment of pelvic prolapse in female patients |
US8968178B2 (en) * | 2002-03-07 | 2015-03-03 | Ams Research Corporation | Transobturator surgical articles and methods |
US6911003B2 (en) | 2002-03-07 | 2005-06-28 | Ams Research Corporation | Transobturator surgical articles and methods |
US7357773B2 (en) | 2002-03-07 | 2008-04-15 | Ams Research Corporation | Handle and surgical article |
CA2478448C (en) | 2002-03-07 | 2011-06-21 | Ams Research Corporation | Transobturator surgical articles and methods |
FR2836820B1 (en) | 2002-03-08 | 2004-12-17 | Vincent Goria | SURGICAL DEVICE AND STRIP FOR THE TREATMENT OF URINARY EFFORT INCONTINENCE IN WOMEN |
DE10211360A1 (en) | 2002-03-14 | 2003-10-09 | Ethicon Gmbh | Implantate band and surgical needle system to support female urethra has distal end region of needle narrower than implantate band |
CA2481275C (en) | 2002-04-11 | 2011-10-25 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
AU2003231229A1 (en) | 2002-04-30 | 2003-11-17 | Cook Biotech Incorporated | Sling for supporting tissue |
WO2003094784A2 (en) | 2002-05-07 | 2003-11-20 | Ams Research Corporation | Urethral prosthesis with tensioning member |
WO2003096928A1 (en) | 2002-05-22 | 2003-11-27 | Sofradim Production | Suburethral support assembly for the treatment of female stress urinary incontinence |
CA2488755C (en) | 2002-06-12 | 2011-07-12 | Barry N. Gellman | Medical slings |
US6881184B2 (en) | 2002-07-16 | 2005-04-19 | Stephen M. Zappala | Absorbable pubovaginal sling system and method |
ITFI20020145A1 (en) | 2002-08-01 | 2004-02-02 | Giulio Nicita | DEVICE FOR THE SURGICAL TREATMENT OF FEMALE PROLAXIS. |
US7371245B2 (en) | 2002-08-02 | 2008-05-13 | C R Bard, Inc | Transobturator introducer system for sling suspension system |
JP4589867B2 (en) | 2002-08-14 | 2010-12-01 | ボストン サイエンティフィック リミテッド | System and device for delivery of medical implants |
CA2495105C (en) * | 2002-08-23 | 2012-06-05 | Peter Emmanuel Petros | Anchoring device and its implementation |
US7611454B2 (en) | 2002-08-29 | 2009-11-03 | Universite De Liege | Surgical procedure for the treatment of female urinary incontinence: tension-free inside-out transobturator urethral suspension |
FR2843876B1 (en) | 2002-08-30 | 2004-11-26 | Bernard Bouffier | SURGICAL PROSTHESIS DEVICE FOR THE IMPLANTATION OF A SUPPORT OF A MAMMALIAN BODY |
EP2250973B1 (en) | 2002-11-15 | 2012-07-04 | Ethicon, Inc. | Kit for surgical repair of vagina damaged by pelvic organ prolapse |
DE60331358D1 (en) | 2002-12-17 | 2010-04-01 | Boston Scient Ltd | SPACER FOR A SURGICAL SLEDDING INTAKE SYSTEM |
US7494495B2 (en) | 2003-03-28 | 2009-02-24 | Coloplast A/S | Method and implant for curing cystocele |
FR2852813B1 (en) | 2003-03-28 | 2005-06-24 | Analytic Biosurgical Solutions | INTRODUCER AND PERFORATOR GUIDE FOR THE IMPLEMENTATION OF A BANDLET IN THE HUMAN BODY |
FR2852817B1 (en) | 2003-03-28 | 2006-04-28 | Emmanuel Delorme | IMPLANT FOR THE TREATMENT OF THE RECTOCELE AND DEVICE FOR THE PLACEMENT OF THIS IMPLANT |
BRPI0408903A (en) | 2003-03-28 | 2006-03-28 | Analytic Biosurgical Solutions | implant for treatment of the rectocele and / or vaginal dome prolapse, device for inserting an implant and process for treating the rectocele in a woman |
EP1608271A1 (en) | 2003-04-03 | 2005-12-28 | Ethicon GmbH | Surgical implant system for treating female urinary incontinence |
US7273448B2 (en) | 2003-04-24 | 2007-09-25 | Ams Research Corporation | Male urethral prosthesis |
WO2004096088A2 (en) * | 2003-04-25 | 2004-11-11 | Boston Scientific Limited | Systems and methods for sling delivery and placement |
ITRM20030210A1 (en) | 2003-04-30 | 2004-11-01 | Mauro Cervigni | PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY |
US6981944B2 (en) | 2003-07-07 | 2006-01-03 | Ethicon, Inc. | Implantable surgical mesh having a lubricious coating |
US20070088390A1 (en) | 2003-07-11 | 2007-04-19 | Endogun Medical Systems Ltd. | Surgical fasteners and devices for surgical fastening |
US8047981B2 (en) | 2003-08-14 | 2011-11-01 | Boston Scientific Scimed, Inc. | Medical slings |
US7303525B2 (en) | 2003-08-22 | 2007-12-04 | Ams Research Corporation | Surgical article and methods for treating female urinary incontinence |
US7347812B2 (en) | 2003-09-22 | 2008-03-25 | Ams Research Corporation | Prolapse repair |
US7393319B2 (en) | 2003-10-14 | 2008-07-01 | Caldera Medical, Inc. | Implantable sling having bladder support |
US20050090827A1 (en) * | 2003-10-28 | 2005-04-28 | Tewodros Gedebou | Comprehensive tissue attachment system |
US20060028828A1 (en) | 2003-10-31 | 2006-02-09 | Phillips Todd L | Light fixture candle assembly |
US7261723B2 (en) | 2003-11-12 | 2007-08-28 | Ethicon, Inc. | Surgical instrument and method for the treatment of urinary incontinence |
WO2005048850A2 (en) | 2003-11-17 | 2005-06-02 | Scimed Life Systems, Inc. | Systems and methods relating to associating a medical implant with a delivery device |
WO2005046511A2 (en) | 2003-11-17 | 2005-05-26 | Prolapse Inc. | Pelvic implant with anchoring frame |
ATE377491T1 (en) | 2004-01-12 | 2007-11-15 | Graphic Packaging Int Inc | METHOD AND DEVICE FOR PRODUCING A REVERSE CUTTING AND SCORING LINE IN A SHEET MADE OF DEFORMABLE MATERIAL |
ATE394077T1 (en) | 2004-02-19 | 2008-05-15 | Ams Res Corp | PROLAPSE REPAIR |
US20050199249A1 (en) * | 2004-03-15 | 2005-09-15 | Karram Mickey M. | Apparatus and method for incision-free vaginal prolapse repair |
US20050234291A1 (en) | 2004-03-30 | 2005-10-20 | Peter Gingras | Medical device |
JP4730303B2 (en) | 2004-04-28 | 2011-07-20 | 小野薬品工業株式会社 | Crystal composed of (2R) -2-propyloctanoic acid and amine |
US7351197B2 (en) | 2004-05-07 | 2008-04-01 | Ams Research Corporation | Method and apparatus for cystocele repair |
US7500945B2 (en) | 2004-04-30 | 2009-03-10 | Ams Research Corporation | Method and apparatus for treating pelvic organ prolapse |
AU2005244221B2 (en) | 2004-05-03 | 2011-02-10 | Ams Research Corporation | Surgical implants and related methods |
US8062206B2 (en) * | 2004-05-07 | 2011-11-22 | Ams Research Corporation | Method and apparatus for treatment of vaginal anterior repairs |
GB0411360D0 (en) | 2004-05-21 | 2004-06-23 | Mpathy Medical Devices Ltd | Implant |
FR2871364B1 (en) * | 2004-06-10 | 2007-09-14 | Cie De Rech En Composants Impl | PROTHETIC IMPLANT OF SUPPORT UNDER URETRAL AND SURGICAL INSTRUMENT FOR ITS IMPLANTATION |
US20050278037A1 (en) * | 2004-06-11 | 2005-12-15 | Analytic Biosurgical Solutions-Abiss | Implant for the treatment of cystocele and rectocele |
AU2005254105B2 (en) * | 2004-06-14 | 2012-01-12 | Boston Scientific Limited | Systems, methods and devices relating to implantable supportive slings |
US7553438B2 (en) | 2004-06-15 | 2009-06-30 | Siemens Energy, Inc. | Compression of resin impregnated insulating tapes |
US20050288708A1 (en) | 2004-06-25 | 2005-12-29 | Kammerer Gene W | Soft tissue fastener having integral biasing section |
EP1784141B1 (en) | 2004-07-28 | 2011-10-12 | Ethicon, Inc. | Minimally invasive medical implant and insertion device |
US7527588B2 (en) | 2004-09-15 | 2009-05-05 | Ethicon, Inc. | System and method for surgical implant placement |
WO2006041861A2 (en) * | 2004-10-05 | 2006-04-20 | Ams Research Corporation | Device and method for supporting vaginal cuff |
US8500624B2 (en) * | 2004-10-25 | 2013-08-06 | Boston Scientific Scimed, Inc. | Systems and methods for sling delivery and placement |
US7794385B2 (en) | 2004-12-20 | 2010-09-14 | Ams Research Corporation | System and method for treatment of anal incontinence and pelvic organ prolapse |
AU2005319320B2 (en) | 2004-12-20 | 2011-03-31 | Rosenblatt Associates Llc | Treatment of anal incontinence |
US7914437B2 (en) | 2005-02-04 | 2011-03-29 | Ams Research Corporation | Transobturator methods for installing sling to treat incontinence, and related devices |
AU2006210494B2 (en) | 2005-02-04 | 2011-01-06 | Ams Research Corporation | Needle design for male transobturator sling |
US20060217589A1 (en) | 2005-03-22 | 2006-09-28 | Wan Shaw P | Pubovaginal sling implanter and procedure for the usage |
WO2006105084A2 (en) * | 2005-03-25 | 2006-10-05 | Mitralsolutions, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US7740576B2 (en) | 2005-04-05 | 2010-06-22 | Ams Research Corporation | Articles, devices, and methods for pelvic surgery |
WO2006108145A1 (en) * | 2005-04-06 | 2006-10-12 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for treating pelvic floor disorders |
US7393320B2 (en) | 2005-04-29 | 2008-07-01 | Ams Research Corporation | Pelvic floor health articles and procedures |
US7431690B2 (en) | 2005-04-30 | 2008-10-07 | Coloplast A/S | Implantable sling for the treatment of male incontinence and method of using the same |
US7338420B2 (en) * | 2005-05-04 | 2008-03-04 | Takeo Imahata | Versatile toolholder for numerically controlled machine tool for holding tool through collet |
US20060252980A1 (en) | 2005-05-04 | 2006-11-09 | Arnal Kevin R | Methods and Apparatus for Securing and Tensioning a Urethral Sling to Pubic Bone |
US8864650B2 (en) | 2005-06-21 | 2014-10-21 | Ams Research Corporation | Methods and apparatus for securing a urethral sling to a pubic bone |
WO2007002071A1 (en) | 2005-06-21 | 2007-01-04 | Ams Research Corporation | Apparatus for securing a urethral sling to pubic bone |
EP1909687A1 (en) * | 2005-07-13 | 2008-04-16 | Boston Scientific Scimed, Inc. | Snap fit sling anchor system and related methods |
US9248010B2 (en) | 2005-07-15 | 2016-02-02 | Boston Scientific Scimed, Inc. | Tension-adjustable surgical sling assembly |
US7878969B2 (en) | 2005-07-25 | 2011-02-01 | Boston Scientific Scimed, Inc. | Pelvic floor repair system |
WO2007016083A1 (en) | 2005-07-26 | 2007-02-08 | Ams Research Corporation | Methods and systems for treatment of prolapse |
US8123671B2 (en) | 2005-08-04 | 2012-02-28 | C.R. Bard, Inc. | Pelvic implant systems and methods |
WO2007027592A1 (en) | 2005-08-29 | 2007-03-08 | Ams Research Corporation | System for positioning support mesh in a patient |
WO2007059368A1 (en) * | 2005-11-11 | 2007-05-24 | Ams Research Corporation | Integral sling connection system and method |
WO2007059199A2 (en) | 2005-11-14 | 2007-05-24 | C.R. Bard, Inc. | Sling anchor system |
US7637860B2 (en) | 2005-11-16 | 2009-12-29 | Boston Scientific Scimed, Inc. | Devices for minimally invasive pelvic surgery |
US7513865B2 (en) | 2005-12-20 | 2009-04-07 | Boston Scientific Scimed, Inc. | Flattened tubular mesh sling and related methods |
AU2006332514B2 (en) | 2005-12-28 | 2013-01-17 | C.R. Bard, Inc. | Apparatus and method for introducing implants |
AU2007204943B2 (en) * | 2006-01-10 | 2013-01-24 | Roger D. Beyer | Apparatus for posterior pelvic floor repair |
US8585577B2 (en) | 2006-01-10 | 2013-11-19 | Ams Research Corporation | Multi-leveled transgluteal tension-free levatorplasty for treatment of Rectocele |
WO2007081955A1 (en) | 2006-01-10 | 2007-07-19 | American Medical Systems, Inc. | Levator for repair of perineal prolapse |
US9144483B2 (en) | 2006-01-13 | 2015-09-29 | Boston Scientific Scimed, Inc. | Placing fixation devices |
EP1991133B1 (en) | 2006-02-16 | 2018-10-24 | Boston Scientific Scimed, Inc. | Surgical articles for treating pelvic conditions |
WO2007137226A2 (en) | 2006-05-19 | 2007-11-29 | Ams Research Corporation | Method and articles for treatment of stress urinary incontinence |
WO2007146784A2 (en) | 2006-06-08 | 2007-12-21 | Ams Research Corporation | Method and apparatus for levator distension repair |
WO2007149348A2 (en) * | 2006-06-16 | 2007-12-27 | Ams Research Corporation | Surgical implants and tools for treating pelvic conditions |
US20090259092A1 (en) * | 2006-06-22 | 2009-10-15 | Ogdahl Jason W | Adjustable Sling and Method of Treating Pelvic Conditions |
WO2007149555A2 (en) * | 2006-06-22 | 2007-12-27 | Ams Research Corporation | Adjustable tension incontinence sling assemblies |
US7828715B2 (en) | 2006-06-29 | 2010-11-09 | Ams Research Corporation | Method of treating anal incontinence |
CA2653253C (en) * | 2006-07-25 | 2014-03-18 | Ams Research Corporation | Surgical articles and methods for treating pelvic conditions |
BRPI0718177A2 (en) * | 2006-10-26 | 2013-12-17 | Ams Res Corp | PELVIC IMPLANT, KIT, AND, METHOD TO USE THE SAME. |
JP5443990B2 (en) | 2006-10-26 | 2014-03-19 | エーエムエス リサーチ コーポレイション | Surgical supplies and methods for treating pelvic conditions |
AU2008236731B2 (en) | 2007-04-04 | 2013-09-19 | Ajay Rane | Kit for levator avulsion repair |
CN101801310B (en) | 2007-06-29 | 2013-10-30 | Ams研究公司 | Surgical articles and methods for treating pelvic conditions |
KR101494190B1 (en) | 2007-07-27 | 2015-02-17 | 에이엠에스 리서치 코포레이션 | Pelvic floor treatments and related tools and implants |
AU2009200974B2 (en) * | 2008-03-14 | 2014-06-12 | Ams Research Corporation | Apparatus and method for repairing vaginal reconstruction |
TWI481196B (en) * | 2008-12-31 | 2015-04-11 | Ind Tech Res Inst | Bioelectricity signal sensing apparatus and device for canceling baseline drift in bioelectricity signal |
-
2007
- 2007-06-22 WO PCT/US2007/014553 patent/WO2007149555A2/en active Application Filing
- 2007-06-22 CA CA2654294A patent/CA2654294C/en not_active Expired - Fee Related
- 2007-06-22 US US12/308,598 patent/US8628463B2/en not_active Expired - Fee Related
- 2007-06-22 JP JP2009516595A patent/JP2009540937A/en not_active Withdrawn
- 2007-06-22 US US12/305,874 patent/US8460169B2/en active Active
- 2007-06-22 CA CA2936752A patent/CA2936752A1/en not_active Abandoned
- 2007-06-22 BR BRPI0712370-1A patent/BRPI0712370A2/en not_active Application Discontinuation
- 2007-06-22 WO PCT/US2007/014780 patent/WO2007149593A2/en active Application Filing
- 2007-06-22 AU AU2007261254A patent/AU2007261254B2/en not_active Ceased
- 2007-06-22 EP EP07809886A patent/EP2049039A2/en not_active Withdrawn
- 2007-06-22 KR KR1020097000386A patent/KR101424564B1/en active IP Right Grant
-
2013
- 2013-07-04 JP JP2013140972A patent/JP2013240606A/en active Pending
-
2014
- 2014-01-13 US US14/153,717 patent/US9375302B2/en not_active Expired - Fee Related
-
2016
- 2016-06-24 US US15/191,920 patent/US10441400B2/en not_active Expired - Fee Related
Cited By (173)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10278800B2 (en) | 2000-07-05 | 2019-05-07 | Coloplast A/S | Method and device for treating urinary incontinence |
US8920304B2 (en) | 2000-07-05 | 2014-12-30 | Coloplast A/S | Method and device for treating urinary incontinence |
US8454492B2 (en) | 2000-10-12 | 2013-06-04 | Coloplast A/S | Absorbable anchor and method for mounting mesh to tissue |
US8449450B2 (en) | 2000-10-12 | 2013-05-28 | Coloplast A/S | Pass through introducer and sling |
US8932202B2 (en) | 2000-10-12 | 2015-01-13 | Coloplast A/S | Incontinence implant with soft tissue anchors and length not allowing abdominal wall penetration |
US8920308B2 (en) | 2000-10-12 | 2014-12-30 | Coloplast A/S | Surgical implant with anchor introducer channel |
US10449025B2 (en) | 2000-10-12 | 2019-10-22 | Coloplast A/S | Surgical device implantable to treat female urinary incontinence |
US8911347B2 (en) | 2000-10-12 | 2014-12-16 | Coloplast A/S | System and method for treating urinary incontinence |
US8888678B2 (en) | 2000-10-12 | 2014-11-18 | Coloplast A/S | Pelvic implant with suspending system |
US9089394B2 (en) | 2000-10-12 | 2015-07-28 | Coloplast A/S | Pelvic implant with suspending system |
US8852075B2 (en) | 2000-10-12 | 2014-10-07 | Coloplast A/S | Pelvic implant systems and methods with expandable anchors |
US10076394B2 (en) | 2000-10-12 | 2018-09-18 | Coloplast A/S | Method of treating urinary incontinence |
US8821369B2 (en) | 2000-10-12 | 2014-09-02 | Colorplast A/S | Method for soft tissue anchoring with introducer |
US8821370B2 (en) | 2000-10-12 | 2014-09-02 | Coloplast A/S | Device, system and methods for introducing soft tissue anchors |
US9089396B2 (en) | 2000-10-12 | 2015-07-28 | Coloplast A/S | Urinary incontinence treatment and devices |
US8801596B2 (en) | 2000-10-12 | 2014-08-12 | Coloplast A/S | Sling with support and suspending members formed from same polymer |
US8118728B2 (en) | 2000-10-12 | 2012-02-21 | Coloplast A/S | Method for implanting an adjustable surgical implant for treating urinary incontinence |
US8123673B2 (en) | 2000-10-12 | 2012-02-28 | Coloplast A/S | Adjustable surgical implant for treating urinary incontinence |
US8128554B2 (en) | 2000-10-12 | 2012-03-06 | Coloplast A/S | System for introducing a pelvic implant |
US9113992B2 (en) | 2000-10-12 | 2015-08-25 | Coloplast A/S | Apparatus and method for treating urinary incontinence |
US8668635B2 (en) | 2000-10-12 | 2014-03-11 | Coloplast A/S | Pelvic implant with suspending system |
US8162818B2 (en) | 2000-10-12 | 2012-04-24 | Coloplast A/S | Adjustable surgical implant for pelvic anatomy |
US8182413B2 (en) | 2000-10-12 | 2012-05-22 | Coloplast A/S | Method for fibrous anchoring of a pelvic support |
US8182412B2 (en) | 2000-10-12 | 2012-05-22 | Coloplast A/S | Pelvic implant with fibrous anchor |
US8512223B2 (en) | 2000-10-12 | 2013-08-20 | Coloplast A/S | Pelvic implant with selective locking anchor |
US9968430B2 (en) | 2000-10-12 | 2018-05-15 | Coloplast A/S | Surgical device implantable to treat female urinary incontinence |
US8469877B2 (en) | 2000-10-12 | 2013-06-25 | Coloplast A/S | System for introducing a pelvic implant |
US8273011B2 (en) | 2000-10-12 | 2012-09-25 | Coloplast A/S | Adjustable surgical implant and method for treating urinary incontinence |
US8118727B2 (en) | 2000-10-12 | 2012-02-21 | Coloplast A/S | Method for supporting pelvic anatomy |
US8574148B2 (en) | 2000-10-12 | 2013-11-05 | Coloplast A/S | System for introducing soft tissue anchors |
US9918817B2 (en) | 2000-10-12 | 2018-03-20 | Coloplast A/S | Method of post-operatively adjusting a urethral support in treating urinary incontinence of a woman |
US8157821B2 (en) | 2001-03-30 | 2012-04-17 | Coloplast A/S | Surgical implant |
US10682213B2 (en) | 2001-03-30 | 2020-06-16 | Coloplast A/S | Surgical implant consisting of non-absorbable material |
US9248011B2 (en) | 2001-03-30 | 2016-02-02 | Coloplast A/S | Surgical implant and methods of use |
US8100924B2 (en) | 2001-03-30 | 2012-01-24 | Coloplast A/S | Surgical implant |
US9943390B2 (en) | 2001-03-30 | 2018-04-17 | Coloplast A/S | Method of treating pelvic organ prolapse in a female patient by accessing a prolapsed organ trans-vaginally through a vagina |
US8603119B2 (en) | 2001-03-30 | 2013-12-10 | Coloplast A/S | Surgical implant having strands and methods of use |
US8603120B2 (en) | 2001-03-30 | 2013-12-10 | Coloplast A/S | Low mass density surgical implant and methods of use |
US8632554B2 (en) | 2001-03-30 | 2014-01-21 | Coloplast A/S | Low mass density surgical implant having strands and methods of use |
US8157822B2 (en) | 2001-03-30 | 2012-04-17 | Coloplast A/S | Surgical implant and methods of use |
US9532862B2 (en) | 2002-08-02 | 2017-01-03 | Coloplast A/S | Self-anchoring sling and introducer system |
US9005222B2 (en) | 2002-08-02 | 2015-04-14 | Coloplast A/S | Self-anchoring sling and introducer system |
US9532861B2 (en) | 2002-08-02 | 2017-01-03 | Coloplast A/S | Self-anchoring sling and introducer system |
US9872750B2 (en) | 2002-08-02 | 2018-01-23 | Coloplast A/S | Self-anchoring sling and introducer system |
US9186489B2 (en) | 2003-03-27 | 2015-11-17 | Coloplast A/S | Implantable delivery device system for delivery of a medicament to a bladder |
US9345867B2 (en) | 2003-03-27 | 2016-05-24 | Coloplast A/S | Device implantable in tissue of a prostate gland or a bladder |
US8709471B2 (en) | 2003-03-27 | 2014-04-29 | Coloplast A/S | Medicament delivery device and a method of medicament delivery |
US9555168B2 (en) | 2003-03-27 | 2017-01-31 | Coloplast A/S | System for delivery of medication in treatment of disorders of the pelvis |
US8215310B2 (en) | 2004-05-21 | 2012-07-10 | Coloplast A/S | Implant for treatment of vaginal and/or uterine prolapse |
US10064714B2 (en) | 2004-05-21 | 2018-09-04 | Coloplast A/S | Implantable device configured to treat pelvic organ prolapse |
US9060838B2 (en) | 2004-05-21 | 2015-06-23 | Coloplast A/S | Tissue supported implantable device |
US9283064B2 (en) | 2005-07-26 | 2016-03-15 | Ams Research Corporation | Methods and systems for treatment of prolapse |
US8535217B2 (en) | 2005-07-26 | 2013-09-17 | Ams Research Corporation | Methods and systems for treatment of prolapse |
US9060839B2 (en) | 2005-07-26 | 2015-06-23 | Ams Research Corporation | Methods and systems for treatment of prolapse |
US9144426B2 (en) | 2006-02-16 | 2015-09-29 | Ams Research Corporation | Surgical articles and methods for treating pelvic conditions |
US10105160B2 (en) | 2006-02-16 | 2018-10-23 | Boston Scientific Scimed, Inc. | Surgical articles and methods for treating pelvic conditions |
US9084664B2 (en) | 2006-05-19 | 2015-07-21 | Ams Research Corporation | Method and articles for treatment of stress urinary incontinence |
US8834350B2 (en) | 2006-06-16 | 2014-09-16 | Ams Research Corporation | Surgical implants, tools, and methods for treating pelvic conditions |
US10271936B2 (en) | 2006-06-16 | 2019-04-30 | Boston Scientific Scimed, Inc. | Surgical implants, tools, and methods for treating pelvic conditions |
US8460169B2 (en) | 2006-06-22 | 2013-06-11 | Ams Research Corporation | Adjustable tension incontinence sling assemblies |
US10441400B2 (en) | 2006-06-22 | 2019-10-15 | Boston Scientific Scimed, Inc. | Adjustable tension incontinence sling assembles |
US8628463B2 (en) | 2006-06-22 | 2014-01-14 | Ams Research Corporation | Adjustable tension incontinence sling assemblies |
US9375302B2 (en) | 2006-06-22 | 2016-06-28 | Astora Women's Health, Llc | Adjustable tension incontinence sling assemblies |
US10039661B2 (en) | 2006-10-20 | 2018-08-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11234849B2 (en) | 2006-10-20 | 2022-02-01 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11672684B2 (en) | 2006-10-20 | 2023-06-13 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
EP2001398B1 (en) * | 2007-03-07 | 2010-05-26 | Assut Europe S.P.A. | Prosthesis for the treatment of urinary incontinence |
US11207165B2 (en) | 2007-06-29 | 2021-12-28 | Boston Scientific Scimed, Inc. | Surgical articles and methods for treating pelvic conditions |
US9974636B2 (en) | 2007-06-29 | 2018-05-22 | Boston Scientific Scimed, Inc. | Surgical articles and methods for treating pelvic conditions |
EP2510903A3 (en) * | 2007-06-29 | 2012-12-05 | AMS Research Corporation | Non-continuous pelvic implant |
US8597173B2 (en) | 2007-07-27 | 2013-12-03 | Ams Research Corporation | Pelvic floor treatments and related tools and implants |
WO2009017680A3 (en) * | 2007-07-27 | 2009-03-19 | Ams Res Corp | Pelvic floor treatments and related tools and implants |
WO2009017680A2 (en) * | 2007-07-27 | 2009-02-05 | Ams Research Corporation | Pelvic floor treatments and related tools and implants |
US10022210B2 (en) | 2007-07-27 | 2018-07-17 | Boston Scientific Scimed, Inc. | Pelvic floor treatments and related tools and implants |
US8961448B2 (en) | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
US9060771B2 (en) | 2008-01-29 | 2015-06-23 | Peter Forsell | Method and instrument for treating obesity |
US10639138B2 (en) | 2008-02-28 | 2020-05-05 | Coloplast A/S | Method for providing support to a urethra in treating urinary incontinence |
WO2009106878A1 (en) | 2008-02-28 | 2009-09-03 | Gyne Ideas Limited | Urethral support system |
US9022922B2 (en) | 2008-07-31 | 2015-05-05 | Ams Research Corporation | Methods and implants for treating urinary incontinence |
US10039628B2 (en) | 2008-07-31 | 2018-08-07 | L. Dean Knoll | Methods and implants for treating urinary incontinence |
US8727963B2 (en) | 2008-07-31 | 2014-05-20 | Ams Research Corporation | Methods and implants for treating urinary incontinence |
US9918816B2 (en) | 2008-08-25 | 2018-03-20 | Boston Scientific Scimed, Inc. | Minimally invasive implant and method |
US11547542B2 (en) | 2008-08-25 | 2023-01-10 | Boston Scientific Scimed, Inc. | Minimally invasive implant and method |
US9017243B2 (en) | 2008-08-25 | 2015-04-28 | Ams Research Corporation | Minimally invasive implant and method |
US10537416B2 (en) | 2008-08-25 | 2020-01-21 | Boston Scientific Scimed, Inc. | Minimally invasive implant and method |
US9072907B2 (en) | 2008-10-10 | 2015-07-07 | Peter Forsell | Heart help device, system, and method |
US10583234B2 (en) | 2008-10-10 | 2020-03-10 | Peter Forsell | Heart help device, system and method |
US11123171B2 (en) | 2008-10-10 | 2021-09-21 | Peter Forsell | Fastening means for implantable medical control assembly |
US10219898B2 (en) | 2008-10-10 | 2019-03-05 | Peter Forsell | Artificial valve |
WO2010042010A1 (en) * | 2008-10-10 | 2010-04-15 | Milux Holding Sa | Variable sling for urinary incontinence |
EP4091579A1 (en) * | 2008-10-10 | 2022-11-23 | Implantica Patent Ltd. | Variable sling for urinary incontinence |
US8874215B2 (en) | 2008-10-10 | 2014-10-28 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
US9370656B2 (en) | 2008-10-10 | 2016-06-21 | Peter Forsell | System, an apparatus, and a method for treating a sexual dysfunctional female patient |
EP2346438A4 (en) * | 2008-10-10 | 2017-01-25 | Kirk Promotion LTD. | Variable sling for urinary incontinence |
US9526649B2 (en) | 2008-10-10 | 2016-12-27 | Peter Forsell | Method and instrument for treating obesity |
US11628053B2 (en) | 2008-10-10 | 2023-04-18 | Peter Forsell | Variable sling for urinary continence |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US9370363B2 (en) | 2009-02-05 | 2016-06-21 | Coloplast A/S | Anchor assembly for an implantable, pelvic support device |
US9615904B2 (en) | 2009-02-05 | 2017-04-11 | Coloplast A/S | Sacrocolpopexy support |
US8585578B2 (en) | 2009-02-05 | 2013-11-19 | Coloplast A/S | Implantable devices, tools and methods for anatomical support |
WO2010088917A1 (en) * | 2009-02-05 | 2010-08-12 | Coloplast A/S | Implantable devices, tools and methods for anatomical support |
EP2400920A1 (en) * | 2009-02-25 | 2012-01-04 | MIS Solutions, Inc. | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
AU2010217963B2 (en) * | 2009-02-25 | 2013-10-17 | FreeHold Surgical, LLC | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
US8251889B2 (en) | 2009-02-25 | 2012-08-28 | Mis Solutions, Inc. | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
WO2010099327A1 (en) * | 2009-02-25 | 2010-09-02 | Scott J Stephen | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
EP2400920A4 (en) * | 2009-02-25 | 2013-07-17 | Mis Solutions Inc | Apparatus and method for intra-abdominally moving a first internal organ to a position away from a second internal organ and then holding the first internal organ in the position without manual input |
US8430826B2 (en) | 2009-03-04 | 2013-04-30 | Covidien Lp | Specimen retrieval apparatus |
EP2700383A1 (en) * | 2009-06-08 | 2014-02-26 | Coloplast A/S | Anatomical augmentation device |
US8617050B2 (en) | 2009-06-08 | 2013-12-31 | Coloplast A/S | Anatomical augmentation device |
WO2010142294A1 (en) * | 2009-06-08 | 2010-12-16 | Coloplast A/S | Anatomical augmentation device |
US10952836B2 (en) | 2009-07-17 | 2021-03-23 | Peter Forsell | Vaginal operation method for the treatment of urinary incontinence in women |
US9949812B2 (en) | 2009-07-17 | 2018-04-24 | Peter Forsell | Vaginal operation method for the treatment of anal incontinence in women |
EP2308383A3 (en) * | 2009-10-09 | 2012-01-18 | Tyco Healthcare Group LP | Internal retractor systems |
EP2308383A2 (en) * | 2009-10-09 | 2011-04-13 | Tyco Healthcare Group LP | Internal retractor systems |
WO2011060788A1 (en) * | 2009-11-19 | 2011-05-26 | Coloplast A/S | Implantable anatomical support |
US20130109910A1 (en) * | 2009-12-30 | 2013-05-02 | James A. Alexander | Systems, implants, tools, and methods for treatments of pelvic conditions |
US10045842B2 (en) | 2009-12-30 | 2018-08-14 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
AU2010339436B2 (en) * | 2009-12-30 | 2015-01-15 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US9364308B2 (en) | 2009-12-30 | 2016-06-14 | Astora Women's Health, Llc | Implant systems with tensioning feedback |
WO2011150938A1 (en) | 2010-06-03 | 2011-12-08 | Coloplast A/S | Sacrocolpopexy support and method of implantation |
US8720446B2 (en) | 2010-06-04 | 2014-05-13 | Coloplast A/S | Sacrocolpopexy support and method of implantation |
WO2011157274A1 (en) | 2010-06-14 | 2011-12-22 | Coloplast A/S | Incontinence treatment device and method of treating incontinence |
EP3028667A1 (en) * | 2010-06-14 | 2016-06-08 | Coloplast A/S | Incontinence treatment device |
US8273010B2 (en) | 2010-06-14 | 2012-09-25 | Coloplast A/S | Incontinence treatment device |
US8550979B2 (en) | 2010-06-15 | 2013-10-08 | Coloplast A/S | Method of treating incontinence |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10028813B2 (en) | 2010-07-22 | 2018-07-24 | Boston Scientific Scimed, Inc. | Coated pelvic implant device and method |
US9968346B2 (en) | 2010-09-29 | 2018-05-15 | Boston Scientific Scimed, Inc. | Systems, tools, and methods for treatments of pelvic conditions |
US9949814B2 (en) | 2010-09-29 | 2018-04-24 | Boston Scientific Scimed, Inc. | Systems, tools, and methods for treatments of pelvic conditions |
US9572648B2 (en) | 2010-12-21 | 2017-02-21 | Justin M. Crank | Implantable slings and anchor systems |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US9233238B2 (en) | 2011-02-23 | 2016-01-12 | Ams Research Corporation | Drug releasing pelvic treatment system and method |
US10272235B2 (en) | 2011-02-23 | 2019-04-30 | Boston Scientific Scimed, Inc. | Drug releasing pelvic treatment system and method |
US9125717B2 (en) | 2011-02-23 | 2015-09-08 | Ams Research Corporation | Implant tension adjustment system and method |
US9750590B2 (en) | 2011-03-28 | 2017-09-05 | Andrew P. VanDeWeghe | Implants, tools, and methods for treatment of pelvic conditions |
US10039629B2 (en) | 2011-03-28 | 2018-08-07 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatment of pelvic conditions |
US20120253107A1 (en) * | 2011-03-28 | 2012-10-04 | Gindele Paul J | Implants, tools, and methods for treatment of pelvic conditions |
US8808162B2 (en) * | 2011-03-28 | 2014-08-19 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
US9089393B2 (en) | 2011-03-28 | 2015-07-28 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
US9737388B2 (en) | 2011-03-28 | 2017-08-22 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
US9179992B2 (en) | 2011-03-28 | 2015-11-10 | Ams Research Corporation | Implants, tools, and methods for treatment of pelvic conditions |
US9492259B2 (en) | 2011-03-30 | 2016-11-15 | Astora Women's Health, Llc | Expandable implant system |
US9782245B2 (en) | 2011-03-30 | 2017-10-10 | James R. Mujwid | Implants, tools, and methods for treatment of pelvic conditions |
US10058240B2 (en) | 2011-06-29 | 2018-08-28 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US20130006049A1 (en) * | 2011-06-30 | 2013-01-03 | Alexander James A | Implants, tools, and methods for treatments of pelvic conditions |
US10500027B2 (en) | 2011-06-30 | 2019-12-10 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatments of pelvic conditions |
US9351723B2 (en) | 2011-06-30 | 2016-05-31 | Astora Women's Health, Llc | Implants, tools, and methods for treatments of pelvic conditions |
US10653411B2 (en) | 2011-06-30 | 2020-05-19 | Boston Scientific Scimed, Inc. | Implants, tools, and methods for treatments of pelvic conditions |
US11284983B2 (en) | 2011-07-22 | 2022-03-29 | Boston Scientific Scimed, Inc. | Pelvic implant system and method |
US9414903B2 (en) | 2011-07-22 | 2016-08-16 | Astora Women's Health, Llc | Pelvic implant system and method |
US9492191B2 (en) | 2011-08-04 | 2016-11-15 | Astora Women's Health, Llc | Tools and methods for treatment of pelvic conditions |
US10390813B2 (en) | 2011-08-05 | 2019-08-27 | Boston Scientific Scimed, Inc. | Systems, implants, tools, and methods for treatments of pelvic conditions |
US10098721B2 (en) | 2011-09-01 | 2018-10-16 | Boston Scientific Scimed, Inc. | Pelvic implant needle system and method |
USD721807S1 (en) | 2011-09-08 | 2015-01-27 | Ams Research Corporation | Surgical indicators |
USD721175S1 (en) | 2011-09-08 | 2015-01-13 | Ams Research Corporation | Backers for surgical indicators |
USD746462S1 (en) | 2011-09-08 | 2015-12-29 | Ams Research Corporation | Surgical indicators |
USD736382S1 (en) | 2011-09-08 | 2015-08-11 | Ams Research Corporation | Surgical indicator with backers |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US11123107B2 (en) | 2011-11-01 | 2021-09-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11213330B2 (en) | 2012-10-29 | 2022-01-04 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US9480546B2 (en) | 2013-08-05 | 2016-11-01 | Coloplast A/S | Hysteropexy mesh apparatuses and methods |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US12076051B2 (en) | 2015-02-19 | 2024-09-03 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
FR3047408A1 (en) * | 2016-02-09 | 2017-08-11 | Cl Medical | DEVICE FOR TREATING URINARY INCONTINENCE OF EFFORT IN A HUMAN PATIENT |
US10426586B2 (en) | 2017-01-16 | 2019-10-01 | Coloplast A/S | Sacrocolpopexy support |
WO2019058180A3 (en) * | 2017-09-25 | 2019-05-02 | Marian Devonec | Readjustable and reversible tensioning means for urinary incontinence |
Also Published As
Publication number | Publication date |
---|---|
US20100261950A1 (en) | 2010-10-14 |
AU2007261254B2 (en) | 2013-12-12 |
US8460169B2 (en) | 2013-06-11 |
CA2654294C (en) | 2016-09-20 |
KR101424564B1 (en) | 2014-08-06 |
WO2007149555A3 (en) | 2008-04-10 |
EP2049039A2 (en) | 2009-04-22 |
WO2007149593A3 (en) | 2008-05-22 |
JP2013240606A (en) | 2013-12-05 |
US8628463B2 (en) | 2014-01-14 |
BRPI0712370A2 (en) | 2012-06-12 |
WO2007149593A2 (en) | 2007-12-27 |
CA2654294A1 (en) | 2007-12-27 |
KR20090023470A (en) | 2009-03-04 |
CA2936752A1 (en) | 2007-12-27 |
US10441400B2 (en) | 2019-10-15 |
US20110124954A1 (en) | 2011-05-26 |
US20140128664A1 (en) | 2014-05-08 |
US20160302904A1 (en) | 2016-10-20 |
JP2009540937A (en) | 2009-11-26 |
US9375302B2 (en) | 2016-06-28 |
AU2007261254A1 (en) | 2007-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8460169B2 (en) | Adjustable tension incontinence sling assemblies | |
US9980801B2 (en) | Adjustable sling and method of treating pelvic conditions | |
US10792140B2 (en) | Partial cuff | |
US5507754A (en) | Apparatus and method for applying and adjusting an anchoring device | |
US7229404B2 (en) | Surgical prosthesis-forming device used to implant an organ support in a mammal | |
AU769863B2 (en) | Method and apparatus for adjusting flexible areal polymer implants | |
EP2242446B1 (en) | Partial cuff | |
US9492191B2 (en) | Tools and methods for treatment of pelvic conditions | |
US9433485B2 (en) | Implant tension adjustment system and method | |
US20100063351A1 (en) | System for surgical treatment of urinary incontinence and method of use | |
CA2659325A1 (en) | Suburethral hammock | |
CN104220025A (en) | Hydraulic urethral occlusive device | |
CN107645940A (en) | Hydraulic pressure Urethral occlusive devices | |
AU2014201320B2 (en) | Adjustable tension incontinence sling assemblies | |
AU2015234356A1 (en) | Adjustable tension incontinence sling assemblies | |
US20210161636A1 (en) | Stress urinary incontinence treatment medical implant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07796354 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07796354 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12305874 Country of ref document: US |